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EPIGENETICS HAS BEEN LAUDED AS THE PUTATIVE MECHANISM THROUGH
WHICH ‘NATURE AFFECTS NURTURE’. SUCH A MECHANISM COULD EXPLAIN
HOW EARLY STRESSFUL EXPERIENCES CAN HAVE MAJOR PSYCHOLOGICAL
CONSEQUENCES LATER IN LIFE.  AN OFTEN-STUDIED FORM OF EPIGENETICS IS 
DNA METHYLATION. HOWEVER, RESEARCH ON DNA METHYLATION IS TYPICALLY
LIMITED BY SMALL SAMPLE SIZES AS WELL AS CROSS-SECTIONAL STUDY
DESIGNS, WHICH MAKE IT DIFFICULT TO INTERPRET RESEARCH RESULTS WITHIN
A DEVELOPMENTAL FRAMEWORK. IN THE CURRENT THESIS, WE THEREFORE 
STUDIED DNA METHYLATION AND STRESS THROUGHOUT CHILD DEVELOPMENT
IN A POPULATION-BASED APPROACH.
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“Such gene–environment interactions could be explained by epigenetic effects..”1 is one 
of many similar statements in the Discussion section of research articles, aiming to explain 
associations between genetic variations, environment and psychosocial wellbeing, or lack 
thereof 2-18. Indeed, life events may affect small molecular structures on and around the 
DNA, thereby adding a layer of information on top of the genetic code itself and affecting 
gene functioning. An enticing example of the environment affecting the genetic functioning 
was given by Weaver, Szyf, and Meaney19. They categorized mother rats by the amount of 
caretaking they did for their pups, and saw epigenetic differences between pups that had 
received more versus less caretaking. These epigenetic differences coincided with higher 
stress reactivity in the pups who were less taken care of by their mother and ultimately, 
when the female pups became mothers themselves they showed less caretaking behavior. 
These findings could have major implications if similar processes can be identified in humans, 
since they may explain how stress can get ‘under the skin’, and, as the authors illustrated, 
they may explain transgenerational transmission of stress and associated psychopathology. 
Finding such epigenetic patterns associated with stress may ultimately help understand how 
to intervene before stress develops into psychopathology, or such patterns may be used as 
‘markers’ (biomarkers) to identify individuals exposed to stress, or sensitive to stressors. In 
the current thesis, we therefore set out to detect associations between DNA methylation 
and stress in a population-based sample of children.
Epigenetics
‘Epigenetics’ was first introduced as a term by Conrad Waddington, in 193920. He envisioned 
an ‘epigenetic landscape’ – which he portrayed as a mountainous landscape – formed by 
genes and ‘the chemical tendencies which the gene produce’, and affected by environmental 
stimuli. The developing organism – portrayed as a ball rolling down the ridges and valleys 
of the landscape – was envisioned to have its phenotype formed by this landscape21, 22. In 
present times, now that scientific advances have made it possible to measure the DNA 
structure and the chemical compounds around it, Waddington’s ‘epigenetic landscape’ does 
not seem far from reality.
Many different forms of epigenetics have been identified and generally they affect the 
accessibility of the genome to transcription. Our human chromosomes, the 23 pairs of DNA 
strands, are altogether about 2 meters long, but fit within a cell nucleus, which only has a 
diameter of about 10 µm23. This is possible because the chromosomes are coiled and tightly 
packed by proteins called histones. For a gene to be ‘read’ and turned into a functioning protein, 
the DNA structure needs to uncoil, activators need to attach to enhancers, transcription factors 
need to attach, the DNA structure needs to bend over, so that finally RNA polymerase can 
attach to the promoter of that gene, transcribe a copy of it, and translate it into a protein24 
(Figure 1). This is exactly the point at which epigenetics can alter gene functioning; by changing 
the three-dimensional structure of the DNA so that the gene becomes more or less accessible 
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to activators and/or RNA polymerase and can thereby be more or less transcribed. Known 
forms of epigenetics often have to do with modification of the histones around which the 
DNA is packed (e.g. histone acetylation, histone methylation, histone phosphorylation)25. 
Another form is DNA methylation, in which case a methyl group (one carbon atom with 
three hydrogen atoms) is attached directly to the DNA, on the phosphor bridge between a 
cytosine and guanine nucleotide (cytosine-phosphor-guanine site; CpG site). This is a more 
stable form of epigenetic modification and is most frequently studied. For example, when 
a methyl group is bound to a CpG site located on the promoter of a gene, it is thought that 
DNA methylation can block RNA polymerase, which would result in less transcribed protein 
from that gene26. DNA methylation, however, can also bind at other parts on or around the 
genes and there are also examples of DNA methylation íncreasing the transcription, or DNA 
methylation on one gene affecting the transcription of another gene, sometimes even on a 
different chromosome, probably due to changing the three-dimensional structure and the 
consequential alignment of different chromosomes27-29. With these characteristics, we know 
that DNA methylation affects basic developmental processes, such as cell differentiation30, 31, 
X-chromosomal inactivation32, and genome stability33. We further know that DNA methylation 
is influenced by the genes themselves34, as well as by environmental aspects, such as smoking35, 





36. Here we will try to specify whether we can measure associations between DNA methylation 
and stress exposure and–outcomes in children.
Measurement of epigenetics
In the example of the research on rats given above, DNA methylation was studied on the 
promoter of a single gene. Such an approach is often used with so-called candidate genes, 
genes that are suspected to be relevant for phenotype of interest. A candidate-gene approach 
can function as a ‘proof-of-principle’, showing that DNA methylation affects the functioning 
of a familiar gene. To be able to find novel biological pathways through epigenetic analyses, 
however, one needs to cast a wider net. In recent years, epigenome-wide array testing has 
become increasingly available. With epigenome-wide association studies (EWASs), one 
can measure DNA methylation at hundreds of thousands of CpG sites widespread over the 
genome. Here, we will use both candidate epigenetic research as well as epigenome-wide 
approaches to study DNA methylation in blood tissue. Further, while studies on animals 
or candidate-gene studies have shown a critical role of DNA methylation in development, 
changes in DNA methylation in blood during childhood are not well-characterized. This lack 
of knowledge is impeding interpretation of findings in current EWASs. As one of the goals of 
the current thesis, we aimed to form an encompassing epigenome-wide characterization of 
DNA methylation throughout development.
Stress
All people encounter stress, some more than others. Our body is adapted to deal with stress 
through the hypothalamic-pituitary-adrenal axis, or HPA axis. When a stressor occurs and 
this is registered in the brain, the hypothalamus produces corticotropin-releasing hormones, 
which signals to the pituitary to produce adrenocorticotropic hormone, and this in turn to the 
adrenal cortices to produce cortisol. Amongst others, cortisol helps activate the hippocampus to 
encode the event into a memory. When cortisol feeds back to the hippocampus, hypothalamus, 
and pituitary, it signals to reduce the production of corticotropin-releasing hormone and 
adrenocorticotropic hormone in a negative feedback loop37. Cortisol levels vary throughout the 
day, are related to the sleep-wake cycle, and variations in cortisol facilitate the consolidation 
of memories in the hippocampus during sleep38, 39. Because DNA methylation might impact 
the genetic expression of cortisol or related hormones, we will study sleep in association 
with DNA methylation.
It is thought that childhood experiences can have long-term effects on HPA axis functioning. 
Early family experiences and attachments to the parents are important in the development of 
the child’s cognition representation of how safe the world is, and how to deal with stressors40, 
41. When children start moving into adolescence, peers take on a more formative role in their 
development42. We will therefore study attachment and stress within the family setting in 




In this thesis, we will study associations between stress and DNA methylation in the developing 
child.
Setting
The main study population in the current thesis are the children in the Generation R Study. As 
part of this study, pregnant women residing in Rotterdam, the Netherlands, with an expected 
delivery date between April 2002 and January 2006 were invited to enroll43. Children of the 
Generation R Study are ethnically diverse, DNA methylation was however measured in a 
subsample of children, all of which have parents born in the Netherlands. DNA methylation was 
measured in these children at birth, 6 years, and 10 years. Further, hands-on measurements, 
such as parent-child observations and sleep measures, were also conducted in a subsample of 
children with parents born in the Netherlands. Two studies in this thesis additionally make use 
of data from the Avon Longitudinal Study of Parents and Children (ALSPAC). Here, pregnant 
women residing in the study area of former county Avon, in the United Kingdom, with an 
expected delivery date between April 1991 and December 1992 were invited to enroll44, 45. 
In a subsample of children, DNA methylation was taken at birth, 7 years, and 17 years of age.
Outline
We will start this thesis by giving an overview of current literature on DNA methylation and 
stress in the family in Chapter II. Here, we will highlight several shortcomings in these previous 
studies, such as the use of small sample sizes, a lack of effort to replicate results, and a lack 
of knowledge on longitudinal characteristics of DNA methylation, which are issues that we 
try to address in the following Chapters. In Chapter III, we will perform a proof of principle, 
studying if DNA methylation of a single candidate gene previously shown to be involved in 
HPA functioning also in our data, affects cortisol reactivity. From Chapter IV onwards, we 
will extend our approach towards the whole genome to examine if maternal sensitivity is 
associated with DNA methylation and, in another study, with sleep. Subsequently, we will 
study the associations of interpersonal stress in Chapter V and VI . In Chapter V, we will present 
our application of a social exclusion paradigm and a new method of micro-coding facial 
expressions, showing how stressful social exclusion can be. In Chapter VI, using a longitudinal 
design we will study if bullying is related to change in DNA methylation, both in children of 
Generation R as well as in children of ALSPAC. Since epigenome-wide longitudinal studies 
are becoming more prevalent, but basic information on which methylated CpGs change is 
currently lacking, in our final study in Chapter VII we will detail the epigenome-wide change 
from birth to late adolescence. This again is a study with participants from Generation R and 
ALSPAC. Finally, in Chapter VIII, we will discuss our findings on DNA methylation and stress 
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In this Chapter, we provide an overview of empirical studies evaluating the role of 
epigenetics in mediating the association between parenting stress and adverse child 
development. We focus on DNA methylation, as this epigenetic mechanism is most often 
studied in humans. Here, parenting stress will be defined as including both prenatal stressors 
(e.g. maternal psychopathology during pregnancy) as well as postnatal maladaptive 
parenting (e.g. harsh discipline). We define adverse child development in terms of 
biological (e.g. cortisol reactivity, brain morphology), as well as psychological outcomes.
Most epigenetic research focuses on either the association between parenting stress and 
DNA methylation or on the association between DNA methylation and child outcomes. In 
the current Chapter, we emphasize the mediation of the association between parenting 
stress and adverse child outcomes via epigenetics. We conclude with some caveats that 
should be considered when conducting or reading epigenetic studies on parenting and 




In the contemporary version of the nature versus nurture debate it is taken for granted that the 
(parental) environment as well as the genetic make-up determine the behavior of a developing 
child, with the child’s genome being differentially open to environmental influences. For 
example, in their ground-breaking gene-by-environment (G × E) study, Caspi et al.1 found that 
individuals who had experienced stressful life events were more often depressed when they 
carried one or two short alleles of the serotonin transporter gene (5-HTT or SLC6A4) in the 
serotonin-transporter-linked polymorphic region (5-HTTLPR). Likewise, in a first randomized 
controlled G × E trial, Bakermans-Kranenburg et al.2 showed that changing sensitive parenting 
and limit setting only influenced the externalizing behavior if the child was a carrier of the 
dopamine D4 receptor (DRD4) 7-repeat allele.
However, in G × E studies it remains unknown where and how genetics and the environment 
exactly interact. The field of epigenetics might suture this gap between nature and nurture3. 
‘Epigenetics’ is a term coined by the embryologist Conrad Waddington4, 5, who used it to 
describe the interplay of genes and external cues in the development of the omnipotent cell 
into a fully specialized one. A related term, epigenesis, was later used by Gilbert Gottlieb to 
emphasize how variation in the DNA does not simply lead to variation in functioning proteins 
in a one-to-one fashion, but rather contributes in a bidirectional manner with several layers 
to the developmental system, going from the genetic level, via the neural and behavior level 
all the way to the environmental level6. Indeed, with modern lab technologies, different 
epigenetic mechanisms have been identified through which the environment can get ‘under 
the skin’ and act upon genetic variation to affect the transcriptional and translational processes 
to form genes’ main product: proteins.
One of these epigenetic mechanisms is DNA methylation, involving a methyl group (CH3) that 
attaches to the cytosine nucleotide in the DNA, in places where the cytosine nucleotide is 
situated alongside a guanine nucleotide, connected via a phosphate bridge (hence cytosine-
phosphate-guanine site, or CpG site)7, 8. The human genome has millions of CpG sites where a 
methyl group might be attached, which has been found to affect the three-dimensional DNA 
formation so that it may hinder or facilitate transcription of the DNA9. Other mechanisms work 
at the level of the histones, proteins around which the chromatin is packaged. Examples would 
be histone acetylation, or histone methylation10, 11. Again, these histone-based mechanisms 
change the accessibility of the gene for transcriptional processes. Epigenetic mechanisms 
might also take place further into the translational process, for example, in the form of small 
non-coding RNA, which can affect splicing variants12.
Since DNA methylation takes place through the covalent binding of the methyl group to the 
cytosine nucleotide, this is the most physically stable form of epigenetics and most likely to 
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survive the chemical treatment that takes place in the lab. Therefore, it is the most frequently 
studied form of epigenetics. It has been shown that DNA methylation indeed makes the genome 
more dynamic and is involved, as postulated by Waddington, in cell differentiation13, 14, as well 
as in X-chromosomal inactivation in female mammals15, 16 and in aberrant cell functioning such 
as cancer17. The downstream effects of DNA methylation are complex: it might functionally 
silence a gene by decreasing its accessibility by DNA polymerase, promote gene transcription 
by increasing its accessibility but could also, for example, indirectly affect transcription of 
genes by altering accessibility of distal regulatory regions such as enhancers or silencers18, 19.
Importantly, it seems that DNA methylation can be affected by life events. In a series of 
experiments on rodents, Weaver and colleagues showed that early life stress, for example 
maternal separation, is related to altered stress reactivity in the adult offspring, and that this 
effect seemed to be mediated by methylation of the promoter of the glucocorticoid receptor 
gene (NR3C1 or GR) in the hippocampus20. The binding of corticosterone (rodents) or cortisol 
(humans) to the glucocorticoid receptors causes negative feedback to the hypothalamic-
pituitary-adrenal axis (HPA-axis) and is necessary to control stress reactivity. Intriguingly, 
the results of Weaver, Szyf and Meaney imply not only that DNA methylation is affected by 
life events, but also that it could influence gene transcription to the extent that it changes 
behavior into adulthood. Moreover, Weaver et al.21 showed that normal variation in maternal 
caretaking, as measured by the amount of licking and grooming, could alter methylation of 
the NR3C1 promoter.
In humans, it has also been shown that major life events can modify outcomes in later life, 
possibly via DNA methylation. Examples can be found in the Dutch Hunger Winter Families 
Studies22, which focused on offspring conceived in the winter of 1944-45 during the Second 
World War, a period in which food was extremely scarce and starvation ubiquitous. In these 
studies, it was found that fetuses who were exposed to famine in the first trimester after 
conception had less methylation of the insulin-like growth factor II gene (IGF2)23, resulting in 
lower birth weights, and LDL cholesterol24 in adulthood.
In this Chapter, we examine whether DNA methylation mediates the relation between parenting 
stress and child development. Parenting stress is typically indicated by the recording of actual 
stressors, of parental psychological affliction such as depression or anxiety, and/or of a history 
of abuse in the child. Such stress might occur during pregnancy, as well as postnatally. Child 
development may be operationalized as psychological, hormonal, or neurological development. 
Importantly, throughout the Chapter, several methodological issues will be touched upon as 
behavioral epigenetics is an emerging field facing a large number of problems and pitfalls.
In the following section, we review studies on the association between parenting stress 
and DNA methylation, prenatally and postnatally. Effects of DNA methylation cannot be 
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separated from the genes they act upon, and we will elaborate on such epi-allelic interactions. 
Subsequently, we consider research on the association between DNA methylation and adverse 
child development, with a special emphasis on the mediation of the association between 
parenting stress and child development via epigenetics. In a final discussion section, we 
summarize our findings, and address some caveats.
Epigenetic Signatures as Biomarkers of Exposure
Candidate Epi-Gene Approaches
Adversities and related stress (e.g., maternal depression and anxiety in the prenatal period) 
have been suggested to affect epigenetic patterns in the neonate, and differences in epigenetic 
signatures have been speculated to be markers of prenatal programming for postnatal 
life circumstances (see also Neuenschwander and Oberlander25), in accordance with the 
Barker hypothesis26. Several studies examined the association between prenatal stress and 
methylation state of the NR3C1 promotor region of the offspring. NR3C1 has been found to 
co-regulate secretion and re-uptake of cortisol and might thus be important for regulation 
of stress. In a ground-breaking study building on earlier work by Weaver and colleagues21 
on rodents, McGowan et al.27 investigated the postmortem hippocampal brain tissues of 
male suicide victims with (n = 12) and without (n = 12) a history of child abuse and those of 
matched controls who died in car accidents (n = 12). They found that suicide victims with 
a history of child abuse had less GR expression and more methylation of NR3C1 than did 
suicide victims without a history of child abuse or controls, whereas no significant difference 
was found between suicide victims without a history of abuse and controls. Specifically, DNA 
hypermethylation was found in 3 out of 38 measured CpG sites. Moreover, it was found that 
within the group of suicide victims with child abuse, more DNA methylation was associated 
with less GR messenger RNA, as well as less GR messenger RNA overall (messenger RNA 
triggers the production of associated proteins downstream). These findings indicate that 
childhood abuse is related to DNA methylation, which decreases NR3C1 transcription. This 
might lead to aberrant HPA-axis functioning and dysfunctional stress regulation, rendering 
the affected individual more susceptible to the development of psychopathologies such as 
depression and anxiety, ultimately increasing the risk of suicide.
DNA methylation might also be a mechanism through which the intergenerational transmission 
of stress dysregulation takes place (see also Mileva-Seitz and Fleming28). This hypothesis was 
tested by Yehuda et al.29, who examined NR3C1 promoter methylation in a sample of adult 
offspring (without PTSD) with at least one Holocaust survivor parent (with or without PTSD) 
(n=80) and demographically matched participants without parental Holocaust exposure or 
PTSD (n=15). Yehuda et al.29 found an interaction between maternal and paternal PTSD in 
the prediction of offspring NR3C1 promoter methylation. Specifically, only in the absence 
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of maternal PTSD, offspring exposed to paternal PTSD had higher levels of NR3C1 promoter 
methylation. Offspring exposed to both maternal and paternal PTSD showed lower levels of 
NR3C1 promoter methylation. Interestingly, NR3C1 promoter methylation negatively correlated 
with NR3C1 expression. Furthermore, stronger cortisol suppression was related to lower DNA 
methylation. Replication of the rather complicated interactions in a relatively small sample is 
of course needed, and the results should be considered potentially fruitful hypotheses about 
the biological underpinnings of the intergenerational transmission of posttraumatic stress.
Thus far, we primarily discussed the association between postnatal parental stress and DNA 
methylation in the child. It is theorized however, that prenatal parenting, may it be through 
the intake of harmful agents or through psychological stress, can have a lasting harmful 
impact on the child30, 31. Below, we discuss two studies on how prenatal psychological stress 
may affect NR3C1 methylation.
In a study of 83 pregnant women, Hompes et al.32, 33 assessed maternal stress each trimester 
and found it to be significantly associated with methylation of one specific CpG site of the 
NR3C1 promoter in the cord blood of their newborns. Also, several dimensions of pregnant 
women’s anxiety about their impending delivery predicted methylation of various CpG sites of 
the nerve growth factor inducible protein A (NGFI-A) binding sites of NR3C132. The study was 
meant to replicate the earlier results of a pioneering study by Oberlander et al34. who found 
no multivariate association between the methylation state of 13 CpG sites in NR3C1 with 
several measures for prenatal depression and anxiety in 82 mothers (n = 46 depressed), but 
did find that the methylation of 3 CpG sites were correlated with some prenatal depression 
and anxiety indicators. Oberlander et al.’s results were not replicated by Hompes et al.32 who 
conducted statistical analyses with corrections for multiple testing and found associations 
during different time windows, on different CpG sites and with different directions. In spite 
of these inconsistencies, it seems likely that maternal stress during pregnancy is capable of 
altering gene expression in offspring in ways that increase the risk of stress dysregulation at 
future points in their development (see also Neuenschwander and Oberlander25).
In another related study, 23 mother-child dyads were assessed with retrospective reports of 
intimate partner violence during mothers’ pregnancy and DNA methylation was extracted from 
blood samples when the children were 10-19 years old35. These authors found a significantly 
higher mean DNA methylation percentage in 10 CpG sites of the promotor region of NR3C1 
in those adolescents whose mothers had experienced intimate partner violence during 
pregnancy. However, the small number of subjects from various ethnic backgrounds and the 
relatively large number of statistical tests (not corrected for multiple testing) might make 
replication of these results difficult. Together, the results of Radtke et al. and Hompes et al. 
show that stress during pregnancy might affect NR3C1 methylation of the fetus in a lasting 
way, but replication is needed.
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Taking into account all aforementioned studies, it seems that the effect of stress on NR3C1 
promoter methylation that was initially found in rats, translates into studies on humans. 
Following, we will briefly discuss some studies that also focus on methylation of genes other 
than NR3C1.
In a study on 57 mothers and their offspring Braithwaite, Kundakovic, Ramchandani, Murphy, 
and Champagne36 studied the association between 2nd and 3rd trimester depressive symptoms 
in the mother and methylation of NR3C1 and BDNF in 2 months old offspring, while controlling 
for postnatal maternal depressive symptoms. They found that prenatal depressive symptoms 
were associated with neonatal increased NR3C1 DNA methylation in male infants, and they 
also found decreased methylation of an exon upstream of the brain-derived neurotrophic 
factor gene (BDNF) in both male and female infants. In an earlier study on prenatal depression 
in 82 pregnant women Devlin, Brain, Austin, and Oberlander37 showed associations with 
methylation status of 5-HTT, but in contrast to Braithwaite et al.36, they did not find associations 
with methylation of BDNF.
Using a sample of 152 females, Vijayendran, Beach, Plume, Brody, and Philibert38 examined 
the associations between childhood sexual abuse and DNA methylation at 16 sites across the 
5-HTT gene in females. One out of the 16 measured CpG sites was positively associated with 
both genotype and sexual abuse, whereas DNA methylation of another CpG site was associated 
solely with sexual abuse. In a cross-sectional study, Unternaehrer et al.39 investigated the 
association between maternal care and DNA methylation of BDNF (one sequence including 
7 CpG sites) and the oxytocin receptor gene (OXTR; two sequences including 6 and 17 CpG 
sites, respectively). They showed that university students reporting low maternal care in 
childhood and adolescence (n = 45) had higher levels of DNA methylation in the BDNF target 
sequence than students reporting high maternal care (n = 40). Similarly, students reporting 
low maternal care had higher levels of DNA methylation in the first OXTR target sequence 
but not in the second target sequence.
Together, these studies suggest that candidate genes involved in stress regulation as well 
those affecting other regulators of the central nervous system are affected by parenting 
stress. However, research driven by a priori hypotheses on genes involved can form an 
‘information bottleneck’40, as it is unlikely to reveal new genes or mechanisms. Like genome-
wide association studies (GWASs), epigenome-wide association studies (EWASs) are hypothesis 
free, and cover the length of the whole genome. With the latest arrays, EWASs can gauge up 
to 850,000 CpG sites, in locations such as the promoter, intergenic regions, and intragenic 
regions. In the following paragraph, we will discuss studies that relate stressful parenting to 
epigenome-wide DNA methylation.




In developmental and psychiatric epigenetics, the dominant approach is based on methylation 
patterns of candidate genes and their promotor areas. Epigenome-wide association studies 
(or EWASs) seem less often used, presumably because the sample sizes involved in this type 
of research are too small to offer sufficient power for the large numbers of CpG sites to 
be examined. The Illumina Infinium 450K HumanMethylation array is often used to assess 
DNA methylation at 485,577 CpG sites. The array is considered a highly suitable platform 
for large-scale studies, but it still targets only < 2% of the CpG sites present in the human 
genome. Nonetheless, some rather small EWASs have been conducted on pregnant women 
with psychiatric symptoms and possible epigenetic alterations in infant cellular function.
In a prospective study on 201 pregnant women suffering from (mainly depressive) psychiatric 
illness and using various medications, Schroeder et al.41 found no significant methylation effects 
across 27,578 CpG sites in the newborn cord blood. However, the authors did find an average 
methylation rate difference of 3 percent at 2 loci, tumor necrosis factor receptor subfamily 
21 (TNFRSF21) and cholinergic receptor, nicotinic, α1 (CHRNA2), for use of antidepressant 
medication. In contrast, Non, Binder, Kubzansky, and Michels42 compared cord blood DNA 
methylation in newborns of mothers not medicated during pregnancy (n = 13), of newborns 
of mothers using SSRIs during pregnancy (n = 22), and of unexposed newborns (n = 23), and 
did not find DNA methylation effects as a result of maternal depression that was treated 
with SSRIs. On the other hand, non-medicated prenatal depression was associated with 10 
differentially methylated CpG sites, most of which had slightly lower DNA methylation rates, 
compared to non-depressed controls in genes clusters involved in regulation, translation and 
cell division processes.
Labonté et al.43 took an epigenome-wide approach in brain tissue, studying DNA methylation 
of 400K promoters of 25 suicide completers with a history of childhood abuse and of 16 
control subjects. They found 362 promoters to be differentially methylated, about two-thirds 
of which were hypermethylated. In a subsample (13 suicide with abuse and 9 controls), these 
hypermethylated CpG sites were shown to be related to decreased expression levels. Moreover, 
it seemed that most of the differentially methylated promoters were in the neuronal, rather 
than the glial tissue of the hippocampus and that most genes of affected promoters were 
involved in neuronal plasticity.
Nemoda et al.44 also studied DNA methylation using the Illumina 450K array, and compared 
EWAS hits from cord blood with DNA methylation ratios in brain tissue, in children of mothers 
who had experienced depression. They compared the DNA methylation level of T-cells in 
cord blood of 15 newborns with mothers with current depression, 14 with mothers with past 
(but not during pregnancy) depression, and 15 newborns of mothers without any history 
of depression. Differences of the separate depression groups versus control group were 
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negligible, but when the two depression groups were taken together and compared with 
the control group, 145 differentially methylated CpG sites were found. In a comparison of 
hippocampal tissue of 12 males with a history of maternal depression with 50 males without 
a history of maternal depression, some genes were found to be differentially methylated in 
the brain that were also differentially methylated in the cord blood. These genes were often 
associated with immune function.
One of the largest studies on epigenome-wide DNA methylation patterns in newborns to 
date (N = 912 mother-newborn dyads) was conducted by our research group as part of the 
Generation R cohort study45, 46, with a replication in the Avon Longitudinal Study of Parents 
and Children47. The aim of this study was to examine the association between a composite 
score of prenatal exposure to maternal stress and offspring genome-wide cord blood 
methylation using meta-analysis, follow-up pathway analyses, and differentially methylated 
regions (DMRs) analyses. The composite measure of prenatal maternal stress was based on 
maternal reports at several points in time during pregnancy, covering four stress domains48: 
(i) life stress (e.g., death in family, illness, work problems), (ii) contextual stress (e.g., financial 
difficulties, housing problems), (iii) personal stress (e.g., psychopathology, substance abuse 
including alcohol and drugs), and (iv) interpersonal stress (e.g., family relationship difficulties, 
arguments with partner).
It was remarkable that the large meta-analysis (total N = 1,740) across the two studies revealed 
no epigenome-wide associations of prenatal maternal stress exposure with neonatal differential 
DNA methylation. Follow-up analyses of the top hits derived from the epigenome-wide 
meta-analysis indicated an over-representation of the methyltransferase activity pathway. 
Methyltransferases are important in regulating gene expression and might therefore form an 
efficient system for feedback regulation of the response to initial environmental pressures and 
stress might decrease the plasticity of the genomic regulation of protein levels48. However, 
we identified no DMRs associated with prenatal maternal stress exposure. When the two 
extreme top and bottom 10% scoring respondents on the prenatal stress composite were 
compared, no significant DNA methylation differences emerged. Three marginally significant 
DMRs in Generation R were not replicated in ALSPAC. Concluding, combining data from two 
independent population-based samples in an epigenome-wide meta-analysis, Rijlaarsdam, 
Pappa, et al.48 did not find large, replicable effects of prenatal maternal stress exposure on 
neonatal DNA methylation.
To summarize, candidate epi-gene studies indicate that parenting stress is associated with 
DNA methylation in the child. However, EWASs do not confirm that methylation of genes 
such as NR3C1 is associated with parenting stress and employ rather lenient corrections for 
multiple comparisons to find associations with methylation of other genes. Here of course 
null findings trigger a large number of alternative interpretations related to the normalcy of 
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the samples, the self-reported strains and stresses in specific periods of pregnancy, but fact 
is that in this study state-of-the-art methods were used, and a built-in replication effort was 
conducted. Although they might disappoint high but premature expectations of significant 
hits in earlier, smaller studies such replication efforts are essential in the search for robust 
associations, whether derived from candidate gene methylation or epigenome-wide studies. 
This is reason why Rijlaarsdam, Pappa, et al.48 sub-titled the paper: ‘A model approach for 
replication’. Myriad of problems and pitfalls are inherent to EWAS including limited coverage 
of the genome and extremely large numbers of tests. In addition previous studies found small 
effect sizes in small samples without replication in independent samples or animal model 
systems, which raise concerns regarding the reproducibility of the epigenetic findings in the 
behavioral sciences.
In summary, it is likely that a global environmental influence such as parenting stress has a 
global effect on many CpG sites adjacent to many genes, instead of a very localized effect on 
a few CpG sites. This makes it a challenge to pinpoint where parenting stress exactly affects 
DNA methylation. Moreover, child development is expected to be influenced by many small, 
pleiotropic DNA methylation effects. Furthermore, these effects on and of DNA methylation 
are unlikely to stand alone. Rather, it is expected that they interact with the underlying genetic 
code. These issues will be discussed below.
Bidirectional Effects of the Genome and Epigenome
When considering literature on the effect of the environment on DNA methylation, one should 
bear in mind that in some cases, DNA methylation patterns and associations may be allele-
specific49. Hence, DNA methylation, or the environmental effects on DNA methylation, might be 
affected by the genome itself. For example, Van der Knaap et al.50 showed in 939 adolescents 
that stressful life events were positively associated with methylation of 5-HTTLPR for those 
with the protective ll variant, but not among those with the sl/ss variants. Van IJzendoorn et 
al.51 reported that methylation of the 5-HTT gene at 5-HTTLPR was positively associated with 
risk of unresolved loss or trauma in the 5-HTTLPR ll variant but not in the sl and ss variants 
in 143 adoptees. The authors observed this gene by DNA methylation interaction in the 
absence of (epi)genetic main effects, suggesting that opposing associations cancelled each 
other out. Together, these studies provide suggestive evidence that DNA methylation might 
be allele-specific, masking or revealing associations between genotype and stress exposure.
Similar to associations between stress exposure and DNA methylation, associations between 
DNA methylation and psychological outcomes (e.g., emotional and behavioral problems) 
might be allele-specific. Hence, the effect of DNA methylation on child outcomes should not 
be seen separately from the genome it acts upon. Ziegler et al.52 compared OXTR methylation 
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in unmedicated 110 social anxiety patients and matched 110 controls, taking into account 
OXTR rs53576 allelic variation. They showed that OXTR methylation was predominant in 
social anxiety patients carrying the OXTR rs53576 A-allele. Similarly, Reiner et al. reported 
that, in their sample of 43 clinically depressed women and 42 healthy controls, OXTR rs53576 
clinically depressed A-allele carriers, but not G-allele homozygotes, exhibited significantly 
increased OXTR methylation levels.
In a population-based study on 298 mother-child dyads53, we showed that cord blood 
methylation patterns of the FKBP5 gene, which is involved in hypothalamic-pituitary-adrenal 
(HPA) axis functioning, increased cortisol reactivity of 14-month old infants. This association 
was especially present when the infants were also T-allele carriers of rs1360780 FKBP5, and 
when infants had an insecure-resistant attachment to their mother. While the temporal 
organization of the study did not allow for examination of potential environmental effects 
on DNA methylation, this Gene × Methylation × Environment (G ×M × E) study does expose 
some of the complexities that are involved in the study of epigenetics.
In all, we discussed how the association between parenting stress and DNA methylation may 
be modified by the genetic variance of the child. Furthermore, it seems that the effect of 
DNA methylation on child outcomes might be dependent on the genetic code as well. We 
will encounter more epi-allelic effects in the following section, as we discuss studies that take 
into account the suspected antecedents as well as the consequences of DNA methylation.
DNA Methylation as Mediation
Candidate (Epi-) Genomic Approaches
Whereas studies discussed above imply that the family environment can affect DNA methylation 
and that DNA methylation may influence child outcomes, studies that incorporate both the 
presumed precursors as well as the consequences of DNA methylation are needed to confirm 
that DNA methylation is a true mediator of parenting stress and child development. An early 
example of this approach is the Oberlander et al.34 study showing that maternal depressed/
anxious prenatal mood was associated with methylation of NGFI-A binding site of the NR3C1 
gene, which was in turn associated with increased salivary cortisol. An important caveat, 
however, is that no formal mediation testing was conducted, which leaves open whether 
mediation was only partial or complete.
Using a longitudinal design embedded in in the Avon Longitudinal Study of Parents and 
Children (ALSPAC), Cecil et al.54 demonstrated that neonates (N = 84) who were exposed to 
maternal stress (e.g., maternal psychopathology, criminal behaviors, substance use) in the 
prenatal period had higher methylation levels of the oxytocin receptor (OXTR) gene than 
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non-exposed neonates. Higher neonatal OXTR methylation, in turn, showed temporal stability 
(from birth to 9 years of age) and was associated with callous-unemotional (CU) traits at 
age 13 years independent of postnatal stress exposure and associated OXTR methylation. 
Interestingly, these associations were observed exclusively in early-onset persistent (EOP) 
conduct problem (CP) youth with low internalizing problems versus EOP CP youth with high 
internalizing problems, suggesting distinct developmental pathways to CU. However, despite 
this innovative path analytic model that incorporated stress exposure, OXTR methylation and 
CU traits, no formal mediation analysis was presented.
Using data from the Generation R Study, our research group55, examined OXTR rs53576 allele-
specific sensitivity for neonatal OXTR methylation in relation to both prenatal maternal stress 
exposure and child autistic traits at age 6 in 743 children. Specifically, we investigated the 
extent to which prenatal maternal stress exposure was predicted by of OXTR methylation 
variation among neonates, while taking into account OXTR rs53576 genotype. In addition, 
we investigated the extent to which prenatal maternal stress exposure and neonatal OXTR 
methylation combined either additively or interactively with OXTR rs53576 genotype to 
influence child autistic traits. We demonstrated that prenatal maternal stress exposure, but not 
OXTR rs53576 genotype and OXTR methylation, showed a main effect on child autistic traits. 
Because prenatal maternal stress exposure and OXTR DNA methylation were unrelated across 
both OXTR rs53576 G-allele homozygous children and A-allele carriers, findings argued against 
a mediating role of OXTR methylation in the association between prenatal maternal stress 
exposure and child autistic traits. However, we did observe a significant OXTR rs53576 genotype 
by OXTR methylation interaction for child autistic traits in general and social communication 
problems in particular. More specifically, OXTR methylation levels were positively associated 
with social problems for OXTR rs53576 G-allele homozygous children but not for A-allele 
carriers. These results highlight the importance of incorporating epi-allelic information and 
support the role of both stress exposure and OXTR methylation in child autistic traits.
Elevated methylation of the OXTR CpG island is expected to decrease gene expression56 
and subsequently levels of circulating oxytocin57. Evidence also suggests, that the OXTR 
rs53576 A-allele is a “risk allele” for autistic traits58-60. Thus, OXTR methylation may decrease 
the expression of the otherwise protective OXTR rs53576 GG-allele and elevate the risk 
for emotional or behavioral problems. Consequently, one would expect the emotional or 
behavioral problems of G-allele homozygous children to more closely resemble those of 
A-allele carriers. Together, these findings suggest that DNA methylation might (i) nullify the 
effect of the protective allele, resulting in a functionality equivalent to the risk allele or (ii) 
mask the effect of risk alleles50-52, 55, 61.
By means of a formal mediation test, another longitudinal study embedded in ALSPAC 
Rijlaarsdam, Cecil, et al.62 also highlights the importance of the prenatal environment. The 
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authors examined, for youth with early-onset persistent (EOP, n = 83) versus low conduct 
problems (CP, n = 81), the extent to which high-fat and -sugar diet (prenatal, postnatal) 
associates with ADHD symptoms (age 7-13) via DNA methylation of the insulin-like growth 
factor 2 gene (IGF2; birth, age 7, collected from blood). Results showed a positive association 
between prenatal high-fat and –sugar diet with IGF2 DNA methylation at birth across both 
EOP and low CP youth. However, only for EOP youth, higher IGF2 DNA methylation at birth 
predicted ADHD symptoms. Interestingly, only for EOP youth, the association between prenatal 
high-fat and –sugar diet and higher ADHD symptoms was mediated by IGF2 DNA methylation 
at birth independent of postnatal diet and associated IGF2 methylation. Together, these 
studies support ideas focusing on prenatal maternal health as an important risk for postnatal 
child disease vulnerability26, 63. For example, a prenatal maternal high-fat and -sugar diet may 
alter the DNA methylation status of the IGF2 gene at birth, which in turn, may increase risk 
for psychiatric and health disorders –as was illustrated dramatically in the pioneering Dutch 
Hunger Winter study23.
IGF2 was also targeted in our prospective Generation R study by Bouwland-Both et al.64 
focusing on the influence of prenatal maternal smoking on newborn birthweight via IGF2 
methylation in 506 newborns. Prenatal maternal smoking should in fact be considered a risky 
type of prenatal parenting that in the population-based cohort of Generation R was shown 
by an impressive 25% of the pregnant women who reported on their tobacco smoking habits 
at three time-points before the birth of their child. Continued maternal prenatal smoking 
was inversely related to the level of DNA methylation in a differentially methylated region of 
IGF2 , in a dose-response manner. A formal mediation test showed that prenatal maternal 
smoking led to lower birthweight via lower IGF2 DMR methylation levels, which explained 
part of the variance in weight (partial mediation). Paternal tobacco smoking did not show a 
similar cascade of effects64.
We have seen that postnatal stressors might also leave their traces in epigenetic signatures. 
Klengel et al.65 found that trauma in childhood (n = 30; versus n = 46 controls) was related to 
FKBP5 demethylation, which was exclusively the case for T-carriers of the FKBP5 rs1360780 
SNP. Importantly, adult trauma did not seem to be related to FKBP5 methylation in either 
the childhood trauma group, or the control group, indicating that it was especially childhood 
trauma and not later trauma that affected FKBP5 methylation. Investigating the effects of 
FKBP5 methylation, Klengel et al.65 also found that methylation of the FKBP5 gene attenuated 
the response to dexamethasone administration, indicating that methylation of the FKBP5 
gene can affect stress reactivity. This study shows us both sides of the equation: childhood 
trauma may affect DNA methylation, and DNA methylation might have long term effects on 
psychobiological functioning. However, no formal test of mediation was conducted.
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Demonstrating the feasibility of DNA methylation mediation testing, Beach, Brody, Todorov, 
Gunter, and Philibert66 examined in 155 women whether methylation of the 5-HTT promoter 
mediated the association between childhood sexual abuse and symptoms of antisocial 
personality disorder in adulthood, by contrasting models with direct and indirect pathways 
between the three variables. First, they found that childhood sexual abuse was related to 
antisocial personality disorder, that childhood sexual abuse was related to 5-HTT promoter 
hypermethylation, and that 5-HTT hypermethylation was associated with antisocial personality 
disorder. Importantly, in a second step, they showed that a model with a direct path from 
sexual abuse to antisocial personality disorder differed significantly from a model with only 
the indirect paths, via 5-HTT methylation, included. Therefore, it was concluded that the 
association between childhood sexual abuse and antisocial personality disorder was mediated 
by 5-HTT promoter methylation.
In summary, these candidate epi-gene studies substantiate the idea that DNA methylation 
can be a mediator between parenting stress and child outcomes and that its role is often 
dependent upon the genetic code itself. In the next paragraph, we will explore whether such 
candidate epi-gene associations also emerge in EWASs.
Epigenome-Wide Association Studies (EWASs)
In an EWAS on 169 participants with and without PTSD Mehta et al.67 found that PTSD patients 
with a history of childhood trauma (n = 32) and PTSD patients without childhood trauma 
but otherwise matched on adult trauma (n = 29) had dissimilar genome expression profiles, 
suggesting that converging clinical syndromes can arise from different genetic transcription 
profiles. Further analysis showed that the PTSD group with child abuse especially had differential 
DNA methylation in gene expression networks involved in CNS development, amongst others, 
while the PTSD group without child abuse especially had differential methylation in gene 
expression networks involved in apoptosis and growth rate. Importantly, the genes associated 
with these two expression profiles were tested for DNA methylation within each group versus 
controls (PTSD but no trauma, or trauma but no PTSD, respectively). It was found that much 
more (up to 12 times) of the variance of the genetic transcripts was explained by variance 
in DNA methylation in the PTSD group that had experienced childhood trauma than in the 
PTSD group that had only experienced trauma in adulthood. It seems that childhood abuse 
may have a long lasting effect on psychosocial functioning, possibly through the effect on 
DNA methylation (see also McGowan et al.27) and that the traumatic experiences associated 
with the development of PTSD are in particular related to methylomic changes when they 
happen early in life. However, formal mediation tests were not reported.
In another small EWAS on 83 males who were 60 years or older, Khulan et al.68 studied DNA 
methylation differences between participants who were separated from their families for about 
two years during the Second World War at the age of 5 years, and a group of non-separated 
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men. Ten years later, a psychological follow-up was performed. Earlier research in the Helsinki 
Birth Cohort Study already had shown that separated individuals have a higher prevalence of 
psychological problems, altered cortisol reactivity, and poorer cognitive control69-71. However, 
no difference in DNA methylation was found between separated and non-separated men.
Earlier, we discussed how allelic variation should be taken into account when investigating 
associations of DNA methylation with child development. In an EWAS, this would of course 
lead to major statistical power issues. However, Chen et al.72 did take into account the variation 
of one particular SNP in their EWAS in the Singaporean GUSTO birth cohort (N = 237). In this 
study, Chen et al. examined the associations between prenatal maternal anxiety, epigenome-
wide methylation and neonatal brain volumes, while taking BDNF genotype into account. 
Maternal prenatal anxiety was found to be related to methylation of a SNP dependent way; 
for infants with methione (Met/Met) genotype, methylation of more CpG sites was related 
to maternal prenatal anxiety than in infants with Met/valine (Val) and Val/Val genotypes. In a 
second step, they examined the association between epigenome-wide methylation and neonatal 
brain volumes. It was found that DNA methylation was associated with the volumetrics of 
several brain areas, again in a BDNF SNP dependent way. Unfortunately, it remains unclear to 
what extent CpG sites implicated in prenatal maternal anxiety corresponded to the CpG sites 
related to neonatal brain volumes, thereby precluding strong inferences on the role of DNA 
methylation as a mediator between prenatal maternal anxiety and neonatal brain volumes.
Altogether, the results from candidate epi-gene studies and EWASs offer support for the 
notion that epigenetics, in the form of DNA methylation, can mediate the association 
between parenting stress and child outcomes. Interestingly, genes that appear differentially 
methylated in candidate epi-gene studies, do not necessarily appear among the hits in the 
EWASs discussed. One reason for this might be that EWASs are still underpowered to find 
the effects that are observed in candidate studies. However, this discrepancy might also 
confirm the idea the hypothesis-driven approach of candidate epi-gene studies creates an 
‘information bottleneck’. The human DNA contains over 20,000 genes and focusing on the 
DNA methylation of only a few seems far-fetched. These and other methodological issues, 
will be elaborated upon in the following section, before coming to a final conclusion.
Caveats and Conclusions
Reliability and Validity of DNA Methylation Measurement
While the number of studies on DNA methylation in developmental and family psychology is 
increasing, pivotal questions regarding the reliability and validity of DNA methylation indicators 
in human research remain unanswered. In fact, basic research on these essential characteristics 
of any adequate measure has been neglected. Several issues should be mentioned here.
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First, it is not clear which markers of DNA methylation are stable over what periods of 
time (trait-like indicators) and which markers can change rapidly depending on momentary 
endogenous or exogenous changes (state-like markers). For parenting and developmental 
studies, this is crucial information, as we are mostly interested in influences of parenting 
on long-term and more persistent, trait-like changes in the child’s development. Regarding 
epigenome-wide array analyses, large parts of the epigenome as assessed by the Illumina 
approach is stable by definition because it pertains to CpG sites that show no methylation 
at all or, in contrast, show maximum methylation (with a confidence interval indicating 
imprecision of measurement) which may inflate epigenomic stability figures. Nevertheless, 
Lévesque et al.73 found that more than half of the probes measured with the 450K Illumina 
were unstable over a 3 to 6 months’ time period in young adolescents. In contrast, Wang et 
al.74 analyzed the methylome of newborns and found that only 5% of CpG sites made a true 
shift from methylated to unmethylated, or vice versa, within the first 2 years of life.
CpG sites of interest to developmentalists can potentially vary due to environmental pressures 
but at the same time should not show short-term volatility. In a small sample of adults we 
found that at some genes, such as DRD4 or 5-HTT, almost all indicators of reliability across 
time were satisfactory. In contrast, at BDNF, many probes showed poor reliability especially 
in blood spots75. Talens et al.76 found some evidence for stable DNA methylation patterns in 
peripheral blood over a period of one to two decades in CpG sites of eight genes, of young to 
middle-aged individuals. Taken together, these results seem to indicate that DNA methylation 
can be stable over a prolonged period of time, but the disparity in age range, array methods, 
and definition of temporal stability makes it impossible to draw firm conclusions before more 
systematic reliability studies become available.
Second, tissue is the issue. The central question for parenting and developmental research is 
the link between DNA methylation markers derived from peripheral tissue and methylation 
patterns in behaviorally relevant regions of the brain. Because in humans brain DNA methylation 
patterns are nearly inaccessible ante mortem, very few studies have looked into the association 
with peripheral DNA methylation, with somewhat disappointing results. For example, Hannon, 
Lunnon, Schalkwyk, and Mill77 examined inter-individual methylomic variation across blood, 
cortex, and cerebellum and found that the majority of DNA methylation derived from whole 
blood was not a strong predictor of variation in the brain, although the relation with cortical 
regions appeared to be stronger than with the cerebellum. DNA methylation of only about 1% 
of CpG sites were strongly correlated between blood and brain, and about 6% are moderately 
correlated.
DNA methylation patterns derived from blood may however not be the most valid indicator 
of methylation in the brain, not only because of the blood-brain barrier but also because of 
the heterogeneity of cellular composition of blood samples that might be corrected for in 
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various ways78. Buccal tissue has been used rather frequently as a source of information about 
methylation levels because it is less invasive compared to blood sampling. Buccal epithelial 
tissue has been argued to be less heterogeneous than blood cells and to be ‘closer’ to brain 
tissue in a developmental sense79. Without going into technical details, we found better 
test-retest reliability figures for DNA methylation levels established in buccal cells than for 
blood or blood spots75. Of course, some part of DNA methylation stability may depend on the 
heritability of DNA methylation levels as suggested by rather strong associations between 
some genotypes and DNA methylation level80 but it would be premature to conclude that 
DNA methylation is in fact determined by variations in structural DNA and thus potentially 
completely genotypic instead of (endo-)phenotypic.
Reproducibility
In the behavioral and biomedical sciences, the problem of reproducibility of research has 
been discussed quite vigorously, starting with the (in-)famous Ioannidis81 paper on ‘Why most 
published research findings are false’. The replication controversies around candidate G × E 
studies seem to be still ongoing82-85 with considerable emphasis on the need for large sample 
sizes and built-in replication or meta-analysis efforts, parallel to current practices in the GWAS 
area. For DNA methylation studies based on selection of one or few candidate genes for which 
DNA methylation data are collected, the issue of statistical power, and thus the problem of 
reproducibility may be aggravated because the number of tests might increase considerably 
compared to the few tests with bi-allelic candidate genes. The advantage, though, which also 
comes up in the candidate gene versus GWAS debate, is the theory-guided hypothesis testing 
approach for which the functionality of hyper- or hypo-methylation might already have been 
established67. Factor analysis to reduce the number of CpG sites to a few dimensions might 
also be helpful53, 62. Last but not least, meta-analyses to synthesize a large number of small 
candidate gene methylation studies are indispensable.
Epigenome-wide association studies (EWASs) suffer from power issues similar to the hypothesis-
free approach of GWAS, and certainly even more so in comparison to candidate epigenetic 
approaches, simply because of the large number of CpG sites interrogated by the standard 
Illumina 450K, a problem that might become exacerbated by the new Illumina 850K chip. 
Alternative methods of significance testing (e.g., permutation testing) are important as well 
as robust statistical corrections for multiple testing, and analyses that account for dependence 
of CpG sites in differentially methylated regions86 and through bump hunter87, 88 or block 
finder89. Nevertheless, EWAS results will be difficult to replicate because of the small effect 
sizes to be expected, and the large number of tests on a relatively small number of subjects48. 
Therefore, replication of EWAS findings in independent studies are needed before more 
definite conclusions can be reached and large consortia like the Pregnancy And Childhood 
Epigenetics (PACE) consortium are badly needed. As an example, in the PACE consortium 
with 16 cohort studies Joubert et al.90 identified more than 6,000 differentially methylated 
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CpG sites in newborns in relation to prenatal maternal smoking, with nearly half of the sites 
not previously associated with smoking and DNA methylation in either newborns or adults.
Causality
The large majority of human DNA methylation studies are correlational–whether conducted 
with a retrospective, concurrent or prospective design with regard to timing of assessment 
of biological tissue, and the predictors and outcomes of interest. This design is beset with 
problems of confounding, spurious associations because of unmeasured third factors, and 
reversed causality. In this respect, epigenetics is not different from any other epidemiological 
approach91. One of the statistical means to address the question of causality is through 
mediation modeling, preferably based on longitudinal study designs92, 93. Full mediation 
provides insights into the cascade from environmental determinants through mediating 
DNA methylation changes to some developmental outcome. In the foregoing sections we 
emphasized the need for mediation analyses to shed light on the role of DNA methylation in 
the association between environmental input and behavioral output, but only few studies 
successfully probed this mediation mechanism. DNA methylation should be considered a 
mechanism instead of endpoint of child development determined by prenatal adversities or 
the ultimate determinant of later developmental outcomes. Crucial is the combination of 
stressful (prenatal) parenting influencing child development mediated by DNA methylation.
Of course, for inferring causality, no design can beat real experiments with randomized 
assignment of subjects to experimental manipulation and control group (for an excellent 
example on nonhuman primates, see Provençal et al.94). The number of quasi-experimental 
studies on DNA methylation is increasing as methylation signatures have been used as 
indicators of symptom improvement in psychotherapy of combat veterans with PTSD95, as 
markers of therapeutic success in a matched-controls design with clinically depressed in-
patients61 or in a pre- posttest only design96, in studies of cognitive behavior therapy with 
anxious individuals96, 97, and in studies of foster care based on a randomized control design 
turned into a correlational approach98.
These are important exploratory advances in the field of therapygenetics96 because they suggest 
that DNA methylation may not only change for the worse, but with the right intervention, also for 
the better. At the least, these preliminary results do suggest the usefulness of DNA methylation 
as a biomarker, with which one might be able to gauge responsiveness to therapy. However, 
the quasi-experiments need to be followed by genuine experiments similar to randomized 
G × E interventions. We initiated experimental human candidate G × E research more than 
10 years ago99 and recently showed that the statistical power of experimental candidate G 
× E is some 13 times higher than the regular correlational candidate G × E studies100. Such 
experiments also adequately prevent gene-environment correlations from confounding the 
G × E results. The same might be true for DNA methylation studies in which DNA methylation 
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changes are considered proximal outcomes or mediators of subsequent behavioral changes 
as a consequence of the intervention.
DNA methylation may be a crucial component of genetic differential susceptibility that 
explains why interventions usually show disappointingly small effects on child development. 
Differential susceptibility theory suggests that some children are more susceptible to the 
environment, for better and for worse, than their peers without a susceptible genotype. We 
found that dopamine- and serotonin-related genes are involved in differential susceptibility 
to parenting and speculated that DNA methylation might play a role in G × E interactions 
leading to Gene × Methylation × Environment interplay100 (G × M × E). DNA methylation may 
modulate adaptation to a changing environment and make the organism less dependent 
on its structural DNA. A prime example is the crucial role of DNA methylation in genetically 
identical apomictic dandelions that adapt to a great variety of ecological niches only due to 
epigenetic changes superimposed on an asexually inherited fixed genotype101. Genetic markers 
of differential susceptibility in humans might in part reflect allelic differences coding for 
degree of plasticity of DNA methylation that make some individuals less adaptive to adverse 
(prenatal) circumstances and thus dispose them to sub-optimal development, whereas these 
same individuals may benefit more from benign environments compared to their peers with 
more flexible epi-allelic characteristics.
Conclusion and Future Directions
We presented some evidence for the exciting hypothesis that distressed parenting can affect 
DNA methylation of the offspring, which in turn through regulating the expression of genes 
may influence behavioral development. DNA methylation is one of the epigenetic mechanisms 
that holds great promise for the unification of the fields of nature- and nurture-centered 
research. We also argued, however, that research on behavioral epigenetics in humans often 
fails to ascertain the reproducibility of its results, using unreliable and invalid measures and 
samples that are too small, often also failing to address the question of mediation and causality. 
We did not touch on the million-dollar question of the transgenerational transmission (see 
also Mileva-Seitz and Fleming28) of DNA methylation –epigenetic heritability through the 
germline– potentially explaining the transmission of (abusive or positive) parenting across 
generations. Whereas in some plant species101, 102 and in rodents103 this transgenerational 
transmission of epigenetic signatures has been experimentally illustrated, in humans it still 
is one of the most challenging and outstanding issues to be addressed in a rigorous manner. 
For a Lamarckian cry of victory it is way too early.
Looking ahead, whereas many questions regarding DNA methylation specifically and epigenetics 
in general have been left unanswered, its possible applications are titillating. Since the research 
discussed in the current Chapter seems to indicate that stressful parenting can affect the 
epigenetic profile of the developing child in a detrimental way, one wonders whether positive 
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parenting or intervention might influence the child’s epigenetics beneficially. In a study in 
adult rats performed by Weaver et al.104, methyl supplementation was able to reverse NR3C1 
methylation and stress responses induced by experienced maternal stress early in life. Also, 
in a study performed by Roberts et al.97, it was shown that children with anxiety disorders 
who responded well to cognitive behavior therapy, had an increase in DNA methylation 
of a CpG site upstream of 5-HTT, whereas methylation of this CpG site decreased in non-
responding children. Even though we cannot be certain that the change in DNA methylation 
is a functional one, its possible use as a diagnostic tool is intriguing. We are evidently a long 
way from using epigenetics validly in a therapeutic setting, but a continuous investment in 
epigenetic research may bring us closer to understanding the intricacies of the interplay of 
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The parent-child attachment relationship plays an important role in the development 
of the infant’s stress regulation system. However, genetic and epigenetic factors such 
as FK506 binding protein 51 (FKBP5) genotype and DNA methylation have also been 
associated with hypothalamic-pituitary-adrenal (HPA) axis functioning. In the current 
study, we examined how parent-child dyadic regulation works in concert with genetic 
and epigenetic aspects of stress regulation. We study the associations of attachment, 
extreme maternal insensitivity, FKBP5 SNP 1360780, and FKBP5 methylation, with cortisol 
reactivity to the Strange Situation Procedure in 298 14-month-old infants. Results indicate 
that FKBP5 methylation moderates the associations of FKBP5 genotype and resistant 
attachment with cortisol reactivity. We conclude that the inclusion of epigenetics in 
the field of developmental psychopathology may lead to a more precise picture of the 




The attachment relationship between infant and parent is important in shaping the development 
of the child’s stress regulation system1. In the first year of life, human infants are dependent 
on protective caregivers to regulate their temperature, food and fluid intake, and also to 
regulate stress in the face of threats and dangers2. Sensitive parents, who promptly and 
adequately respond to their infants’ distress signals, help to create a safe haven from which 
the child can freely explore the environment3. These infants are more likely to develop a 
secure attachment relationship and the associated expectation that, in times of need, their 
parent will be available to protect them4. Insensitive parents, however, may be less prompt 
and effective in buffering stressful events and settings for their infant. In turn, their infants 
will be less likely to develop trust and the expectancy of reassuring parental support in times 
of illness, threat, anxiety and other stressful situations. These infants are also more likely to 
develop an insecure attachment relationship and a more tenuous style of coping with stressors, 
potentially resulting in a more reactive hormonal stress system5. Stress regulation takes place 
via the hypothalamic-pituitary-adrenal axis (HPA axis) and one of the crucial hormones involved 
is cortisol. Therefore, cortisol reactivity to stressors is usually considered to be a measure 
of the amount of stress experienced by children when confronted with challenges such as 
separation from the parent or entering an unknown environment or meeting with a stranger6, 7.
Extreme insensitivity of a parent, including displays of fright because of memories of traumatic 
experiences, or other threatening behaviors towards the infant, like physical abuse, may elicit 
even more disturbed attachment behaviors. In particular, extreme parental insensitivity or 
otherwise frightening behaviors may lead to disorganized/disoriented attachment, reflected 
in infant behavior, for example, in prolonged stilling, rapid approach–avoidance vacillation, 
sudden unexplained affect changes, severe distress followed by avoidance, or expressions of 
fear or disorientation upon return of a parent who has been away for a couple of minutes. 
Disorganized attachments are overrepresented in clinical samples and in samples with a high 
prevalence of child maltreatment and family violence7-9. Dysregulation of the hormonal stress 
system has been noted in infants with a disorganized attachment relationship to the parent10, 11.
In the current study, we examined how attachment and extreme insensitivity interact with 
infants’ stress-related genetics to explain variability in their stress regulation. Specifically, 
we focus on the FK506 binding protein 51 (FKBP5) gene. FKBP5 has been shown to impede 
negative feedback of the HPA axis12, and variants, amongst which the rs1360780 SNP in 
the FKBP5 gene has been related to recovery from psychosocial stress13. Moreover, it was 
found that rs1360780 interacts with child abuse in the prediction of later development of 
posttraumatic stress disorder14, 15 and of attempt of suicide after childhood trauma16. In a 
subsample with European ancestry of the Generation R cohort, we previously found that 
rs1360780 interacts with variations in attachment quality in the prediction of stress reactivity. 
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More specifically, infants with an insecure-resistant attachment to their mother—but not those 
with an insecure-disorganized attachment—had heightened cortisol reactivity to a mildly 
stressful situation (the Strange Situation Procedure, SSP4), especially if these children were 
carriers of the T allele in the rs1360780 SNP17. Here we aim at extending our previous study 
in the Generation R subsample, by including extreme maternal insensitivity as an indicator 
of atypical parental caregiving behavior, as well as by taking DNA methylation into account.
Epigenetics is a relatively new avenue in the field of developmental psychopathology. One of 
the most often studied epigenetic processes in cohort studies is DNA methylation, where a 
methyl group attaches to a cytosine nucleotide located next to a guanine in the DNA at a so-
called CpG (cytosine-phosphate-guanine) site. Methylation can change the three-dimensional 
formation of the chromatin18, and subsequently affect gene transcription. DNA methylation 
is thought to be influenced by prenatal19-21 and postnatal life events22-24, as well as by genetic 
background. It can therefore be seen as the dynamic interface between genes and the 
environment25, 26. These genotype-by-methylation patterns may in turn affect associations 
between environmental factors and developmental outcomes27. Hence, SNP associations 
with phenotypes such as stress reactivity may become more clearly apparent when DNA 
methylation is included in the analysis.
In rodents, maternal separation has been related to differential DNA methylation in a variety 
of HPA-axis related genes and altered stress-responsiveness24, 28, 29. In humans, similar results 
have been found. For example, in individuals who were adopted after stressful early life 
experiences, the short variant of the serotonin-transporter-linked polymorphic region predicted 
more unresolved loss or trauma, but only if methylation was low27. Another study showed that 
prenatal exposure to maternal depressed mood was associated with nuclear receptor subfamily 
3, group C, member 1 (NR3C1) gene methylation, which was in turn related to increased 
cortisol reactivity in 3-month-old infants30. The NR3C1 gene codes for the glucocorticoid 
receptor (GR), and methylation is presumed to impede transcription of the NR3C1 gene 
into the GR protein, decreasing HPA-axis negative feedback through corticosteroid binding.
For the FKBP5 gene, which is associated with the binding of cortisol to the GR, Klengel et 
al.15 found that experienced early trauma was related to methylation of FKBP5, especially 
in carriers of the rs1360780 T-allele. The T-allele of rs1360780 facilitates gene transcription, 
which would lead to less sensitive GRs and ultimately to more or prolonged cortisol reactivity. 
Functionally, Klengel et al.15 showed that FKBP5 methylation affected cortisol reactivity as 
well and, in a separate sample, they found that GR sensitivity was especially affected in 
T-carriers of rs1360780 that had also experienced childhood abuse. Although these findings
are elucidating, we do not know whether they generalize to the general population, where
early traumatic experiences are relatively uncommon. Paquette et al.31 analyzed placental
samples of the general population and infant neurodevelopment. They found an rs1360780
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dependent effect of methylation of FKBP5 on mRNA expression in placental cells. Moreover, 
higher levels of placental FKBP5 methylation were found to be related to more arousal in 
3-year-olds. However, it should be noted that arousal does not necessarily equate to cortisol 
regulation.
The goal for this report was to further explore the relationship between extreme maternal 
insensitivity, attachment, and cortisol reactivity, for the first time including both genetic and 
epigenetic factors. In the findings of Luijk, Velders, et al.17, it remained puzzling why insecure-
resistant attached infants seemed most affected by the SSP in terms of their cortisol reactivity, 
more so than disorganized infants. Resistant attachment behavior is usually accompanied with 
explicit signs of distress such as crying and the display of anger to the parent on return after a 
brief separation. As a result, children with insecure-resistant attachments might show higher 
cortisol stress reactivity to this challenge than securely attached infants. But infants with 
insecure-disorganized attachments might have even more difficulties with coping, and may be 
more dysregulated than insecure-resistant children because their previous experiences with 
extremely insensitive and frightening parental behaviors may have made them hypersensitive 
to stress and to lack of parental support when badly needed32, 33. Including genetic as well as 
epigenetic factors influencing the expression of the FKBP5 gene might be necessary to uncover 
the associations between parenting, attachment, and allelic differences. G × E interactions 
might emerge more clearly when epigenetic variance is taken into account.
In sum, in this study, we aim to clarify if DNA methylation interacts with genetic effects and 
parenting on cortisol reactivity. We expand the study by Luijk, Velders, et al.17 by investigating 
if and how FKBP5 methylation affects the rs1360780 SNP-by-resistant attachment interaction 
reported in that study. Moreover, by including extreme maternal insensitivity, we take a 
broader perspective on the caregiver-child interaction. We hypothesize that the group with the 
highest risk for increased stress reactivity includes infants who show resistant or disorganized 
attachment behaviors, whose mothers display signs of extreme insensitive parenting, who 
are rs1360780 T-carriers, and who have the highest levels of FKBP5 methylation.
Methods
Setting
The current study is embedded in Generation R, a prospective population-based cohort from 
fetal life onwards. Pregnant women living in the study area of Rotterdam, the Netherlands, 
with an expected delivery date between April 2002 and January 2006 were invited to 
participate. A more detailed description of the Generation R Study can be found elsewhere34, 
35. In a randomly assigned subgroup of European pregnant women and their infants, detailed 
assessments were performed, including the Strange Situation Procedure (SSP). This subgroup 
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is ethnically homogenous (all with European ancestry) to exclude confounding or ethnic 
stratification effects. The Generation R Study is conducted in accordance with the World 
Medical Association Declaration of Helsinki and has been approved by the Medical Ethics 
Committee of the Erasmus Medical Center, Rotterdam. Written informed consent was obtained 
from the parents of all participating infants.
Study population
DNA was collected from cord blood samples at birth. Information on rs1360780 genotype 
and FKBP5 methylation levels was available for 956 infants. At the age of 14 months (mean 
= 14.58, SD = 0.87), 568 of them participated in a lab visit, during which the SSP, extreme 
maternal insensitivity, and salivary cortisol samples were obtained. We were able to retrieve 
salivary cortisol samples from a total of 298 of these infants. This sample is nearly identical 
to the sample used by Luijk, Velders, et al.17 (n = 310), with the discrepancy primarily caused 
by missing FKBP5 methylation data. Unsuccessful cortisol sampling was mainly due to the 
infants’ unwillingness to chew on the cotton swabs, and was especially seen in infants who 
were unfamiliar with pacifiers or who ceased using them. Sample characteristics are presented 
in Table 1. Excluded infants (i.e., infants without data on salivary cortisol, N = 270) did not 
differ from included children (N = 298) on resistant behavior during the SSP (t(566) = 0.16, 
p = 0.87, d = 0.01), disorganized attachment behavior (t(566) = 1.06, p = 0.29, d = 0.09), 
extreme maternal insensitivity (t(513) = -0.87, p = 0.39, d = 0.08) or maternal smoking during 
pregnancy (χ²(1) = 0.06, p = 0.80, d = 0.02). However, excluded infants differed from included 
infants in terms of age at the time of the SSP (t(566) = 2.37, p = 0.02, d = 0.20), sex (χ²(1) = 
7.98, p < 0.01, d = 0.24) and maternal education (χ²(1) = 4.64, p = 0.03, d = 0.19). Specifically, 
infants with successful cortisol sampling were younger (mean age was 14.6 years in the 
included group, versus 14.8 years in the excluded group), were more often boys (57.0% in 
the included group, versus 45.2% in the excluded group) and their mothers were more often 
lower educated (39.5% of the mothers in included group had no formal higher education, 
versus 30.9% of the excluded group).
In 12 of the 298 infants for whom cortisol samples were available, observations of extreme 
maternal insensitivity were missing, due to procedural problems. To avoid reducing the 
group size of infants with the rs1360780 TT genotype (the hypothesized risk group), extreme 
maternal insensitivity scores were imputed using the expectation-maximization (EM) algorithm, 
using all other variables as well as prenatal maternal lifetime depression and breastfeeding 
at 6 months. Imputation with the EM algorithm was also performed to impute two missing 
values on the amount of crying during the SSP. Results remained essentially unchanged when 





Cord blood DNA was genotyped for the rs1360780 single nucleotide polymorphism (SNP) of 
the FK506 Binding Protein 5 (FKBP5) with the TaqMan allelic discrimination assay (Applied 
Biosystems, Foster City, CA) and Abgene QPCR mix (Abgene, Hamburg, Germany). Polymerase 
chain reaction (PCR) took place with the GeneAmp® PCR system 9600, at 95 °C for 15 min, 
followed by 40 cycles of 94 °C for15s and 60 °C for 1 min. The 7900HT Fast Real-Time PCR 
System (Applied Biosystems) was used for fluorescence detection and genotypes were 
determined with SDS software (version 2.3, Applied Biosystems).
Contamination with the mother’s blood was checked for the boys, by examination of the 
sex chromosomes. Samples in which contamination had occurred were excluded (< 1%). 
Furthermore, genotyping of the FKBP5 SNP was successful in 97-99% of the cases and reanalysis 
of 276 randomly selected samples showed an error rate of < 1%. Genotype frequencies were 
in Hardy-Weinberg equilibrium (χ² = 1.07, p = 0.30).
Table 1. Sample Characteristics (N = 298)
Variable  Mean  (SD)
Infant characteristics
Age at assessment of SSP, months  14.6  (0.9)
Sex, % girls 43.0




FKBP5 methylation factor 1, score  0.15  (0.02)
FKBP5 methylation factor 2, score  0.31  (0.04)
Resistant behavior, continuous score  2.2  (1.3)
Resistant attachment, % resistant 24.5
Disorganized attachment behavior, score  3.4  (1.8)
Cortisol reactivity in Δ nmol/L  0.7  (6.2)
Mother characteristics
Educational level, % lower  39.9
Smoking during pregnancy, % yes  11.4
Extreme insensitivity, continuous score  1.4  (1.0)
Extreme insensitive behaviors, % one or more  16.1
Note. SSP = Strange Situation Procedure




Per sample, 500 nanogram of leukocyte DNA was extracted from cord blood and underwent 
bisulfite conversion with the EZ-96 DNA Methylation kit (Shallow) (Zymo Research Corporation, 
Irvine, USA). Methylation was analyzed with the Illumina Infinium Human Methylation 450K 
BeadChip (Illumina Inc., San Diego, USA). Quality control of samples was performed using 
standardized criteria. Samples were checked for < 99% call rate (six samples were excluded), 
color balance > 3, staining efficiency, extension efficiency, hybridization performance, stripping 
efficiency after extension (no samples excluded in each case), and bisulfite conversion (one 
sample excluded). Also, two samples were removed due to a sex mismatch, leaving a total 
of 969 samples that passed quality control. Dasen normalization was ran using a pipeline 
adapted from Touleimat and Tost36, as described by Pidsley et al.37, and samples were dye 
bias corrected.
We extracted the beta values of 32 CpGs that mapped to the FKBP5 gene or overlapping 
regions adjacent to FKBP5 (i.e. position 35543611 to 35697760; see Figure 1). Beta values 
represent the ratio of methylated signal relative to the sum of the methylated and unmethylated 
signals, per CpG. To avoid multiple testing issues due to the large number of CpG beta values, 
we decided to examine the dimensional structure of the data (mean r = 0.01, range r [-0.63, 
0.77]) by using factor analysis in MPlus Version 7.3138. The factor analysis took place in the full 
DNA methylation sample, using the 29 CpG beta values with sufficient variation (SD > 0.01). 
Factor analysis proceeded in two steps. First, exploratory factor analysis (EFA) was performed. 
The optimal number of underlying factors was assessed by inspecting the Scree-plot and by 
comparing fit statistics between models estimating one to five factors. CpGs with a Geomin 
(oblique) rotated absolute loading of > 0.40 to one of the factors were included. Model fit 
Figure 1. Beta values of 32 CpGs that mapped to the FKBP5 gene or overlapping regions adjacent to FKBP5
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was established using the chi-square statistic. In the event of significant chi-square values, 
we further examined relative fit indices, including the mean square error of approximation 
(RMSEA; acceptable fit ≤ 0.08), as well as the comparative fit index and the Tucker-Lewis 
index (CFI and TLI respectively; acceptable fit ≥ 0.90). A two-factor model was identified 
(χ²[53] = 367.56, p < 0.001; RMSEA = 0.078; TLI = 0.949; CFI = 0.926). The first factor had an 
eigenvalue of 5.2 and contained eight CpGs, of which five had positive and three had negative 
factor loadings. The second factor had an eigenvalue of 2.4 and contained five CpGs, all of 
which had positive factor loadings (see Figure 1). In the second step, we used confirmatory 
factor analysis (CFA) to validate the two-factor model (χ²(64) = 438.60; RMSEA = 0.077; CFI 
= 0.913; TLI = 0.894). For each FKBP5 methylation factor, we computed average methylation 
scores based on the relevant CpGs, using reversed scores for those with negative loadings on 
factor 1. These average methylation factor scores were used throughout. In an exploratory 
analysis, regression analyses were repeated for each CpG inidividually, to gauge if our main 
finding was caused by only one or a few CpGs, or rather by the combined effect of all CpGs.
Attachment
Mother-infant dyads were observed in the Strange Situation Procedure (SSP). During the 
SSP, mild stress evokes attachment behavior in the infant by the unfamiliar lab environment, 
a stranger entering the room and engaging with the infant, and the parent briefly leaving 
the room twice. The total procedure consists of seven three-minute episodes, with the 
preseparation and separation in our study shortened by 1 min each, keeping the critical 
reunion episodes intact39, 40.
Two reliable coders, trained at the University of Minnesota, coded the SSP recordings, 
according to the Ainsworth et al.4 and Main and Solomon33 coding systems. For each of two 
reunions with the mother, the infant received a resistant behavior score ranging from 1 to 
7. These scores were averaged to create a resistant behavior score. Examples of resistant 
behavior include (i) a struggle against being held or (ii) throwing away toys that are handed 
to the infant. Intercoder reliability (intraclass correlation or ICC, single measure, absolute 
agreement) for resistant behavior was 0.86 (n = 70). For a sensitivity analysis (see below), a 
resistant attachment classification was derived from a pattern of attachment behaviors during 
the reunion periods. A typically resistant infant actively seeks proximity to the mother and 
tries to maintain contact with her, while at the same time showing obvious signs of resistance 
to her attempts of consolidation. Intercoder agreement for resistant attachment was 77% (κ = 
0.63, n = 70). Resistant behavior in the reunion episodes and resistant attachment classification 
were strongly correlated (r = 0.78, p < 0.01). Disorganization of attachment behavior was rated 
using the 9-point Main and Solomon33 coding system. Examples of disorganized/disoriented 
behaviors are prolonged stilling, rapid approach–avoidance vacillation, sudden unexplained 
affect changes, severe distress followed by avoidance, and expressions of fear or disorientation 
upon return of mother. The ICC for the disorganization rating scale was 0.88 (n = 70)41.




Extreme maternal insensitivity was observed during the psychophysiological assessment and 
during the break of the 14-month lab visit and was rated by coders unaware of the attachment 
coding. During the psychophysiological assessment, the child had ECG-measurement equipment 
attached while sitting on the mothers lap and watching an episode of the Teletubbies© (BBC/
Ragdoll Limited). The break was unstructured, and mother and child interacted freely. The 
extreme maternal insensitivity scale includes: (1) withdrawal and neglect; and (2) intrusive, 
negative, aggressive or otherwise harsh parental behaviors42. Extremely insensitive behaviors 
were coded on a 9-point scale, with higher scores indicating more extreme insensitivity. The 
ICC was 0.63 (n = 36).
Cortisol reactivity
Saliva samples were taken during the 14-month lab visit with Salivette sampling devices 
(Sarstedt, Rommelsdorf, Germany). Samples were centrifuged and frozen at -80 °C and analyzed 
by the Kirschbaum laboratory (Technical University of Dresden, Biological Psychology, Germany). 
Salivary cortisol concentrations were assessed with a chemiluminescence imunnoassay (CLIA; 
IBL Hamburg, Germany). Intra- and interassay coefficients of variation were below 7% and 
below 9%, respectively. Cortisol concentrations above the 99th percentile (>200 nmol/L) were 
excluded (n = 12) from the analyses. Cortisol reactivity was determined by calculation of the 
difference between cortisol concentration 15 minutes after the SSP (post-SSP cortisol) and 
cortisol concentrations prior to the SSP (pre-SSP cortisol). Mean sampling time of pre-SSP 
cortisol was 11:26 a.m. (SD = 2:01 h), mean sampling time of post-SSP cortisol was 12:22 p.m. 
(SD = 2:00 h). We had information on corticosteroid medication for 248 infants. None of these 
infants used systemic corticosteroid medication, but five infants used other corticosteroid-
containing medication. Since these infants did not differ significantly in cortisol reactivity 
from infants without corticosteroid-containing medication (t(246) < 0.01, p > 0.99, d < 0.01), 
they were included in all further analyses.
Covariates
Information on family background characteristics was obtained by questionnaire during 
pregnancy. We included as covariates infant’s age at the SSP, infant sex, mothers’ highest 
attained educational level (no formal higher education versus higher vocational training or 
higher academic education), maternal smoking during pregnancy (never smoked or quit when 
pregnancy was known versus continued smoking during pregnancy), technical covariates 
(sample array number and position on the array, and leukocyte cell type proportions [CD4+ 
T-lymphocytes, CD8+ T-lymphocytes, natural killer cells, B-lymphocytes, monocytes, and 
granulocytes]43. To account for the negative association (which might be interpreted as a ceiling 
effect) between the initial cortisol value and the slope of the cortisol reactivity, the cortisol 
concentration prior to the SSP (pre-SSP cortisol) was also included as a covariate. Finally, 
to exclude the possibility that resistant behavior and cortisol reactivity are related through 
Chapter III
62
the physiologically arousing nature of crying that often accompanies resistant behavior, we 
performed the regression analysis with and without the inclusion of percentage of crying 
time during the SSP as a covariate.
Statistical analyses
Hierarchical linear regressions were performed using SPSS version 23 (IBM Corporation, 
Chicago, USA) to examine the associations of FKBP5 rs1360780, FKBP5 methylation and 
attachment (resistant or disorganized) with infant cortisol reactivity during the SSP. These 
regression analyses were performed separately for the two FKBP5 methylation factors and 
for each of the two attachment variables.
In the first step of the regression equation, FKBP5 rs1360780, FKBP5 methylation, attachment, 
extreme maternal insensitivity, and the covariates were entered. In the second step, all two-
way interactions between FKBP5 rs1360780, FKBP5 methylation, attachment, and extreme 
maternal insensitivity were entered. In the third step, all three-way interactions were entered. 
In the interest of statistical power, the four-way interaction with all possible predictors was 
not included. When one of the main predictors was not found to have a significant main 
or interaction effect on cortisol reactivity, the steps were repeated excluding this variable.
To reduce the influence of extreme scores on the results, two outliers (z-score >3.29) for FKBP5 
methylation factor 1, four for FKBP5 methylation factor 2, six for cortisol reactivity, and 10 
for extreme insensitivity were winsorized (i.e. transformed to match the next highest value). 
FKBP5 rs1360780, the FKBP5 average methylation factors, resistant and disorganized behavior, 
and extreme maternal insensitivity, were mean-centered in order to reduce collinearity due 
to the scaling of variables.
Sensitivity analyses
Two sensitivity analyses were performed. First, in order to examine whether associations 
were dependent on the continuous resistance scale, we also used the resistant versus non-
resistant attachment classification17 as a predictor instead of the continuous resistant behavior 
score. Second, since most mothers had the lowest possible score on extreme insensitivity, 
which resulted in a skewed distribution of scale scores, we performed a sensitivity analysis 
with a dichotomized extreme insensitivity variable. Mothers not showing any extremely 
insensitive behaviors were contrasted with mothers presenting one or more extremely 
insensitive behaviors.





As can be seen in Table 2, none of the main predictors were correlated, with the exception of 
FKBP5 methylation factors 1 and 2 (r = 0.34, p < 0.01), and disorganized and resistant behavior 
(r = 0.19, p < 0.01). The regression analyses did not show an association of cortisol reactivity 
with extreme maternal insensitivity (β = -0.04, p = 0.43) in the first step, nor a with a two-way 
interaction of extreme maternal insensitivity and FKBP5 rs1360780, FKBP5 methylation factor 
1, or resistant behavior (strongest interaction with FKBP5 rs1360780: β = -0.02 , p = 0.69) in 
the second step, nor with a three-way interaction with extreme maternal insensitivity and 
any combination of these predictors (strongest interaction with FKBP5 methylation factor 
1 and resistant behavior: β = -0.04, p = 0.51) in the final step. This was also the case for the 
analyses with FKBP5 methylation factor 2.
Resistant attachment, FKBP5 rs1360780, and FKBP5 methylation
Table 3 shows that both FKBP5 rs1360780 (β = 0.13, p < 0.01) and resistant behavior (β = 0.30, 
p < 0.01), but not FKBP5 factor 1 methylation (β = -0.06, p = 0.40), were positively associated 
with infant cortisol reactivity. The two-way interaction of rs1360780 and FKBP5 methylation 
factor 1 was significant (β = 0.11, p = 0.03), as was the three-way interaction FKBP5 rs1360780 
× FKBP5 methylation factor 1 × resistant behavior (β = 0.14, p < 0.01). T-allele carriers of FKBP5 
rs1360780 with high FKBP5 methylation factor 1 scores and high levels of resistant behavior 
had the highest cortisol reactivity.
Similarly, FKBP5 methylation factor 2 was unrelated to cortisol reactivity (β = 0.04, p = 0.77; 
Table 4). The interaction between FKBP5 rs1360780 and FKBP5 methylation factor 2 did not 
reach significance, but there was again a positive association between cortisol reactivity and 
resistant behavior (β = 0.28, p < 0.01) and a significant three-way interaction of FKBP5 rs1360780 
× FKBP5 methylation factor 2 × resistant behavior (β = 0.13, p = 0.01), again suggesting that 
Table 2. Pearson correlations (N = 298)
 1  2  3  4  5  6  7  8
1. FKBP5 rs1360780  
2. FKBP5 methylation factor 1  < -0.01
3. FKBP5 methylation factor 2  -0.03  0.34***
4. Resistant behavior  -0.02  -0.03  -0.05
5. Disorganized behavior  0.01  -0.02  < 0.01  0.19**
6. Extreme insensitivity  -0.01  0.05  0.03  0.01  0.02
7. Crying  0.02  0.01  -0.03  0.55***  0.01  0.02
8. Cortisol reactivity  0.14*  -0.04  < 0.01  0.26***  -0.07  < 0.01  0.36***
Note. FKBP5 rs1360780: CC = 0, CT = 1, TT = 2.
*p < 0.05, **p < 0.01, ***p < 0.001
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T-allele carriers of rs1360780, with high FKBP5 methylation factor 2 levels and high resistant 
behavior had the highest cortisol reactivity to the SSP.
Although resistant behavior was positively correlated with crying (r = 0.55, p < 0.001), adding 
crying as a covariate to the model did not meaningfully change the results. The three-way 
interactions of (i) FKBP5 rs1360780 × FKBP5 methylation factor 1 × resistant behavior (β = 
0.14, p < 0.01) and (ii) FKBP5 rs1360780 × FKBP5 methylation factor 2 × resistant behavior (β 
= 0.11, p = 0.03) remained significant.
Finally, to explore whether the results for the methylation factor scores were localized in 
just one or a few CpGs, or were based on the combined effect of all CpGs, the analyses were 
Table 3. Associations between FKBP5 rs1360780, FKBP5 methylation factor 1, and resistant behavior on cortisol 
reactivity during the Strange Situation Procedure (N = 298)
Model  B (95% CI) β
FKBP5 rs1360780  1.13  (0.30; 1.97) 0.13** 
FKBP5 methylation factor 1  -12.99  (-43.50; 17.53) -0.06 
Resistant behavior  1.82  (1.20; 2.45) 0.30***
FKBP5 rs1360780 × FKBP5 methylation factor 1 39.11  (3.38; 74.85) 0.11* 
FKBP5 rs1360780 × resistant behavior  0.89  (-0.14; 1.93) 0.09
FKBP5 methylation factor 1 × resistant behavior  10.43  (-19.47; 40.32) 0.04
FKBP5 rs1360780 × FKBP5 methylation factor 1 × resistant behavior  64.22  (17.34; 111.10) 0.14** 
Note. FKBP5 rs1360780: CC = 0, CT = 1, TT = 2. Analyses are adjusted for technical methylation covariates, cell 
type proportions of DNA methylation sample, infant age at assessment of SSP, infant sex, educational level of the 
mother and maternal smoking during pregnancy. The statistics are derived from the final block of the regression 
model.
*p < 0.05, **p < 0.01, ***p < 0.001.
Table 4. Associations between FKBP5 rs1360780, FKBP5 methylation factor 2, and resistant behavior on cortisol 
reactivity during the Strange Situation Procedure (N = 298)
Model  B  (95% CI)  β  
FKBP5 rs1360780 1.14  (0.30; 1.98) 0.13**
FKBP5 methylation factor 2 5.19  (-29.48; 39.86) 0.04 
Resistant behavior 1.75  (1.14; 2.36) 0.28***
FKBP5 rs1360780 × FKBP5 methylation factor 2 9.69  (-14.00; 33.37) 0.04 
FKBP5 rs1360780 × resistant behavior 0.41  (-0.58; 1.39) 0.04 
FKBP5 methylation factor 2 × resistant behavior -9.44  (-23.80; 4.91) -0.07 
FKBP5 rs1360780 × FKBP5 methylation factor 2 × resistant behavior 31.06  (6.60; 55.51) 0.13*
Note. FKBP5 rs1360780: CC = 0, CT = 1, TT = 2. Analyses are adjusted for technical methylation covariates, cell 
type proportions of DNA methylation sample, infant age at assessment of SSP, infant sex, educational level of the 
mother and maternal smoking during pregnancy. The statistics are derived from the final block of the regression 
model.
*p < 0.05, **p < 0.01, ***p < 0.001.
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repeated for each CpG separately. For methylation factor 1, three out of eight CpGs were 
associated with cortisol reactivity in the FKBP5 rs1360780 × FKBP5 CpG × resistant behavior 
interaction at the p < 0.05 level (Table 5). However, two of the other five CpGs may also have 
contributed to the FKBP5 methylation factor 1 involvement in the three-way interaction, as 
the interaction terms for two CpGs were associated with cortisol reactivity at p < 0.10. For 
methylation factor 2, four out of five CpGs were associated on the p < 0.05 with cortisol 
reactivity in interaction with FKBP5 rs1360780 and resistant behavior (Table 6). For CpGs 
of both FKBP5 methylation factors, no clear localization pattern of p < 0.05 results could be 
distinguished, as they were relatively scattered over the FKBP5 gene.
Table 5. Characteristics of the individual FKBP5 methylation factor 1 CpGs and β and p-value of the FKBP5 rs1360780 
x FKBP5 CpG beta value x resistant behavior in a regression analysis of the associations between FKBP5 rs1360780, 
FKBP5 CpG, and resistant behavior on cortisol reactivity during the Strange Situation Procedure
Three-way interaction values with 
cortisol reactivity
CpG mean beta value (SD) Factor 1 loadings β p-value
cg07061368 .89  (.03) -0.58 -0.01 0.811
cg19014730 .80  (.05) -0.76 -0.14 0.007
cg03546163 .79  (.06) -0.71 -0.12 0.017
cg00862770 .07  (.01)  0.72 0.09 0.071
cg16012111 .10  (.01)  0.63 0.04 0.453
cg00610228 .14  (.04)  0.93 0.09 0.092
cg17030679 .07  (.02)  0.55 0.07 0.210
cg25114611 .35  (.04)  0.73 0.12 0.014
Note. FKBP5 rs1360780: CC = 0, CT = 1, TT = 2. Analyses are adjusted for technical methylation covariates, cell 
type proportions of DNA methylation sample, infant age at assessment of SSP, infant sex, educational level of the 
mother and maternal smoking during pregnancy. The statistics are derived from the final block of the regression 
model.
Table 6. Characteristics of the individual FKBP5 methylation factor 2 CpGs and β and p-value of the FKBP5 rs1360780 
x FKBP5 CpG beta value x resistant behavior in a regression analysis of the associations between FKBP5 rs1360780, 
FKBP5 CpG, and resistant behavior on cortisol reactivity during the Strange Situation Procedure
Three-way interaction values with 
cortisol reactivity
CpG mean beta value (SD) Factor 2 loadings β p-value
cg07633853 .33  (.07) 0.63  0.05 0.313
cg14284211 .26  (.06) 0.90  0.14 0.006
cg03591753 .55  (.03) 0.66  0.11 0.036
cg15929276 .13  (.04) 0.47  0.13 0.008
cg23416081 .27  (.05) 0.86  0.11 0.033
Note. FKBP5 rs1360780: CC = 0, CT = 1, TT = 2. Analyses are adjusted for technical methylation covariates, cell 
type proportions of DNA methylation sample, infant age at assessment of SSP, infant sex, educational level of the 




Disorganized attachment, FKBP5 rs1360780, and FKBP5 methylation
When resistant behavior was replaced by disorganized attachment behavior in the regression 
analyses including FKBP5 methylation factor 1 and maternal extreme insensitivity, neither an 
association between cortisol reactivity and attachment disorganization (β = -0.03, p = 0.56), 
nor any two- or three-way interactions (strongest interaction with FKBP5 methylation factor 1: 
β = -0.06, p = 0.31) with disorganized behavior was found. Results were found to be similarly 
non-significant for the analyses with FKBP5 methylation factor 2 (see also Supplemental Table 
1 and Supplemental Table 2, respectively). Moreover, a z-test indicated that the main effect 
for disorganized attachment behavior and the FKBP5 rs1360780 × FKBP5 methylation factor 1 
× disorganized attachment behavior interaction differed significantly from the main effect for 
resistant behavior (z = 5.11, p < 0.01) and the FKBP5 rs1360780 × FKBP5 methylation factor 
1 × resistant behavior interaction (z = 2.78, p < 0.01).
Sensitivity Analyses
When repeating the analyses using the resistant attachment classification variable(categorical, 
resistant versus nonresistant) instead of the continuous resistant behavior score, a similar 
pattern of findings for FKBP5 methylation factor 1 was observed. That is, we observed 
a significant three-way interactions of FKBP5 rs1360780 × FKBP5 methylation factor 1 × 
resistant attachment (β = 0.19, p < 0.01) in the prediction of infant cortisol reactivity (Table 
7). The three-way interaction of FKBP5 rs1360780 × FKBP5 methylation factor 2 × resistant 
attachment was also significant (Table 8; β = 0.13, p = 0.04).
Last, we inserted the dichotomous extreme insensitivity variable in the model instead of the 
continuous variant. This yielded no significant additive or interactive associations of variables 
with the dichotomous extreme insensitivity variable involved with cortisol reactivity. This 
was the case for the analysis with FKBP5 methylation factor 1 as well as for the analysis with 
FKBP5 methylation factor 2.
Table 7. Associations between FKBP5 rs1360780, FKBP5 methylation factor 1, and resistant attachment classification 
on cortisol reactivity during the Strange Situation Procedure (N = 298)
Model  B  (95% CI)  β
FKBP5 rs1360780 1.72  (0.79; 2.65)  0.20***
FKBP5 methylation factor 1 -4.14  (-39.10; 30.81) -0.02 
Resistant attachment 1.86  (1.26; 2.47)  0.30***
FKBP5 rs1360780 × FKBP5 methylation factor 1 72.95  (32.75; 113.15)  0.20***
FKBP5 rs1360780 × resistant attachment 1.12  (0.20; 2.05)  0.13* 
FKBP5 methylation factor 1 × resistant attachment 18.15  (-10.02; 46.32)  0.08
FKBP5 rs1360780 × FKBP5 methylation factor 1 × resistant attachment 69.22  (29.10; 109.34)  0.19** 
Note. FKBP5 rs1360780: CC = 0, CT = 1, TT = 2. Analyses are adjusted for technical methylation covariates, cell 
type proportions of DNA methylation sample, infant age at assessment of SSP, infant sex, educational level of the 
mother and maternal smoking during pregnancy. The statistics are derived from the final block of the regression 
model.
*p < 0.05, **p < 0.01, ***p < 0.001.




In this population-based cohort study, we found that resistant attachment behavior and FKBP5 
rs1360780 genotype were associated with cortisol reactivity both in an additive and in an 
interactive manner. Methylation of the FKBP5 gene moderated the relationship between FKBP5 
rs1360780 genotype and cortisol reactivity, in that rs1360780 T-carriers had an even higher 
chance of increased cortisol reactivity, when they also had a high FKBP5 methylation factor 
1 score. This might suggest that DNA methylation patterns affect transcription of the FKBP5 
gene to influence subsequent stress responses. The modification of the rs1360780 association 
with cortisol reactivity by FKBP5 methylation factor 1 score, seemed especially pronounced 
in infants who displayed resistant attachment behavior towards their mother. Results for the 
analysis with methylation factor 2 and with the resistant attachment classification corroborated 
these findings. It is noteworthy that the interaction between rs1360780 and methylation was 
specifically modified by resistant attachment behavior, and not by disorganized attachment.
Although our study shows promising findings and does support the potentially important 
role of DNA methylation in infant cortisol reactivity, it should be emphasized that the study 
must be firmly placed in the context of discovery44. For several reasons it is too early for 
this and related human development studies on DNA methylation to provide more definite 
confirmation or falsification of hypotheses or theories in the context of justification. First, 
little is known about the metric qualities of DNA methylation indices. For example, stability 
of DNA methylation across time has not yet been examined thoroughly for most genes 
and developmental periods (see Wong et al.45, for an exception). Second, it is still not fully 
clear whether and how strongly DNA methylation patterns in blood and brain regions are 
associated26. Some recent studies show significant convergence between FKBP5 methylation 
Table 8. Associations between FKBP5 rs1360780, FKBP5 methylation factor 2, and resistant attachment classification 
on cortisol reactivity during the Strange Situation Procedure (N = 298)
Model  B  (95% CI)  β  
FKBP5 rs1360780 1.61  (0.66; 2.56)  0.19**
FKBP5 methylation factor 2 1.64  (-34.35; 37.63)  0.01 
Resistant attachment 1.80  (1.19; 2.41)  0.29***
FKBP5 rs1360780 × FKBP5 methylation factor 2 25.82  (-3.06; 54.70)  0.11 
FKBP5 rs1360780 × resistant attachment 0.99  (0.04; 1.94)  0.12*
FKBP5 methylation factor 2 × resistant attachment -8.64  (-25.60; 8.33) -0.06 
FKBP5 rs1360780 × FKBP5 methylation factor 2 × resistant attachment 30.07  (1.63; 58.52)  0.13*
Note. FKBP5 rs1360780: CC = 0, CT = 1, TT = 2. Analyses are adjusted for technical methylation covariates, cell 
type proportions of DNA methylation sample, infant age at assessment of SSP, infant sex, educational level of the 
mother and maternal smoking during pregnancy. The statistics are derived from the final block of the regression 
model.
*p < 0.05, **p < 0.01, ***p < 0.001.
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derived from peripheral blood and brain tissue46, 47, but more research is certainly needed. 
Third, most studies on DNA methylation in the domain of developmental psychopathology are 
severely underpowered with potentially quite a few false positive findings that may turn out 
to be impossible to replicate. In an epigenome-wide study of a large Generation R sample of 
912 families, we were unable to replicate our suggestive findings on the association between 
maternal prenatal stress and neonatal DNA methylation in another large sample of 828 families, 
the Avon Longitudinal Study of Parents and Children, ALSPAC48. Our current study on almost 
300 children is one of the largest candidate-(epi)gene studies on DNA methylation, but still 
underpowered in view of the Gene × Methylation × Environment27, 49 (G × M × E) three-way 
interactions. Independent replication is therefore badly needed48.
It is somewhat assuring that our findings are in line with Klengel et al.15, who found an association 
between FKBP5 methylation and HPA axis regulation, particularly in FKBP5 rs1360780 T allele 
carriers. However, their sample size for these analyses was only 76 with 30 highly traumatized 
cases and 46 controls in one of their central epigenetic analyses. Paquette et al.31 also found 
an association between placental FKBP5 methylation and postnatal infant arousal, but this was 
specific for infants with the FKBP5 rs1360780 CC genotype. One explanation for this diverging 
result might be that arousal is regulated by the autonomic nerve system, which is related 
to the HPA axis, but does not completely overlap in its function and activity. Also, whereas 
Klengel et al.15 and Paquette et al.31 specifically found effects of methylation of CpG sites in 
intron 7 of the FKBP5 gene, we considered methylation of all FKBP5 CpG sites that contributed 
meaningfully to one of two factors (as in Philibert et al.50). Since these factors, which included 
CpG sites with positive as well as negative factor loadings, were found to be associated with 
cortisol reactivity, it might be that the effects of DNA methylation are less unidirectional than 
assumed previously. Exploratory analyses also showed that the individual CpGs contributing 
to the FKBP5 methylation factor scores were quite scattered along the FKBP5 gene, rather 
than being localized in a specific part. Unfortunately, the different methodologies for DNA 
methylation detection employed do not allow for direct comparison of our approach with 
those of Klengel et al.15 and Paquette et al.31.
The interaction between FKBP5 rs1360780 and FKBP5 methylation was only found in children 
with resistant but not with disorganized attachment behavior. This is somewhat unexpected, 
since disorganized attachment has been related to dysregulation of the HPA axis functioning 
in a number of studies10, 11, 51. Another remarkable result is the negligible role of maternal 
extreme insensitivity in the prediction of cortisol reactivity, since we had expected that 
infants of mothers displaying extreme insensitive parenting behaviors would show increased 
cortisol reactivity. Perhaps our relatively brief observation in a lab setting was not optimal to 
register maternal extreme insensitivity. Moreover, the non-clinical nature of the sample may 
also have contributed to the skewedness of the distribution, thereby hindering detection of 
associations with maternal extreme insensitivity. This might also explain the lack of association 
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between maternal extreme insensitivity and disorganized attachment. Future research on 
maternal extreme insensitivity therefore might include more high-risk populations than the 
one examined here, which could possibly also help in further exploring the (epi-)genetic 
differences in stress regulation between children with disorganized and resistant attachments.
Some limitations of the current study should be mentioned. First, DNA methylation levels 
were measured in cord blood at birth, whereas cortisol reactivity was measured at 14 months. 
Neonatal DNA methylation might be influenced by prenatal environmental factors such as 
maternal smoking19, 52 or prenatal stress53. An important question that remains unanswered, is 
whether DNA methylation levels are stable between birth and our behavioral observations at 
14 months. However, based on Klengel et al.’s15 finding that trauma during childhood affects 
FKBP5 methylation in a way that dysregulates HPA axis functioning, one might speculate that 
insecure-resistant mother-child attachment—although not traumatizing in and of itself of 
course—could affect FKBP5 methylation over the first year of life, so that its associations with 
cortisol reactivity would have been even stronger with FKBP5 methylation measured at 14 
months than at birth. In order to attain a more complete picture of the role of epigenetics in 
shaping the relations between parenting, attachment and stress regulation, longitudinal and 
experimental research is needed to test whether the quality of parenting (i.e., sensitivity) and 
the attachment relationship in itself can affect DNA methylation. Longitudinal data on DNA 
methylation of stress-related genes at multiple time-points may be informative, as well as 
pre- and posttest assessments of DNA methylation patterns in randomized controlled trials 
aiming at enhancing the quality of parent-child interactions and relationship54.
Second, another limitation may be the candidate-(epi-)gene approach that limits the analysis 
to one specific gene, i.e. the FKBP5 gene, in combination with a single SNP, i.e. rs1360780, 
which was a logical follow-up on the study performed by Luijk, Velders, et al.17. It would be 
interesting to try and obtain a more complete picture of DNA methylation in stress regulation 
by including more SNPs of the FKBP5 gene as well as other genes related to cortisol reactivity 
(e.g., NR3C153; or KITLG55). Combinations of such HPA-axis related genes into a genetic 
pathway might provide a better basis for a wider epigenetic search into the influence of DNA 
methylation patterns on stress regulation. It should be noted, however, that focusing on 
methylation patterns of a single gene with documented functionality for the phenotype of 
interest has the advantage of better localization of the effect and of optimizing the statistical 
power that is often lacking in hypothesis-free approaches. Nevertheless, our results are based 
on a complicated three-way interaction (G × M × E) and should be replicated in independent 
samples. In such studies, the factor-analytic method to examine the dimensionality of an 
interrelated set of CpG beta values may reduce the number of tests that otherwise would 
lower statistical power. More specifically, this G × M × E study shows that stress regulation 
in an infant with a resistant attachment to their mother is more likely to be problematic 
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when the infant is a FKBP5 rs1360780 T-carrier and even more so when it also has a higher 
methylation factor score.
In sum, the current findings are a valuable extension of our earlier results on attachment, 
FKBP5 rs1360780 and cortisol reactivity in that genetic effects on child outcomes may be better 
specified when DNA methylation is taken into account. Moreover, whereas most research 
on FKBP5 methylation focuses on extreme circumstances in early life, this study reveals that 
DNA methylation plays a role in coping with everyday stressors in a non-clinical population. 
Although we emphasize that epigenetic studies on (child developmental) psychopathology are 
still in an exploratory stage, neglect of DNA methylation and other regulatory mechanisms in 
molecular genetic studies increases the risk that an incomplete picture of associations between 
genes, environment and development is created25. The study of epigenetics is therefore an 
important asset to the field of developmental psychopathology, and a crucial move to the 
biological level of gene-by-environment interplay.
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Supplemental Table 1. Associations between FKBP5 rs1360780, FKBP5 methylation factor 1, disorganized behavior, 
and extreme insensitivity on cortisol reactivity during the Strange Situation Procedure (N = 298)
Model  B  (95% CI)  β
FKBP5 rs1360780 1.05  (0.15; 1.95)  0.12*
FKBP5 methylation factor 1 -23.11  (-55.80; 9.59) -0.10
Disorganized behavior -0.10  (-0.42; 0.23) -0.03
Extreme insensitivity -0.26  (-1.06; 0.53)  -0.04
FKBP5 rs1360780 × FKBP5 methylation factor 1 35.39  (-3.35; 74.13)  0.10
FKBP5 rs1360780 × disorganized behavior 0.16  (-0.37; 0.68)  0.03
FKBP5 methylation factor 1 × disorganized behavior -7.26  (-21.36; 6.83) -0.06
FKBP5 rs1360780 × extreme insensitivity -0.86  (-2.19; 0.48)  -0.07
FKBP5 methylation factor 1 × extreme insensitivity -2.83  (-30.48; 24.82)  -0.01
Disorganized behavior × extreme insensitivity -0.22  (-0.77; 0.33)  -0.05
Note. FKBP5 rs1360780: CC = 0, CT = 1, TT = 2. Analyses are adjusted for technical methylation covariates, cell 
type proportions of DNA methylation sample, infant age at assessment of SSP, infant sex, educational level of the 
mother and maternal smoking during pregnancy. The statistics are derived from the final block of the regression 
model.
None of the possible three-way interactions was significantly associated with cortisol reactivity.
*p < 0.05.
Supplemental Table 2. Associations between FKBP5 rs1360780, FKBP5 methylation factor 2, disorganized behavior, 
and extreme insensitivity on cortisol reactivity during the Strange Situation Procedure (N = 298)
Model  B  (95% CI)  β
FKBP5 rs1360780 1.02  (0.11; 1.93)  0.12*
FKBP5 methylation factor 2 3.16  (-34.33; 40.64)  0.02
Disorganized behavior -0.04  (-0.36; 0.27)  -0.02
Extreme insensitivity -0.22  (-0.98; 0.55) -0.03
FKBP5 rs1360780 × FKBP5 methylation factor 2 7.68  (-18.39; 33.75)  0.03
FKBP5 rs1360780 × disorganized behavior 0.11  (-0.42; 0.65)  0.02
FKBP5 methylation factor 2 × disorganized behavior 1.66  (-6.96; 10.27)  0.02
FKBP5 rs1360780 × extreme insensitivity -0.84  (-2.22; 0.55)  -0.07
FKBP5 methylation factor 2 × extreme insensitivity 3.84  (-19.22; 26.91) 0.02 
Disorganized behavior × extreme insensitivity -0.27  (-0.81; 0.27)  -0.06
Note. FKBP5 rs1360780: CC = 0, CT = 1, TT = 2. Analyses are adjusted for technical methylation covariates, cell 
type proportions of DNA methylation sample, infant age at assessment of SSP, infant sex, educational level of the 
mother and maternal smoking during pregnancy. The statistics are derived from the final block of the regression 
model.
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Background: Experimental work in animals has shown that DNA methylation, an epigenetic 
mechanism regulating gene expression, is influenced by typical variation in maternal 
care. While emerging research in humans supports a similar association, studies to date 
have been limited to candidate gene and cross-sectional approaches, with a focus on 
extreme deviations in the caregiving environment.
Methods: Here, we investigated the prospective association between typical variation in 
maternal sensitivity and offspring epigenome-wide DNA methylation, in a population-
based cohort of children (N = 235). Maternal sensitivity was observed when children were 
three- and four-years-old. DNA methylation, quantified with the Infinium 450K array, 
was extracted at age six (whole blood). The influence of methylation quantitative trait 
loci (mQTLs), DNA methylation at birth (cord blood), and confounders (socioeconomic 
status, maternal psychopathology) was considered in follow-up analyses.
Results: Genome-wide significant associations between maternal sensitivity and offspring 
DNA methylation were observed at 13 regions (p < 1.06x10-07), but not at single sites. 
Follow-up analyses indicated that associations at these regions were in part related to 
genetic factors, confounders, and baseline DNA methylation levels at birth, as evidenced 
by the presence of mQTLs at five regions and estimate attenuations. Robust associations 
with maternal sensitivity were found at four regions, annotated to ZBTB22, TAPBP, 
ZBTB12, and DOCK4.
Conclusions: These findings provide novel leads into the relationship between typical 
variation in maternal caregiving and offspring DNA methylation in humans, highlighting 
robust regions of associations, previously implicated in psychological and developmental 




Parental sensitivity, i.e. the responsiveness to children’s signals and communications, is an 
important predictor of developmental outcomes across the behavioral, emotional, and cognitive 
domains1–3. Low sensitivity of primary caregivers–typically mothers–has been associated with a 
host of negative outcomes, including higher risk for child psychopathology4,5, externalizing and 
internalizing problems1,6, and lower cognitive abilities7. This influence can be long-lasting, as 
shown by prospective human studies8,9 and experimental work in animals10. Yet, the molecular 
mechanisms underlying the enduring effects of maternal care on neurodevelopmental and 
behavioral outcomes in humans remain unclear.
Previous studies have provided initial support for DNA methylation–an epigenetic modification 
regulating gene expression–as a mechanism of interest for these processes11–13. DNA methylation 
involves the addition of a methyl group to DNA base pairs, primarily to the 5-carbon of cytosine 
nucleotides, resulting in 5-methylcytosine. DNA methylation is sensitive to both environmental 
and genetic influences13–15, with the latter being evidenced by changes in the methylome 
due to DNA variation, named methylation quantitative trait loci (mQTLs)16. Further, DNA 
methylation plays an essential role in healthy development and functioning by modulating 
the programming of wider biological systems (e.g. neural and immune functioning) and by 
coordinating key cellular processes (e.g. tissue differentiation)17. DNA methylation might 
thus represent a mechanism by which genetic and environmental factors, including the early 
caregiving environment, jointly and/or independently predict developmental outcomes14.
Most evidence of maternal care effects on DNA methylation comes from animal models. 
In a seminal study by Weaver et al.13, low levels of maternal care in the first week of life – 
operationalized as the frequency of licking/grooming and arched-back nursing behaviors–
altered DNA methylation patterns in offspring at the glucocorticoid receptor (GR, also known 
as NR3C1), a key regulator of stress response18. Importantly, these epigenetic changes were 
long-lasting, but could be reversed via cross-fostering or chemical interventions, leading to a 
normalization of physiological and behavioral responses to stress13,19. These findings generated 
widespread interest, as they indicated (i) a causal role of maternal care on offspring’s epigenetic 
dysregulation and downstream phenotypes, independent of genetic liability, and (ii) the 
possibility of influencing developmental trajectories through environmental interventions, 
mediated by DNA methylation. Since this initial work, other studies have replicated the effects 
of maternal care on gr methylation in rodents20 and extended findings to demonstrate DNA 
methylation changes in other tissues and genes21–23 (e.g. brain derived neurotrophic factor 
(BDNF) and oxytocin receptor (OXTR)) as well as in other species such as rhesus macaques24.
Although rodents and primates widely differ from humans in their caregiving, a number of 
similarities in maternal-infant relationships have been observed across mammalian species25,26. 
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Parallels at the sensory, hormonal, behavioral, and brain circuit levels have been noted25–27, 
including the touch-based behavior characterizing rodents, primates, and humans in the early 
caregiving and the involvement of the limbic network in maternal-infant relationships25. Guided 
by the animal literature, a growing number of studies have sought to determine the extent 
to which different forms of caregiving and adversities affect DNA methylation in humans.
Human studies have focused on different forms of adversities28 including poly-victimization29, 
and on extreme deviations in the early caregiving environment, such as maltreatment30–34, 
institutionalization35, and maternal psychopathology36. Generally, literature focusing on 
the caregiving environment has provided preliminary support in line with animal findings, 
identifying, for example, similar increases in GR methylation in both postmortem hippocampal 
tissue and peripheral tissues from individuals exposed to childhood maltreatment or early-
life stress20. Studies also indicate that epigenetic patterns associated with the caregiving 
environment extend beyond GR, implicating other genes related to, among other processes, 
neurodevelopment and stress, such as OXTR and BDNF. Moreover, by leveraging epigenome-
wide DNA methylation, novel genes were identified (e.g. KCNQ2, miR124-3) in relation to 
maltreatment and child abuse in individuals with post-traumatic stress disorder32, borderline 
personality disorder33, and depression34.
While these results are promising and suggest a role of the caregiving environment in the 
human methylome, the current evidence in humans is limited in a number of key ways. First, 
since research has mostly focused on extreme deviations in the caregiving environment in 
selected samples, little is known about how typical variation in maternal sensitivity associates 
with offspring DNA methylation in the general population. Second, while studies on extreme 
deviations in maternal care have leveraged epigenome-wide approaches, literature on 
normative variation in maternal care has solely focused on candidate genes. This has impeded 
the identification of novel DNA methylation loci associated with maternal sensitivity, which 
might instead be detected with a hypothesis-free approach by performing an epigenome-wide 
association study (EWAS). Third, studies have typically relied on cross-sectional designs, in which 
the early caregiving environment is measured retrospectively via the use of questionnaires, 
raising doubts about the directionality of observed associations and about the validity of 
measurements, which may be prone to recall bias37,38. Moreover, previous studies rarely 
investigated whether the identified associations may be confounded by genetic background 
shared between parents and offspring. The examination of the relationship between maternal 
care and DNA methylation might indeed capture intergenerational genetic transmission. 
Lastly, the influence on offspring DNA methylation of factors preceding postnatal maternal 
care, including the prenatal environment, remains unexplored.
To address these gaps, we firstly examined how typical variation in observed maternal 
sensitivity prospectively associates with epigenome-wide DNA methylation patterns in a 
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general population of children. Secondly, with a series of follow-up analyses, we explored 
the extent to which associations reflected genetic influences as well as confounding by 
“baseline” DNA methylation levels at birth, which precede exposure to postnatal maternal 
care and might constitute a biological indicator of the prenatal environment as well as of 
genetic effects on the methylome.
Materials and Methods
Participants
The present research was embedded in the Generation R Study, a prospective population-
based cohort study from fetal life onwards in Rotterdam, The Netherlands39 (Supplemental 
Information 1). Ethical approval was obtained from the Medical Ethics Committee of Erasmus 
MC, University Medical Center Rotterdam. For the purposes of this study, children within the 
Generation R Study with data on maternal sensitivity (at three and/or four years) and DNA 
methylation (at six years) were selected (N = 235). Since 5 sibling-pairs were present, we later 
excluded one sibling per pair (N = 230) to ensure genetic relatedness did not impact results.
Participant characteristics are shown in Supplemental Table 1. Participants with data on both 
maternal sensitivity and DNA methylation (age six) differed from participants invited to the 
age six assessment in gestational age at birth (Msubsample = 40.3 weeks (SD = 1.4), Mfullsample = 
39.8 (SD = 1.9), t = 5.6, p = 6.50x10-08), but not other covariates.
Measures
Maternal sensitivity
Maternal sensitivity was assessed at ages three and four years through observations of mother-
child interactions during teaching tasks too complex for the age of the child. These involved 
(i) building a tower and (ii) completing an etch-a-sketch drawing. Mother-child interactions 
were recorded and subsequently coded, according to the revised Erickson 7-point rating scales 
40, based on two interdependent subscales: intrusiveness (IN) and supportive presence (SP), 
which together form the maternal sensitivity construct. Inter-coder reliability amounted to 
0.81 at age three and 0.84 at age four 41.
Eight measures of maternal sensitivity (i.e. IN and SP scales x two tasks x two time-points) 
were available. IN scores were reversed, and both IN and SP scores were standardized. An 
overall maternal sensitivity score was calculated, for participants with data at age three 
and/or four, by averaging such standardized measures42. This was done in line with previous 
literature41, due to the stability of the maternal sensitivity scores between age three and four 
years 1, the temporality of these assessments, which both precede DNA methylation at age 
Epigenome-wide associations with maternal sensitivity
85
IV
six, and to maximize our sample size. Cronbach’s alpha reliability of the obtained measure 
was acceptable (Cronbach’s α = 0.70)43.
DNA methylation
DNA methylation in whole blood at age six was used for our epigenome-wide analyses. 
This was selected due to it being the closest DNA methylation assessment after maternal 
sensitivity observations (age three and four years), and to test the prospective association 
of maternal sensitivity with DNA methylation. Based on previous studies in animals, which 
found maternal care to have long-lasting influences on the methylome13, we expected for 
maternal care effects to endure in early childhood.
To obtain DNA methylation data, DNA extraction and bisulfite conversion via the EZ-96 DNA 
Methylation kit (Shallow) (Zymo Research Corporation, Irvine, USA) were performed, and 
samples were processed with the Illumina Infinium HumanMethylation450 BeadChip (Infinium 
450K), which measures 485 577 CpGs. The incorporating control probe adjustment and 
reduction of global correlation pipeline44 was employed for the preparation and normalization 
of the data using R. Firstly, the minfi package45 in R was used to read the idat files. Probes 
that had a detection p-value above background (based on the sum of methylated and 
unmethylated intensity values) ≥ 1E-16 were set to missing per array. Next, the intensity values 
were stratified by autosomal and non-autosomal probes and quantile normalized for each 
of the six probe-type categories separately: type II red/green, type I methylated red/green 
and type I unmethylated red/green. For each probe, DNA methylation levels were indexed 
by beta values (i.e. the ratio of methylated signal divided by the sum of the methylated and 
unmethylated signal [M / (M + U + 100)]). Quality control procedures were additionally 
performed (e.g. check for sex mismatch). Only arrays with a call rate above 95% per sample 
were considered for additional processing. DNA methylation data was winsorized (> 3 SD) 
to reduce the influence of potential outliers. In total, we obtained information on 457,872 
autosomal sites in 493 six-year-olds.
We additionally used DNA methylation data collected at birth in cord blood for a follow-up 
analysis. This was subject to the same pipeline as the DNA methylation data at age six and 
was also measured based on the Infinium 450K BeadChip. Only CpGs identified as significant 
or within DNA methylation significant regions were selected for these analyses.
Covariates
All analyses were adjusted for a key set of potential covariates guided by previous literature46–49, 
including batch effects (plate number), sex, gestational age at birth, maternal smoking during 
pregnancy (never smoked, smoked until pregnancy known, continued during pregnancy), and 
estimated cell-type proportions50 (Supplemental Information 1). We additionally adjusted 
for two sets of covariates: (i) maternal education (highest level completed) as proxy for 
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socioeconomic status, and postnatal maternal psychopathology (Brief Symptom Inventory), 
and (iii) DNA methylation levels at birth (cord blood tissue), together with respective cell-type 
and batch effect adjustments (Supplemental Information 1).
Statistical Analyses
Analyses were performed in R (version 4.0.0) and are described in-depth in Supplemental 
Information 1. A probe-level EWAS (multiple linear regression models) was run with the CpGassoc 
R package51, to test for associations of maternal sensitivity with each DNA methylation site 
individually (Bonferroni epigenome-wide significance threshold: p < 1.09x10-07). To account 
for potential bias and inflation, the BACON R package52 was used.
Moreover, to capture correlations across CpGs, reduce data dimensionality, and attenuate 
the multiple testing burden, a regional-level EWAS was performed by using the R package 
DMRff53. This estimates correlations across nominally-significant probes within a 500 bp 
window (default setting) and combines the EWAS summary statistics of such neighboring 
CpGs to identify differentially methylated regions while accounting for multiple testing with 
a Bonferroni procedure in both gene regions and sub-regions54.
A candidate gene look-up was also performed to maximize comparability with previously 
reported DNA methylation-maternal care associations. To date, DNA methylation levels of 
four genes have been associated with maternal care in humans55–58, by at least one study: 
GR, BDNF, the serotonin receptor (SLC6A4), and OXTR. We looked-up the EWAS results for 
probes located within these genes, as annotated in the HumanMethylation450 v1.2 Manifest 
File. Following previous studies29,59, gene-level Bonferroni correction was used as significance 
threshold (i.e. p < 0.05/number of annotated probes).
To identify enriched biological pathways, we performed an in-house gene ontology (GO) 
analysis59–61 on sites with p < 0.001 in the probe-level EWAS, in line with previous literature59,60,62,63. 
We performed p-value adjustments based on default procedures 61. Enriched pathways were 
confirmed by an independent GO approach from the missMethyl R package64 (p < 0.05).
Finally, a series of follow-up analyses were run. Firstly, the influence of genetic factors 
on our top hits (i.e. Bonferroni-significant sites or sites within Bonferroni-significant DNA 
methylation regions) was assessed by drawing on an mQTL database16 (www.mqtldb.org). 
We examined whether hits were associated with known mQTLs during childhood, based on 
the results from a genome-wide complex trait conditional analysis. Secondly, we explored 
the robustness of top hits to additional adjustments for (i) postnatal maternal education and 
maternal psychopathology (N = 223) and (ii) pre-exposure DNA methylation (N = 226). The 
latter was done to account for the effect of DNA methylation at birth on DNA methylation at 
age six and to capture potential pre-existing influences (e.g. intrauterine exposures) on DNA 
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methylation in childhood. Spearman correlations between DNA methylation at birth and age 
six were also calculated, per CpG. Thirdly, based on a list of our CpG hits, the in-house gene 
ontology analysis and missMethyl validation were run, with the same procedures as the main 
GO analysis specified above. Finally, to understand the relevance of our findings to the brain, 
which is linked to the caregiving environment13,41, we looked up brain-blood concordance 
values for our top hits using the BECon online tool (https://redgar598.shinyapps.io/BECon/)65.
Results
Probe-level EWAS
Maternal sensitivity was not associated with any single CpGs at age six, after genome-wide 
correction (p < 1.09x10-07) (Figure 1, Supplemental Table 2). BACON analysis revealed a normal 
lambda (λ = 1.00), minimal bias (Bayesian estimate of bias = –0.002) and deflation in the test 
results – indicative of low power (Bayesian inflation factor = 0.925) (Supplemental Figure 
1). Following BACON correction for deflation, one intergenic CpG reached genome-wide 
significance: cg25628898 (estimate = –0.008; SE = 0.002; p = 1.03x10-07) (Supplemental Table 2).
Figure 1. Manhattan plot of CpG sites associated with maternal sensitivity
Note. The Manhattan plot displays the log p-values for each site tested in association with maternal sensitivity in  




With a regional-level EWAS, we identified 13 DNA methylation regions associated with maternal 
sensitivity (p < 1.06x10-07; α = 0.05) (Table 1, Figure 2, Supplemental Table 3), spanning 143 CpGs. 
The top three DNA methylation regions coincided with the ANKMY1, RNF39, and ZBTB22 and 
TAPBP genes (Table 1). The largest estimates were shown at regions encompassing COLEC11 
and DOCK4. None of the CpGs within our significant regions was related to prenatal maternal 
smoking, based on previous research in neonates and children66,67, suggesting adjustments 
in the EWAS accounted for its confounding role. When siblings (N = 230) were excluded all 
but one region (annotated to RNF5P1, RNF5, AGPAT1) remained significantly associated with 
maternal sensitivity.
Figure 2. Miami plot of DNA methylation regions associated with maternal sensitivity
Note. The Miami plot displays the log p-values and estimates direction for each DNA methylation region tested 
in association with maternal sensitivity, across autosomal chromosomes. Thirteen regions were Bonferroni 
significant, three of which showed a positive relation with maternal sensitivity and 10 a negative one.




The candidate gene look-up showed that, of the four selected genes (NR3C1, BDNF, SLC6A4, 
OXTR), which included 14 to 74 sites, no CpG met Bonferroni-adjusted gene-wide significance 
in association with maternal sensitivity (Table 2, Supplemental Table 4). Only three sites 
reached nominal significance (p < 0.05).
Gene ontology
The in-house GO analysis, based on sites with p < 0.001 in the probe-level EWAS, revealed 
enrichment for 148 pathways. Yet, this threshold might have been overinclusive. Thirty-nine 
of the 148 pathways were confirmed by the missMethyl GO method (p < 0.05) (Supplemental 
Table 5). Both methods indicated enrichment for, among others, calcium ion channels 
functioning, phosphorylation, and tissue and cell polarity.
Follow-up analyses
Firstly, an mQTL search revealed that five of the 13 significant DNA methylation regions 
contained at least one CpG associated with one or more known SNPs (Table 3, Supplemental 
Table 1. DNA methylation regions significantly associated with maternal sensitivity from the regional-level EWAS










chr2: 241458886-241460002 ANKMY1 8 0.365 0.043 1.17E-17 5.61E-12
chr6: 30039027-30039600 RNF39 22 -0.227 0.028 5.03E-16 2.42E-10
chr6: 33282879-33283184 ZBTB22; TAPBP 17 -0.215 0.027 1.83E-15 8.77E-10
chr2: 21266727-21267334 APOB 10 -0.302 0.040 2.83E-14 1.36E-08
chr2: 3642629-3642867 COLEC11 6 -0.875 0.135 9.80E-11 4.71E-05
chr17: 6797034-6797771 ALOX12P2 6 -0.571 0.088 1.00E-10 4.80E-05
chr7: 111368367-111368847 DOCK4 4 -0.822 0.127 1.02E-10 4.90E-05
chr6: 32145383-32146595 RNF5P1; RNF5; 
AGPAT1*
27 0.047 0.007 3.55E-10 0.000171
chr7: 158749953-158751591 Non-annotated 
region
8 0.558 0.090 4.80E-10 0.000231
chr6: 33280149-33280436 TAPBP 9 -0.282 0.046 8.89E-10 0.000427
chr6: 31867757-31868169 ZBTB12 19 -0.100 0.018 2.35E-08 0.011285
chr4: 147164778-147165097 Non-annotated 4 0.427 0.077 2.53E-08 0.012128
chr1: 11714218-11714254 FBXO44; FBXO2 3 -0.439 0.081 5.82E-08 0.027955
DNAm region location = Genomic location of the DNA methylation region (chromosome, start position, and end 
position)
Annotated gene(s) = Gene(s) annotated to the CpGs within the DNA methylation region
N CpGs included = Number of CpGs included in the DNA methylation region
Estimate = Estimate for the association of maternal sensitivity with DNA methylation at a region
Standard error = Standard error for the association of maternal sensitivity with DNA methylation at a region
Raw p-value = Unadjusted p-value for the association of maternal sensitivity with DNA methylation at a region
Bonferroni adj. p-value = P-value adjusted for multiple testing with Bonferroni correction
*This region was not genome-wide significant when siblings were excluded from the sample.
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Table 6). Eight regions, including ZBTB22/TAPBP (one of our top regions), did not present any 
mQTLs. Of the 143 sites within the 13 significant regions, 22% (n = 31) associated with one 
or more known SNPs. All associations were in cis.
Secondly, after additional adjustments for socioeconomic status and maternal psychopathology, 
associations attenuated at seven regions (median = -1%, range = –44%–13%). Regions which 
did not decrease in effect were TAPBP, RNF39, two non-annotated regions, ANKMY1, and 
ALOX12P2 (Supplemental Table 7). When adjusting for pre-exposure DNA methylation levels, 
(Supplemental Table 8), associations attenuated at ten regions (median = -45%, range = 
-97%–17%), with RNF39 being the most affected. Regions whose estimates did not decrease 
were ZBTB12, FBXO44/FBXO2, and a non-annotated region (chromosome 7). The median 
correlation between each CpG DNA methylation levels at birth and age six was of Rho = 0.43 
(range: 0.11 – 0.86) (Supplemental Table 9).
Thirdly, in a follow-up GO analysis, based on the sites within the significant DNA methylation 
regions (n = 143), enrichment was found at 63 pathways (in-house method). Of these, 33 were 
validated by missMethyl (p < 0.05). Both methods indicated enrichment for, among others, 
several lipoprotein processes (e.g. particle remodeling), and peptide binding (Supplemental 
Table 10).
Lastly, of the 13 significant DNA methylation regions, six contained half or more sites with 
greater than average blood-brain tissue concordance 65 in at least one brain tissue (for BA7 
r > |.36|, for BA10 r > |.40|, for BA20 r > |.33|), for a total of 67 sites (Supplemental Table 
11) (not empirically tested).
Table 2. The association between maternal sensitivity and DNA methylation: Candidate gene look-up
Gene Chr N probes Gene-level 
sign.




% Negative  
associations 
NR3C1 5 40 No Yes (cg17342132) -0.004–0.006 65% 35%
BDNF 11 74 No Yes (cg26840770) -0.010–0.005 50% 50%
SLC6A4 17 14 No Yes (cg06841846) -0.004–0.005 29% 71%
OXTR 3 18 No No -0.006–0.006 56% 44%
Gene = Candidate gene
Chr = Chromosome
N probes = Number of probes annotated to the gene (based on the Infinium 450K)
Gene-level sign. = Gene-level Bonferroni significance in any of the probes annotated to the candidate gene (p < 
0.05/number of annotated probes)
Nominal sign. = Nominal significance in any of the probes annotated to the candidate gene (p < 0.05)
Estimate range = Range of estimates for the probes annotated to the candidate genes
% positive associations = Percentage of probes with a positive association with maternal sensitivity
% negative associations = Percentage of probes with a negative association with maternal sensitivity




This is the first epigenome-wide study investigating the prospective association between 
typical variation in maternal sensitivity (observed) and offspring DNA methylation, in a 
general population of children. Genome-wide significant associations were observed at 13 
DNA methylation regions, four of which did not contain mQTLs and were minimally affected 
by adjustments for postnatal confounders and by pre-exposure DNA methylation levels, thus 
showing robustness in associations.
Summary of Key Findings
Our first aim was to examine the prospective relationship between maternal sensitivity and 
child DNA methylation using complementary approaches. Firstly, no individual CpG was 
identified in the probe-level EWAS after genome-wide correction. This might indicate that 
associations at a site-level are subtle and challenging to identify, especially considering this 
study assessed typical variation in maternal care as opposed to extreme deviations (e.g. 
abuse). The high multiple testing correction burden that probe-level EWASs entail may also 
impede the detection of single sites of small effect, which could be uncovered with larger 
Table 3. mQTLs within the statistically significant DNA methylation regions
DNAm region location Annotated gene(s) N CpGs 
included
N mQTL  
associations




chr2: 241458886-241460002 ANKMY1 8 16 7 88%
chr6: 30039027-30039600 RNF39 22 0 0 0%
chr6: 33282879-33283184 ZBTB22; TAPBP 17 0 0 0%
chr2: 21266727-21267334 APOB 10 19 10 100%
chr2: 3642629-3642867 COLEC11 6 6 6 100%
chr17: 6797034-6797771 ALOX12P2 6 0 0 0%
chr7: 111368367-111368847 DOCK4 4 0 0 0%
chr6: 32145383-32146595 RNF5P1; RNF5; AGPAT1 27 0 0 0%
chr7: 158749953-158751591 Non-annotated region 8 5 5 63%
chr6: 33280149-33280436 TAPBP 9 0 0 0%
chr6: 31867757-31868169 ZBTB12 19 0 0 0%
chr4: 147164778-147165097 Non-annotated region 4 0 0 0%
chr1: 11714218-11714254 FBXO44; FBXO2 3 3 3 100%
Total 143 49 31 22%
DNAm region location = Genomic location of the DNA methylation region (chromosome, start position, and end 
position)
Annotated gene(s) = Gene(s) annotated to the DNA methylation region
N CpGs included = Number of CpGs included in the DNA methylation region
N mQTL associations = Number of SNPs – DNA methylation associations at a region
N CpGs with mQTLs = Number of CpGs presenting one or more mQTL(s) at a region
% CpGs with mQTLs = Percentage of CpGs presenting one or more mQTL(s) at a region
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samples. For instance, with our sample (N = 235) and model (multiple linear regression, 10 
predictors), 80% power, and a genome-wide threshold, only moderate estimates (as small 
as 0.27) could be detected.
When employing a regional approach, which can detect weaker but more widespread signals 
by accounting for correlations across CpGs, 13 DNA methylation regions were significantly 
associated with maternal sensitivity (p < 1.06x10-07, α = 0.05). These findings support the 
presence of offspring methylomic signatures of maternal care, which may be best uncovered 
through hypothesis-free approaches with methods capturing the correlational patterns of DNA 
methylation. Yet, replication of these findings is needed, and the possibility of false-positive 
findings should not be excluded. Notably, when considering a more stringent significance 
threshold (p < 2.18x10-09; α = 0.001), as suggested to reduce false-positive rates 68, most of 
the regions (77%, N = 10) remained significantly related to maternal sensitivity.
Further, we failed to detect an association between maternal sensitivity and DNA methylation 
variation at candidate genes previously identified by studies of maternal care in humans55–58. 
Inconsistencies may reflect several factors, including differences in sample characteristics 
(e.g. psychiatric vs. population-based samples), maternal care assessments (retrospective vs. 
prospective reports) and analysis (e.g. gene regions covered by pyrosequencing vs. Infinium 
450K). Lastly, candidate gene studies may be particularly vulnerable to false positives, as 
shown in the genetic field69.
As a second aim, we explored whether identified maternal sensitivity-DNA methylation 
associations may be influenced by genetic factors, based on mQTL mapping. Twenty-two 
percent of the sites in our significant regions were linked to known SNPs. This suggests that 
associations for those sites may be in part confounded by genetic factors and corroborates 
previous research highlighting DNA methylation responsiveness to both external exposures and 
genetic variation14. However, the presence of mQTLs alone does not preclude environmental 
effects. Indeed, recent studies have found that interindividual variability in DNA methylation is 
primarily explained by gene-environment combinations (additive and interactive effects)70,71. 
Moreover, mQTLs were identified based on a publicly available database, as our sample was 
underpowered to directly test for genetic confounding. Future studies employing genetically-
sensitive designs could more precisely quantify the effect of maternal sensitivity on DNA 
methylation by directly modeling genetic influences.
When exploring the robustness of findings to additional adjustments, we observed attenuations 
at half of the regions, after controlling for socioeconomic status and maternal psychopathology. 
When considering pre-exposure DNA methylation levels, estimates attenuated at most regions. 
Although neonatal methylomic patterns were measured in cord blood at birth and not in 
peripheral blood (used at age six), which may lead to additional differences, these findings 
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indicate that associations partly reflected pre-existing DNA methylation levels. This was 
clearly exemplified by RNF39, a region strongly associated with sensitivity, robust to postnatal 
confounders, and genetic influences. After adjustments, its estimate reduced by 97%, showing 
that associations did not result from postnatal caregiving, as they were already present at 
baseline (birth). These findings cast doubts on previous studies of caregiving which did not 
consider pre-exposure DNA methylation levels, and raise questions on the directionality of 
associations between maternal care and DNA methylation, as well as on the potential role of 
other confounders affecting child DNA methylation at birth and in childhood, and maternal 
sensitivity (e.g. shared genetics, maternal distress).
Here, we highlight four “high-confidence” associations with maternal caregiving, which were 
not linked to any mQTLs, and were most robust to adjustments for confounders and pre-
exposure DNA methylation levels. These spanned (i) ZBTB22/TAPBP, (ii) ZBTB12, (iii) DOCK4, 
and (iv) a non-annotated region in chromosome four. All four genes are protein-coding 
18. DOCK4 is implicated in neuronal processes, such as neuronal migration, and dendritic 
arborization72 and its DNA methylation region presented higher than average blood-BA10 
concordance in this study. ZBTB22 and ZBTB12 are involved in transcriptional regulation and 
nuclear chromatin localization73. These two genes, together with TAPBP, are within the Major 
Histocompatibility Complex (MHC). While these associations should be carefully interpreted 
as the MHC is characterized by extensive linkage disequilibrium74, this genomic region plays 
an important role in immune functioning and has been implicated in neuronal plasticity75,76. 
TAPBP specifically is involved in MHC class I protein complex assembly, gene expression 
regulation, and immunodeficiency73. In this study, enrichment for MHC class I protein assembly 
and peptide binding was found for maternal sensitivity, suggesting that such exposure might 
enact on TAPBP-related functions via DNA methylation.
Generally, our high-confidence genes have been previously associated with psychological and 
developmental problems, inflammation, and stress-responses. Molecular changes were shown 
at TAPBP for major depressive disorder and suicide77, TAPBP and DOCK4 for schizophrenia78–80, 
ZBTB22 for intellectual disability73 and psychopathologies following hypercortisolism81, and 
DOCK4 for autism and dyslexia82,83. Enrichment for pathways including Dock4 has been 
repeatedly associated with stress-related responses in mice84–86, while ZBTB12 DNA methylation 
is related to markers of inflammation (e.g. white blood cell counts)87.
Limitations and Suggestions for Future Research
Our findings should be interpreted in light of several limitations. Firstly, identified associations 
may have been influenced by additional parental factors that we could not control for in the 
present study, either because this information was not available (e.g. parental temperament, 
parental genotype) or due to the low number of cases (e.g. maternal medication and substance 
use in pregnancy). Nevertheless, we did control for the most important maternal confounders 
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(smoking during pregnancy, socioeconomic status, psychopathology). Secondly, if unmeasured 
changes in maternal sensitivity and covariates occurred during the two-to-three-year time-lag 
between our exposure and outcome, noise would be introduced in the identified associations. 
A prospective design, as opposed to a cross-sectional one, remains however preferable due to 
the possibility to better understand the directionality of associations. Nonetheless, repeated 
postnatal measurements of both DNA methylation and maternal sensitivity would be ideal 
to longitudinally examine how associations change over time and disentangle directionality. 
Thirdly, we did not have information on whether the mothers included in this study were 
primary or secondary caregivers (at four years only). Yet, within Generation R, most mothers 
are primary caregivers88. Additionally, while the use of the Infinium 450K provided novel 
insights into the genes affected by maternal sensitivity, future research should employ, when 
possible, the EPIC 850K array due to its wider and more diverse genomic coverage89. Lastly, our 
investigation solely focused on the association of maternal sensitivity on the child methylome. 
Related molecular signatures, such as transcription changes and epigenetic clocks, could be 
examined in future research to better understand the biological consequences of maternal care.
In conclusion, this population-based study supports a prospective association of typical variation 
in maternal sensitivity with epigenome-wide DNA methylation in children. We highlight four 
DNA methylation regions that showed the strongest associations with maternal sensitivity 
as well as minimal evidence of genetic and pre-exposure influences, and which should thus 
be prioritized in future research. These results permit further delineation of the relationship 
between DNA methylation and maternal care in humans and warrant confirmation by future 
research with large, longitudinal, and genetically-sensitive studies.




1.  Kok R, Linting M, Bakermans-Kranenburg MJ, et al. Maternal sensitivity and internalizing problems: 
Evidence from two longitudinal studies in early childhood. Child Psychiatry & Human Development. 
2013;44(6):751-765.
2.  Madigan S, Prime H, Graham SA, et al. Parenting behavior and child language: A meta-analysis. 
Pediatrics. 2019;144(4).
3.  Thomas JC, Letourneau N, Campbell TS, Tomfohr-Madsen L, Giesbrecht GF. Developmental origins 
of infant emotion regulation: Mediation by temperamental negativity and moderation by maternal 
sensitivity. Developmental Psychology. 2017;53(4):611-628.
4.  Kimbrel NA, Nelson-Gray RO, Mitchell JT. Reinforcement sensitivity and maternal style as predictors 
of psychopathology. Personal Individual Differences. 2007;42(6):1139-1149.
5.  Haltigan JD, Roisman GI, Fraley RC. The predictive significance of early caregiving experiences for 
symptoms of psychopathology through midadolescence: Enduring or transient effects? Development 
and Psychopathology. 2013;25(1):209-221.
6.  Rijlaarsdam J, Stevens GWJM, Jansen PW, et al. Maternal childhood maltreatment and offspring 
emotional and behavioral problems: Maternal and paternal mechanisms of risk transmission. Child 
Maltreatment. 2014;19(2):67-78.
7.  Bernier A, Carlson SM, Deschênes M, Matte-Gagné C. Social factors in the development of early 
executive functioning: a closer look at the caregiving environment. Developmental Science. 
2012;15(1):12-24.
8.  Raby KL, Roisman GI, Fraley RC, Simpson JA. The enduring predictive significance of early 
maternal sensitivity: Social and academic competence through age 32 years. Child Development. 
2015;86(3):695-708.
9.  Stams G-JJM, Juffer F, van IJzendoorn MH. Maternal sensitivity, infant attachment, and temperament 
in early childhood predict adjustment in middle childhood: The case of adopted children and their 
biologically unrelated parents. Devevlopmental Psychology. 2002;38(5):806-821.
10.  Meaney MJ. Maternal care, gene expression, and the transmission of individual differences in stress 
reactivity across generations. Annual Review of Neuroscience. 2001;24(1):1161-1192.
11.  Mulder RH, Rijlaarsdam J, van IJzendoorn MH. DNA methylation: A mediator between parenting 
stress and adverse child development? In: Deater-Deckard K, Panneton R, eds. Parental Stress and 
Early Child Development: Adaptive and Maladaptive Outcomes. Springer International Publishing; 
2017:157-180.
12.  Szyf M. The genome- and system-wide response of DNA methylation to early life adversity and its 
implication on mental health. The Canadian Journal of Psychiatry. 2013;58(12):697-704.
13.  Weaver ICG, Cervoni N, Champagne FA, et al. Epigenetic programming by maternal behavior. Nature 
Neuroscience. 2004;7(8):847-854.




15.  Smith AK, Kilaru V, Kocak M, et al. Methylation quantitative trait loci (meQTLs) are consistently 
detected across ancestry, developmental stage, and tissue type. BMC Genomics. 2014;15(1):145.
16.  Gaunt TR, Shihab HA, Hemani G, et al. Systematic identification of genetic influences on methylation 
across the human life course. Genome Biology. 2016;17:61.
17.  Carey N. Life as we know it now. In: The Epigenetics Revolution. Columbia University Press; 2012:72-
73.
18.  Geer LY, Marchler-Bauer A, Geer RC, et al. The NCBI BioSystems database. Nucleid Acids Research. 
2010;38:D492-6.
19.  Weaver ICG, Champagne FA, Brown SE, et al. Reversal of maternal programming of stress responses 
in adult offspring through methyl supplementation: Altering epigenetic marking later in life. Journal 
of Neuroscience. 2005;25(47):11045-11054.
20.  Turecki G, Meaney MJ. Effects of the social environment and stress on glucocorticoid receptor gene 
methylation: A systematic review. Biological Psychiatry. 2016;79(2):87-96.
21.  Doherty TS, Forster A, Roth TL. Global and gene-specific DNA methylation alterations in the 
adolescent amygdala and hippocampus in an animal model of caregiver maltreatment. Behavioural 
Brain Research. 2016;298(0 0):55-61.
22.  Beery AK, McEwen LM, MacIsaac JL, Francis DD, Kobor MS. Natural variation in maternal care 
and cross-tissue patterns of oxytocin receptor gene methylation in rats. Hormones and Behavior. 
2016;77:42-52.
23.  Blaze J, Asok A, Borrelli K, et al. Intrauterine exposure to maternal stress alters Bdnf IV DNA methylation 
and telomere length in the brain of adult rat offspring. International Journal of Developmental 
Neuroscience. 2017;62:56-62.
24.  Provençal N, Suderman MJ, Guillemin C, et al. The signature of maternal rearing in the methylome 
in rhesus macaque prefrontal cortex and t cells. Journal of Neuroscience. 2012;32(44):15626-15642.
25.  Feldman R. The neurobiology of mammalian parenting and the biosocial context of human caregiving. 
Hormones Behavior. 2016;77:3-17.
26.  Knop J, Joëls M, van der Veen R. The added value of rodent models in studying parental influence 
on offspring development: opportunities, limitations and future perspectives. Current Opinion in 
Psychology. 2017;15:174-181.
27.  Glynn LM, Baram TZ. The influence of unpredictable, fragmented parental signals on the developing 
brain. Frontiers in Neuroendocrinology. 2019;53:100736.
28.  Daskalakis NP, Yehuda R. Site-specific methylation changes in the glucocorticoid receptor exon 
1F promoter in relation to life adversity: systematic review of contributing factors. Frontiers in 
Neuroscience. 2014;8.
29.  Marzi SJ, Sugden K, Arseneault L, et al. Analysis of DNA methylation in young people: Limited 
evidence for an association between victimization stress and variation in blood. American Journal 
of Psychiatry. 2018;175(6):517-529.
30.  Cecil CAM, Smith RG, Walton E, Mill J, McCrory EJ, Viding E. Epigenetic signatures of childhood 
abuse and neglect: Implications for psychiatric vulnerability. Journal of Psychiatric Research. 
2016;83:184-194.
Epigenome-wide associations with maternal sensitivity
97
IV
31.  Gouin JP, Zhou QQ, Booij L, et al. Associations among oxytocin receptor gene ( OXTR ) DNA methylation 
in adulthood, exposure to early life adversity, and childhood trajectories of anxiousness. Scientific 
Reports. 2017;7(1):7446.
32.  Mehta D, Klengel T, Conneely KN, et al. Childhood maltreatment is associated with distinct genomic 
and epigenetic profiles in posttraumatic stress disorder. Proceedings of the National Academy of 
Science. 2013;110(20):8302-8307.
33.  Stenz L, Prados J, Courtet P, et al. Borderline personality disorder and childhood maltreatment: A 
genome-wide methylation analysis. European Psychiatry. 2016;33(S1):S183-S183.
34.  Weder N, Zhang H, Jensen K, et al. Child Abuse, Depression, and Methylation in Genes Involved With 
Stress, Neural Plasticity, and Brain Circuitry. Journal of American Academy of Child & Adolescent 
Psychiatry. 2014;53(4):417-424.e5.
35.  Naumova OYu, Lee M, Koposov R, Szyf M, Dozier M, Grigorenko EL. Differential patterns of whole-
genome DNA methylation in institutionalized children and children raised by their biological parents. 
Development and Psychopathology. 2012;24(01):143-155.
36.  Oberlander TF, Weinberg J, Papsdorf M, Grunau R, Misri S, Devlin AM. Prenatal exposure to 
maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and 
infant cortisol stress responses. Epigenetics. 2008;3(2):97-106.
37.  Reuben A, Moffitt TE, Caspi A, et al. Lest we forget: Comparing retrospective and prospective 
assessments of adverse childhood experiences in the prediction of adult health. Journal of Child 
Psychology and Psychiatry. 2016;57(10):1103-1112.
38.  Baldwin JR, Reuben A, Newbury JB, Danese A. Agreement between prospective and retrospective 
measures of childhood maltreatment: A systematic review and meta-analysis. JAMA Psychiatry. 
2019;76(6):584-593.
39.  Kooijman MN, Kruithof CJ, van Duijn CM, et al. The Generation R Study: design and cohort update 
2017. European Journal of Epidemiology. 2016;31(12):1243-1264. doi:10.1007/s10654-016-0224-9
40.  Egeland B, Erickson MF, Clemenhagen-Moon J, Hiester MK, Korfmacher J. 24 months tools coding 
manual. Project STEEP-revised 1990 from Mother-Child project scales. Published online 1990.
41.  Kok R, Thijssen S, Bakermans-Kranenburg MJ, et al. Normal variation in early parental sensitivity 
predicts child structural brain development. Journal of American Academy of Child & Adolescent 
Psychiatry. 2015;54(10):824-831.e1.
42.  Cents RAM, Kok R, Tiemeier H, et al. Variations in maternal 5-HTTLPR affect observed sensitive 
parenting. Journal of Child Psychology and Psychiatry. 2014;55(9):1025-1032.
43.  Cortina JM. What is coefficient alpha? An examination of theory and applications. Journal of Applied 
Psychology. 1993;78(1):98-104.
44.  Lehne B, Drong AW, Loh M, et al. A coherent approach for analysis of the Illumina HumanMethylation450 
BeadChip improves data quality and performance in epigenome-wide association studies. Genome 
Biology. 2015;16(1):37.
45.  Aryee MJ, Jaffe AE, Corrada-Bravo H, et al. Minfi: a flexible and comprehensive Bioconductor package 
for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014;30(10):1363-1369.
Chapter IV
98
46.  Birney E, Smith GD, Greally JM. Epigenome-wide association studies and the interpretation of 
disease -omics. PLoS Genetics. 2016;12:e1006105.
47.  Breton CV, Byun H-M, Wenten M, Pan F, Yang A, Gilliland FD. Prenatal tobacco smoke exposure 
affects global and gene-specific DNA methylation. American Journal of Respiratory Critical Care 
Medicine. 2009;180(5):462-467.
48.  Rakyan VK, Down TA, Balding DJ, Beck S. Epigenome-wide association studies for common human 
diseases. Nature Reviews Genetics. 2011;12(8):529-541.
49.  Liang L, Cookson WOC. Grasping nettles: cellular heterogeneity and other confounders in epigenome-
wide association studies. Human Molecular Genetics. 2014;23(R1):R83-R88.
50.  Houseman EA, Accomando WP, Koestler DC, et al. DNA methylation arrays as surrogate measures 
of cell mixture distribution. BMC Bioinformatics. 2012;13(1):86.
51.  Barfield RT, Kilaru V, Smith AK, Conneely KN. CpGassoc: an R function for analysis of DNA methylation 
microarray data. Bioinformatics. 2012;28(9):1280-1281.
52.  van Iterson M, van Zwet EW, Bios Consortium, Heijmans BT. Controlling bias and inflation in 
epigenome- and transcriptome-wide association studies using the empirical null distribution. 
Genome Biology. 2017;18:19.
53.  Suderman M, Staley JR, French R, Arathimos R, Simpkin A, Tilling K. dmrff: identifying differentially 
methylated regions efficiently with power and control. bioRxiv. Published online December 31, 
2018:508556.
54.  Suderman M, Staley JR, French R, Arathimos R, Simpkin A, Tilling K. Dmrff: Identifying differentially 
methylated regions efficiently with power and control. Bioinformatics; 2018.
55.  Conradt E, Hawes K, Guerin D, et al. The contributions of maternal sensitivity and maternal 
depressive symptoms to epigenetic processes and neuroendocrine functioning. Child Development. 
2016;87(1):73-85.
56.  Unternaehrer E, Meyer AH, Burkhardt SCA, et al. Childhood maternal care is associated with DNA 
methylation of the genes for brain-derived neurotrophic factor ( BDNF ) and oxytocin receptor ( 
OXTR ) in peripheral blood cells in adult men and women. Stress. 2015;18(4):451-461.
57.  Provenzi L, Fumagalli M, Giorda R, et al. Maternal sensitivity buffers the association between SLC6A4 
methylation and socio-emotional stress response in 3-month-old full term, but not very preterm 
infants. Frontiers in Psychiatry. 2017;8.
58.  Bosmans G, Young JF, Hankin BL. NR3C1 methylation as a moderator of the effects of maternal 
support and stress on insecure attachment development. Developmental Psychology. 2018;54(1):29-
38.
59.  Cecil CAM, Walton E, Jaffee SR, et al. Neonatal dna methylation and early-onset conduct problems: 
A genome-wide, prospective study. First Posting Jun 9, 2017. Developmental Psychopathology 2017 
Pp No Pagination Specified Jun Dev Psychopathol. Published online 2017.
60.  Cecil CAM, Walton E, Pingault J-B, et al. DRD4 methylation as a potential biomarker for physical 
aggression: An epigenome-wide, cross-tissue investigation. American Journal of Medical Genetics 
Part B: Neuropsychiatric Genetics. 2018;177(8):746-764.
Epigenome-wide associations with maternal sensitivity
99
IV
61.  Hannon E, Dempster E, Viana J, et al. An integrated genetic-epigenetic analysis of schizophrenia: 
evidence for co-localization of genetic associations and differential DNA methylation. Genome 
Biology. 2016;17:176.
62.  Mulder RH, Walton E, Neumann A, et al. Epigenomics of being bullied: changes in DNA methylation 
following bullying exposure. Epigenetics. 2020;15(6-7):750-764.
63.  Roberts S, Suderman M, Zammit S, et al. Longitudinal investigation of DNA methylation changes 
preceding adolescent psychotic experiences. Translational Psychiatry. 2019;9(1):1-12.
64.  Phipson B, Maksimovic J, Oshlack A. missMethyl: an R package for analyzing data from Illumina’s 
HumanMethylation450 platform. Bioinformatics. 2016;32(2):286-288.
65.  Edgar RD, Jones MJ, Meaney MJ, Turecki G, Kobor MS. BECon: a tool for interpreting DNA methylation 
findings from blood in the context of brain. Translational Psychiatry. 2017;7(8):e1187.
66.  Joubert BR, Felix JF, Yousefi P, et al. DNA methylation in newborns and maternal smoking in pregnancy: 
Genome-wide consortium meta-analysis. American Journal of Human Genetics. 2016;98(4):680-
696.
67.  Rzehak P, Saffery R, Reischl E, et al. Maternal Smoking during Pregnancy and DNA-Methylation in 
Children at Age 5.5 Years: Epigenome-Wide-Analysis in the European Childhood Obesity Project 
(CHOP)-Study. PLoS ONE. 2016;11(5).
68.  Colquhoun D. An investigation of the false discovery rate and the misinterpretation of p-values. 
Royal Society Open Science. 2014;1(3):140216.
69.  Sullivan PF. Spurious Genetic Associations. Biological Psychiatry. 2007;61(10):1121-1126.
70.  Czamara D, Eraslan G, Page CM, et al. Integrated analysis of environmental and genetic influences 
on cord blood DNA methylation in new-borns. Nature Communications. 2019;10(1):1-18.
71.  Teh AL, Pan H, Chen L, et al. The effect of genotype and in utero environment on interindividual 
variation in neonate DNA methylomes. Genome Research. 2014;24(7):1064-1074.
72.  Shi L. Dock protein family in brain development and neurological disease. Communicative & 
Integrative Biology. 2013;6(6):e26839.
73.  Agapite J, Albou L-P, Aleksander S, et al. Alliance of Genome Resources Portal: unified model 
organism research platform. Nucleic Acids Res. 2020;48(D1):D650-D658. doi:10.1093/nar/gkz813
74.  Price AL, Weale ME, Patterson N, et al. Long-range LD can confound genome scans in admixed 
populations. American Journal of Human Genetics. 2008;83(1):132-135.
75.  Shatz CJ. MHC class I: An unexpected role in neuronal plasticity. Neuron. 2009;64(1):40-45.
76.  Sobue A, Ito N, Nagai T, et al. Astroglial major histocompatibility complex class I following immune 
activation leads to behavioral and neuropathological changes. Glia. 2018;66(5):1034-1052.
77.  Murphy TM, Crawford B, Dempster EL, et al. Methylomic profiling of cortex samples from completed 
suicide cases implicates a role for PSORS1C3 in major depression and suicide. Translational Psychiatry. 
2017;7(1):e989.
78.  Alkelai A, Lupoli S, Greenbaum L, et al. DOCK4 and CEACAM21 as novel schizophrenia candidate 




79.  Lee, Kim J-H, Song GG. Pathway analysis of a genome-wide association study in schizophrenia. 
Gene. 2013;525(1):107-115.
80.  Zhang Y, You X, Li S, et al. Peripheral blood leukocyte RNA-Seq identifies a set of genes related to 
abnormal psychomotor behavior characteristics in patients with schizophrenia. Medical Science 
Monitor: International Medical Journal of Experimental Clinical Research. 2020;26:e922426-
1-e922426-31.
81.  Glad CAM, Andersson-Assarsson JC, Berglund P, Bergthorsdottir R, Ragnarsson O, Johannsson 
G. Reduced DNA methylation and psychopathology following endogenous hypercortisolism – a 
genome-wide study. Scientific Reports. 2017;7:44445.
82.  Liang, Wang X, Zou M, et al. Family-based association study of ZNF533, DOCK4 and IMMP2L gene 
polymorphisms linked to autism in a northeastern Chinese Han population. Journal of Zhejiang 
University Science B. 2014;15(3):264-271.
83.  Maestrini E, Pagnamenta AT, Lamb JA, et al. High-density SNP association study and copy number 
variation analysis of the AUTS1 and AUTS5 loci implicate the IMMP2L–DOCK4 gene region in autism 
susceptibility. Molecular Psychiatry. 2010;15(9):954-968. doi:10.1038/mp.2009.34
84.  Lee, Chang D-E, Yeom M, et al. Gene expression profiling in hypothalamus of immobilization-stressed 
mouse using cDNA microarray. Molecular Brain Research. 2005;135(1):293-300.
85.  Lisowski P, Juszczak GR, Goscik J, Wieczorek M, Zwierzchowski L, Swiergiel AH. Effect of chronic mild 
stress on hippocampal transcriptome in mice selected for high and low stress-induced analgesia and 
displaying different emotional behaviors. European Neuropsychopharmacology. 2011;21(1):45-62.
86.  Papale LA, Madrid A, Li S, Alisch RS. Early-life stress links 5-hydroxymethylcytosine to anxiety-related 
behaviors. Epigenetics. 2017;12(4):264-276.
87.  Noro F, Gianfagna F, Gialluisi A, et al. ZBTB12 DNA methylation is associated with coagulation- 
and inflammation-related blood cell parameters: findings from the Moli-family cohort. Clinical 
Epigenetics. 2019;11(1):74.
88.  White T, Muetzel RL, El Marroun H, et al. Paediatric population neuroimaging and the Generation 
R Study: the second wave. European Journal of Epidemiology. 2018;33(1):99-125.
89.  Illumina. Infinium MethylationEPIC Kit | Methylation profiling array for EWAS. Published 2020. 
Accessed July 6, 2020. https://www.illumina.com/products/by-type/microarray-kits/infinium-
methylation-epic.html
Epigenome-wide associations with maternal sensitivity
101
IV
Supplemental Information on the Methods
Participants
Generation R was designed to shed light into environmental, genetic, and other pathways 
involved in (ab)normal development. For the purposes of this study, children within Generation 
R with data on maternal sensitivity (at three and/or four years) and DNA methylation (at six 
years) were selected. Maternal sensitivity assessments at ages three (N = 1247) and four (N 
= 752) years were both considered. This was done in line with previous literature1, due to 
the stability of the maternal sensitivity scores between age 3 and 4 years2, the temporality 
of these assessments, which both precede DNA methylation at age 6, and to maximize our 
sample size. Amongst children with maternal sensitivity data at either time point, 235 also 
had DNA methylation information at age six (i.e. the closest prospective DNA methylation 
assessment). Of note, this sample included 5 sibling-pairs and was the sample used for the 
main analyses. To ensure genetic relatedness did not impact results, one sibling per pair was 
later excluded in a sensitivity analysis. The excluded sibling presented the least covariate data.
In follow-up analyses, where additional adjustments for covariates were made, the main 
sample was further restricted to complete cases. For adjustments for maternal education 
and psychopathology, 223 children had data. For adjustments for DNA methylation levels at 
birth, 226 children had data.
Covariates
The main model in the epigenome-wide association study (EWAS) was adjusted for cell types, 
batch effects, sex, gestational age at birth, and maternal smoking during pregnancy. Further 
information on these variables is shown below.
Cell-type and batch effects
Cell-type adjustments were performed, for analyses with DNA methylation at age six, for the 
following cell types: CD4+ T-lymphocytes, CD8+ T-lymphocytes, B-lymphocytes, monocytes, 
natural killer cells. Of note, granulocyte cells were excluded due to multicollinearity. The 
sample plate was used as a measure of batch effects. This variable presented 17 levels.
Sex and gestational age at birth
Sex and gestational age were measured at child-birth. Sex was coded binarily into males and 
females. Gestational age at birth was measured continuously.
Maternal smoking during pregnancy
We analyzed maternal smoking during pregnancy as a three-level variable: (i) did not smoke 
during pregnancy, (ii) smoked until pregnancy was known, (iii) smoked throughout pregnancy. 
This was based on previous work from Joubert et al.3 showing that sustained smoking throughout 
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pregnancy has the strongest associations with offspring DNA methylation, with any smoking 
in pregnancy also showing significant associations, although not as strong. To ensure such 
variable was not subject to important bias, we additionally examined whether any of our 
hits (i.e. significant sites or sites within significant regions) overlapped with CpGs related to 
smoking, based on previous literature. Given the sample at hand, we used the Pregnancy 
and Childhood Epigenetics (PACE) consortium prenatal smoking exposure reference3. In this 
publication, 6,074 genome-wide significant CpGs were identified in association with maternal 
smoking during pregnancy in cord blood. Additionally, since tissue- and age-specific effects 
might be present, we considered another EWAS of smoking carried out in childhood (age 5.5) 
in whole blood4, which identified five genome-wide significant probes.
Maternal education and maternal psychopathology
In follow-up analyses, we additionally adjusted for maternal education and maternal 
psychopathology. Maternal education was coded into low, medium, and high, respectively 
denoting primary, secondary, and tertiary education levels. Maternal psychopathology 
(postnatal: child age six months) was measured according to the Beck Symptoms Inventory 
(BSI) which presents information on the total maternal psychopathology symptoms.
DNA methylation at birth
In another follow-up analysis, additional adjustments for DNA methylation levels at birth 
were performed. This was done for top hits only. Covariates which are key to appropriately 
measure DNA methylation levels were also included: batch effects (measured by sample 
plate) and cell types (CD4+ T-lymphocytes, CD8+ T-lymphocytes, B-lymphocytes, monocytes, 
natural killer cells, and nucleated red blood cells – a cell type present only in cord blood).
Statistical Analyses
Regional-level EWAS
The dmrff approach, based on simulations, performs better compared to other regional 
methods in terms of false positive control, statistical power, and replicability across datasets5. 
Of note, the probe- and regional-level EWASs were rerun after one sibling per sibling-pair 
was excluded.
Candidate gene look-up
For the candidate gene look-up, we selected genes based on previous literature. We searched 
the PubMed and Google Scholar engines by using a combination of the following terms: 
“maternal care” or “maternal sensitivity” with “DNA methylation”. Only studies in humans 
were considered. Review articles were excluded. Both epigenome-wide association studies 
(probe- and regional-level EWASs) as well as candidate gene studies were considered, yet, no 
EWAS had been performed to date on normative maternal care. Of the identified candidate 
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gene studies, only those with statistically significant results were included, for a total of four 
publications6–9. Genes significantly related with maternal care/sensitivity included NR3C1, 
BDNF, SLC6A4, OXTR, and 11B-HSD2. Due to methylomic values not being available in our 
sample for 11B-HSD2, such gene was excluded. Overall, four genes were selected based on 
previous literature.
Gene Ontology: In-House method
In this method, genes in the test list were tested in relation to pathway membership, with a 
logistic regression approach. We controlled for the number of probes annotated to each gene 
in the test list. The Gene Ontology website was utilized to obtain pathways. Genes annotated 
to parent terms were used too. A gene list was formed based on the probes associated with 
maternal sensitivity at a p-value threshold < 0.001, based on the probe-level EWAS. The 
Illumina UCSC gene annotation permitted the annotation of probes to genes. Genes were 
considered if they were included in, at minimum, one gene ontology pathway and presented 
at least one annotated probe. Pathways were considered if including from 10 to 2000 genes. 
Once this method was used for all pathways, the significant ones with overlapping genes 
were retested. Associations were retested in all significant pathways, after adjusting for the 
most significant term. In case the associations at such pathways were no longer significant, 
the most significant pathway was considered as explaining the relationship. In such situation, 
pathways were grouped together. This process was repeated, with the next most significant 
pathway being adjusted for, till all pathways were considered as the most significant one or 
were identified as pertaining to a more significant pathway. A minimum of two genes was 
necessary for GO terms to be interpreted.
Follow-up analyses
Firstly, the influence of genetic factors on DNA methylation was examined, based on an 
openly-accessible mQTL database. The database mQTL information was based on the results 
from the Accessible Resource for Integrative Epigenomics Studies (ARIES). The ARIES mQTL 
database includes data on the single nucleotide polymorphisms (SNPs) significantly affecting 
DNA methylation levels in cis or trans (p < 1E-14, 1Mb window), at several lifespan stages, 
based on the Infinium 450K array. Here, we selected information for children, based on the 
results from a genome-wide complex trait conditional analysis.
Secondly, we adjusted for an additional set of parental confounders, maternal education 
and psychopathology, in a subsample of children with such information (N = 223). This was 
done on top hits only. To ensure estimate changes resulted from adjustments as opposed 
to the restriction to the subsample, firstly, we ran a multiple linear regression on our top 
hits, within the subsample of children with data on such confounders (Model A, N = 223). 
This model was still unadjusted for maternal education and psychopathology. Subsequently, 
adjustments for maternal education and psychopathology were performed on top hits, within 
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the subsample (Model B, N = 223, adjusted model), with a multiple linear regression. The 
newly-obtained site summary statistics for both models were then inputted in DMRff, where 
the function dmrff.stats enables the recalculation of the statistics per DNA methylation region. 
The percent estimate change was then calculated ((estimate after adjustments – estimate 
before adjustments) / estimate before adjustments * 100).
The same procedure was employed for adjustments for DNA methylation levels at birth. 
Therefore, a multiple linear regression where, for each site, its own DNA methylation levels 
at baseline were used as covariates, was tested in association with maternal sensitivity: site 
DNA methylation at six ~ maternal sensitivity + main set of covariates + site DNA methylation 
at birth (Model B, N = 226). This was compared to a restricted unadjusted model (Model A, 
N = 226). Site statistics were inputted in dmrff.stats to obtain regional-level statistics.
Lastly, the BECon online tool used here includes information on tissue concordance between 
DNA methylation in blood and Brodmann Areas (BA) 7, 10 and 20, based on brain postmortem 
samples from 16 subjects.




Supplemental Figure 1 A-C. BACON-corrected probe-level EWAS of the association between maternal sensitivity 
and DNA methylation
Note. Panel A shows the test statistic histogram. This indicates minimal bias, as shown by the proximity of the 
black and red lines. Panel B depicts uncorrected and BACON-corrected QQ-plots. The uncorrected QQ-plot is from 
the main EWAS and shows no significant associations. The BACON-corrected QQ-plot suggests that values were 
originally deflated in the EWAS and that, after corrections, associations are present. Panel C is a histogram of 
p-values after BACON-correction, showing that there is a greater proportion of sites with low p-values compared 
to the proportion of sites with higher p-values, further suggesting that associations of maternal sensitivity with 




Supplemental Table 1. Sample characteristics





Observed maternal sensitivity 0.05
Maternal Education*
 Primary education 8%
 Secondary education 21%
 Higher education 71%
Gestational age at birth 40.31
Maternal prenatal smoking
 Never smoked 75%
 Quit when pregnancy known 11%
 Continued during pregnancy 14%
Maternal psychopathology* 0.15
Note. % = percentage
*Information was available only for a subsample (n = 223)
Supplemental Table 2-11 will be available online in the published article–https://www.cambridge.org/core/
journals/psychological-medicine
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Objective: DNA methylation has been implicated in the biology of sleep. Yet, how DNA 
methylation patterns across the genome relate to different sleep outcomes, and whether 
these associations overlap with mental health is currently unknown. Here, we investigated 
associations of DNA methylation with sleep and mental health in a pediatric population.
Method: This cross-sectional study included 465 10-year-old children (51.3% female) from 
the Generation R Study. Genome-wide DNA methylation levels were measured using the 
Illumina450K array (peripheral blood). Sleep problems were assessed from self-report, 
and mental health outcomes from maternal questionnaires. Wrist actigraphy was used in 
188 11-year-old children to calculate sleep duration and midpoint sleep. Weighted gene 
co-expression network analysis was used to identify highly co-methylated DNA methylation 
‘modules’, which were tested for associations with sleep and mental health outcomes.
Results: We identified 64 DNA methylation modules, one of which associated with sleep 
duration after covariate and multiple-testing adjustment. This module included CpG sites 
spanning 9 genes on chromosome 17, including MAPT– a key regulator of Tau proteins in 
the brain involved in neuronal function – as well as genes previously implicated in sleep 
duration. Follow-up analyses suggested that DNA methylation variation in this region 
is under considerable genetic control and shows strong blood-brain concordance. DNA 
methylation modules associated with sleep did not overlap with those associated with 
mental health.
Conclusion: We identified one DNA methylation region associated with sleep duration, 
including genes previously reported by recent GWAS studies. Further research is warranted 




Sleep is increasingly recognized as an important factor in child mental health. Sleep disturbances, 
such as short sleep and shifted circadian rhythm, often develop in late childhood and have 
been implicated in mental health problems1, 2. While poor sleep can exacerbate mental 
health difficulties3, 4, mental health problems can also precede and worsen sleep5. Thus, 
the association between sleep and mental health is complex and likely bidirectional1. The 
mechanisms underlying this association, however, remain unknown.
Complex traits, including sleep, result from the interplay of genetic and environmental 
influences6. How these factors jointly influence normative sleep, or the development of 
sleep problems, is currently unclear. Epigenetic processes such as DNA methylation have 
been proposed as a mechanism of interest7, 8. Differential DNA methylation has been linked 
to a broad range of developmental outcomes, including sleep, as well as mental and physical 
health problems9, 10. Most research on this topic emerges from animal models11, with only 
a handful of studies examining DNA methylation and sleep in humans. These have typically 
relied on small samples of adults with dysregulated sleep (e.g. shift workers) and utilized a 
candidate gene approach focusing primarily on ‘clock’ genes: genes driving circadian rhythms 
in metabolism, physiology and behaviour11-13. In contrast, we are aware of only two epigenetic 
studies during development, both of which examined adolescence. One reported an association 
in 18-19 year-olds between sleep duration and DNA methylation of DOCK1, a gene influenced 
by circadian rhythmicity14. The second found that higher DNA methylation in metabolic genes 
PPARA and HSD11B2 was associated with shorter sleep, specifically in girls15 0.
Despite these promising preliminary findings, existing research has been limited in four key 
ways, namely (i) the use of small samples of adults or older adolescents; (ii) a focus on a 
candidate gene approach; (iii) the lack of multi-modal assessments of sleep, making it unclear 
whether associations between sleep and DNA methylation differ between self-report and 
objective measures (e.g., actigraphy); and (iv) despite evidence showing that mental health is 
related to DNA methylation alterations9 and sleep1, no study has examined these factors jointly.
To address these gaps, we examined the relationship between genome-wide DNA methylation, 
sleep and mental health in a general population sample of 10-year old children – an important 
period for development of sleep and mental health problems alike. The aims of our study were 
two-fold: first, to characterize cross-sectional associations of DNA methylation with reported 
(i.e. dyssomnia symptoms) and actigraphy-assessed (i.e. sleep duration and midpoint) sleep 
using both a genome-wide approach and an targeted approach focusing on well-characterized 
clock genes to maximize comparability with existing studies; and second, to investigate whether 
sleep-associated DNA methylation patterns are also associated with common mental health 
problems. Findings were tested for consistency in a small independent sample.





This cross-sectional study included 10-year-old children of European ancestry (51.3% female) 
from the Generation R Study, a prospective population-based cohort from foetal life onward. 
Pregnant women (expected delivery date April 2002–January 2006) living in Rotterdam, the 
Netherlands, were invited to participate16. The current analyses are based on children who 
had DNA methylation data and subjectively assessed sleep (n = 410). Of these, 188 also had 
actigraphy data. Written informed consent was obtained for all participants. The Medical Ethical 
Committee of the Erasmus MC, University Medical Center Rotterdam approved the study.
Measures
DNA methylation
Five-hundred nanograms of DNA were extracted from peripheral blood at age 10 and underwent 
bisulfite conversion with the EZ-96 DNA Methylation kit (Shallow) (Zymo Research Corporation, 
Irvine, USA). Samples were plated onto 96-well plates in no specific order. DNA methylation 
was analyzed with the Illumina Infinium Human Methylation 450K BeadChip (Illumina Inc., 
San Diego, USA). Quality control of samples was performed using standardized criteria using 
the CPACOR workflow17. Probes with a detection p-value above background ≥ 1E-16 were 
set to missing per array. Arrays with observed technical problems including failed bisulfite 
conversion, hybridization or extension, and arrays with a mismatch between child sex and 
sex determined by the chr X and Y probe intensities were removed. Nonautosomal probes 
were excluded. Additionally, only arrays with a call rate > 95% per sample were processed 
further. Methylation beta values outside a range of the 25th percentile minus 3*interquartile 
range to the 75th percentile plus 3*interquartile range were set to missing. The final dataset 
contained 425 samples, analyzing 458,563 CpG sites. For our targeted approach, we examined 
DNA methylation levels of CpG sites that were annotated to well-characterized clock-related 
genes (939 CpG sites across 39 genes18) (Supplemental Table 1). For each CpG site, Beta 
values represent the ratio of methylated signal relative to the sum of (the methylated and 
unmethylated signals plus 100).
Child-reported dyssomnia symptoms
At age 10 years, children completed six questions of the Sleep Disturbance Scale for Children19 
about perceived sleep, for example, “Do you find it difficult to fall asleep?”; “If you wake up 
at night, do you find it difficult to fall asleep again?”; “Do you feel rested when you wake 
in the morning?” (previously described20). The questions were rephrased for our paediatric 
population. Responses were scored on a three-point Likert scale (“No”, “Sometimes” or “Yes”; 




Sleep patterns were estimated with wrist tri-axial actigraphy (GENEActiv) on the non-dominant 
wrist for 5 consecutive school nights in 188 children at age 11 (i.e. after DNA sampling)20, 21. 
The Geneactiv accelerometers were set a frequency of 50 Hz. The binary files were processed 
with the R-package GGIR22. Accompanying sleep diaries were collected and used to guide 
actigraphy analyses. Sleep duration was estimated as the total time scored sleep between 
falling asleep and final waking. Sleep midpoint was estimated as the halfway point between 
sleep onset and final waking. Sleep duration and midpoint were averaged across the week, 
excluding weekends to best approximate typical school-day sleep patterns and to minimize 
the influence of atypical weekend events.
Child psychopathology
The Child Behavior Checklist 6-18 (CBCL/6-18) was assessed using maternal-reports at age 10 
to derive broadband Internalizing and Externalizing problem-scales23. The CBCL/6-18 is widely 
used internationally and has been found to be generalizable across 23 societies, including the 
Netherlands24. Mothers rated various emotional and behavioural problems of the child in the 
previous six months on a three-point scale (0 = not true, 1 = somewhat true, 2 = very true).
Covariates
Sex of the child was obtained from medical records and maternal characteristics by 
questionnaires. Maternal education was defined by the highest attained educational level 
and classified into two categories (higher vocational education and university: yes or no). 
Correction for sample plate and cell type proportions was also applied. We used the Houseman 
method25 to estimate relative proportions of six white blood cell subtypes (CD4+ T-lymphocytes, 
CD8+ T-lymphocytes, NK (natural killer) cells, B-lymphocytes, monocytes and granulocytes), 
based on a standard reference population26.
Statistical analysis
We had nearly complete cases, with four participants missing data on maternal education 
(defined as highest educational level). These participants were excluded from the analysis. 
Statistical analyses were performed in R27, following three steps:
Step 1. Associations between DNA methylation and sleep
We applied weighted gene co-expression network analysis28 (WGCNA) – a system-level data 
reduction approach – to reduce the dimensionality of the data and identify clusters (so called 
‘modules’) of highly co-methylated DNA methylation sites across genome. As such, rather 
than focusing on individual sites or genes, WGCNA enables utilization of correlation patterns 
between sites to identify wider DNA methylation networks, which may also be functionally 
related29. Block-wise network construction was run using default settings (power threshold of 
6; minimal module size of 30 sites; merge cut height of 0.25). Each derived module was colored 
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by size automatically and summarized by a ‘module eigengene’ (ME) value, the first principal 
component of the given module. We numbered the derived modules by significance with 
outcome for simplicity. CpG sites that do not co-methylate were assigned to an ‘unclassified’ 
module. WGCNA analyses were performed twice: first based on the entire genome-wide data 
(i.e. hypothesis free; N = 458,563 sites), and second based on the subset of clock genes (i.e., 
targeted approach, n = 939 CpG sites).
Next, we tested bivariate correlations between the co-methylated modules and the three 
sleep outcomes (i.e. child-reported dyssomnia symptoms, actigraphy-estimated sleep duration 
and midpoint sleep). We selected modules that were associated with sleep outcomes after 
Bonferroni correction for multiple testing (0.05/n modules*3 sleep measures)30. These modules 
were further examined using linear regression models controlling for batch, cell-types, child 
sex and age, and maternal education.
Modules that were significantly associated with sleep were examined further using publicly 
available resources to characterize (i) their genomic location; (ii) potential genetic influences, 
by checking whether the CpG sites included in the modules are known to be polymorphic31 (i.e. 
overlapping with single nucleotide polymorphisms(SNPs)) linked to methylation quantitative 
trait loci32 (mQTLs; i.e. SNPs that associate with DNA methylation levels, either in cis or in 
trans; http://www.mqtldb.org/; GCTA set) or heritable, based on twin data33 (i.e. explained by 
additive genetic influences as opposed to shared and non-shared environmental influences); 
and (iii) blood-brain concordance, based on postmortem data from 122 individuals with DNA 
methylation from whole blood and four brain regions (the prefrontal cortex, entorhinal cortex, 
superior temporal gyrus, and cerebellum34 (https://epigenetics.essex.ac.uk/bloodbrain/).
Step 2: Testing the overlap of associations with mental health
Bivariate correlations between the co-methylated modules, sleep and mental health measures 
were examined to establish whether associations of DNA methylation and sleep are co-localized 
on the genome with associations of DNA methylation and internalizing and externalizing 
problems.
Step 3. Generalizability in independent sample
Associations identified in Steps 1 and 2 were estimated in an independent sample of 63 older 
adolescents (14.5±0.3 years, 54% girls) of the Generation R Study to judge generalizability of 
results, with information on DNA methylation available at 10 years and actigraphy-assessed 
sleep at 14 years (i.e. prospective association). The children in this sample were recruited for 
a second actigraphy study at a later age than the first study described above due to logistic 




Characteristics of the study sample are presented in Table 1. For correlations across sleep 
and mental health variables, see Supplemental Table 2. The average midpoint sleep was 2:49 
(SD = 35min) and the mean sleep duration was 7:36 (SD = 40min).
1. Are DNA methylation patterns associated with sleep outcomes in 
children?
Genome-wide analyses
We identified 64 co-methylated modules, containing between 30 and 65,804 CpG sites 
(Supplemental Table 3). The majority of sites were unclassified (n = 261,374), suggesting they 
did not correlate strongly enough to form modules. Two modules correlated with sleep after 
Bonferroni correction for multiple testing (0.05/64 modules * 3 outcomes = 0.00026042) – 
both of which associated with sleep duration (module1 r = -0.18, p = 0.00006, module2 r = 
-0.18, p = 0.0001) (Table 2), but not with sleep midpoint or dyssomnia symptoms. Only the 
association between module1 and sleep duration remained significant in a regression model 
adjusting for covariates (ß = -0.22, 95% CI = -0.37−-0.07, p = 0.004). As a sensitivity analysis 
we replaced the missing values (n = 4) on maternal highest educational level attained by 
Table 1. Sample characteristics
Reported dyssomnia 
symptoms 
  (N = 410)
Actigraphic sleep  
  (N = 188)
Demographics
Sex, female, % 234 (50.3%) 93 (49.5%)
Age (years) 9.8±0.3 11.7±0.1
Maternal education, %
 Low & Intermediate 152 (32.7%) 64 (34.0%)
 High 308 (66.2%) 121 (64.4%)
Dyssomnia symptoms, self-reported (score;range) 10.80 (8.00-18.00) 10.86 (6.00-17.00)
Sleep duration, actigraphy (hours:minutes) - 7:35±0:44
Midpoint sleep, actigraphy, time (hours:minutes) - 02:48±0:35
Internalizing problems, mother-reported, mean(SD) 4.16 (4.38) 4.03 (4.28)
Externalizing problems, mother-reported, mean(SD) 3.41 (4.25) 3.16 (3.82)
Table 2. Associations between DNA methylation modules and actigraphy-derived sleep duration in children (N = 188)
A. Correlations of the WGCNA modules with sleep 
duration
B. Standardized regression 
coefficients
Module r p-value N cpgs N genes β CI p-value
Module1 -0.18 0.00006 32 9 -0.22 -0.37– -0.07 0.004
Module2 -0.18 0.0001 5845 3462 -0.14 -0.54–36 0.07
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maternal highest educational level, yielding highly consistent results. Additionally, as time 
of blood sampling corrected for the time of habitual awakening could be of influence, we re-
ran analyses adjusting for these variables, and found that results remained highly consistent 
(ß = -0.19, 95% CI = -0.34−-0.05, p = 0.008). Lastly, as cell proportions are estimated, rather 
than derived from actual cell counts, we re-ran analyses without cell type correction to test 
stability of associations, and found that results were highly consistent (ß = -0.22, 95% CI = 
-0.36−-0.07, p = 0.004).
Targeted circadian clock CpG site analyses.
The targeted WGCNA approach containing exclusively clock-related genes identified 5 modules 
(ranging from 19-300 CpG sites over 10-39 genes), each including CpG sites spanning multiple 
genes, as opposed to clustering by gene. The majority of the CpG sites were unclassified (n 
= 540). No modules were associated with sleep outcomes after multiple testing correction.
Functional characterization of module1 (Table S4).
Annotation to genes and genomic region
Module1 contained 32 sites spanning 9 genes. The largest number of sites (n = 6) were 
annotated to the Microtubule-Associated Protein Tau (MAPT) gene. The CpCs of module1 
Figure 1. Intercorrelations between CpG sites in module1
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were highly correlated with each other (Figure 1), as well as with sleep duration and were all 
located in the chromosome 17q21.31 region, chr17:43502999-62843696, with the exception 
of one CpG site on chromosome 5.
Genetic influences
Six of the CpGs included in module1 were previously identified as polymorphic (three of which 
in MAPT), and twelve (37.5%) were found to be associated to mQTLs on chromosome 17, with 
a total of 71 associations (between 4 and 10 associations per CpG). The CpG site located on 
chromosome 5 (cg07870213) associated with both mQTLs on chromosome 5 in cis as well as 
chromosome 17 in trans, all of which were located in the module1 region (chr17:41993881-
44852612). Finally, 10 of the 32 CpG sites in module1 had twin heritability estimates available, 
all of which showed moderate to strong genetic influences (r = 0.34–1.00).
Blood-brain concordance
For all but one of the CpG sites in module1, DNA methylation levels in blood correlated 
significantly with DNA methylation levels in at least one brain region. The three MAPT CpG 
sites that associated most strongly with sleep duration showed high blood-brain correlations 
(Figure S1). Of these, cg24801230 (one of the sites found to be polymorphic) showed an 
almost perfect correlation (r = 0.99) between blood and brain, with DNA methylation levels 
across tissues clustering into three alleles (Supplemental Figure 1).
2. Are DNA methylation-sleep associations overlapping with child 
psychiatric symptoms?
No modules were associated with internalizing and externalizing problems after correction 
for multiple testing. Generally, we found weak associations between the DNA methylation 
modules and internalizing (strongest association: r = 0.15, p = 0.001) and externalizing problems 
(strongest association: r = 0.14, p = 0.002). Associated modules did not overlap with those 
identified for sleep duration (Supplemental Figure 2).
3. Are results consistent in an independent sample?
The association between module1 and sleep duration was tested in an independent sample 
of older children, in order to test for consistency across developmental stage. Results from 
a regression analysis, controlling for covariates, yielded a highly comparable effect size 
(Discovery: ß = -0.22, 95% CI = -0.37−-0.07, p = 0.004; Generalization sample: ß = -0.23, 95% 
CI = -0.50−0.04, p = 0.09), although the association was not statistically significant, likely due 
to the larger confidence intervals resulting from the use of a smaller sample (1/3 of discovery 
sample).




The current study utilized a network-based approach to investigate associations between 
genome-wide DNA methylation, sleep, and mental health in a pediatric population. We 
highlight here two key findings. First, we found that DNA methylation patterns associated 
with sleep duration, but not with other sleep parameters. Specifically, our hypothesis-free 
analyses identified one DNA methylation module associated with actigraphy-assessed sleep 
duration. This module (i) contained 32 sites annotated to multiple genes previously linked to 
sleep duration in GWASes, including MAPT; (ii) showed strong evidence of genetic influences 
based on molecular and twin data; and (iii) showed cross-tissue concordance between blood 
and brain. In contrast, hypothesis-driven analyses did not reveal associations between DNA 
methylation in clock genes and sleep parameters. Second, we found that DNA methylation 
patterns were only weakly associated with mental health outcomes. These associations did 
not overlap with those identified for sleep outcomes, suggesting co-methylation modules 
associated with sleep and mental health are largely independent.
Self-reported and actigraphic sleep assess distinct sleep domains1, 35, as reflected in the weak 
correlations between these metrics found in the present study. Of note, self-reported measures 
capture sleep perception and reports may be biased by subject characteristics. Interestingly, 
we found here that DNA methylation associated with actigraphic sleep duration but not with 
self-reported dyssomnia. This could be due to the fact that actigraphic sleep shows greater 
variability in the general population and has less measurement error36. Furthermore, we did 
not find associations between DNA methylation and actigraphic determined midpoint sleep. 
Nights assessed in our sample have been constrained by school schedules, limiting variability 
in midpoint. Since circadian preference changes during adolescence37 future research should 
study the longitudinal association between DNA methylation, and sleep and circadian rhythm 
across this age period.
Most epigenetic research on sleep in humans has focused on sleep deprivation11. In this 
study, we show that DNA methylation patterns associate with typical variation in sleep in 
10-year old children. Specifically, one DNA methylation module was found to associate with 
actigraphic sleep duration. This association was generalizable to a smaller, independent 
sample of Generation R participants at age 14 years. The lack of significance could be due to 
low power in this smaller sample. The fact that we found a generally comparable effect size 
supports the robustness of our findings.
The sleep-associated module contained 32 CpG sites spanning a large region on chromosome 
17. Based on accessible databases, we found that several of the sites in the module were 
located directly on SNPs, and over a third were linked to known mQTLs. Intriguingly, the one 
CpG site in this module on chromosome 5 was associated with multiple mQTLs located within 
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the chromosome 17 region, supporting a genetically-driven link in DNA methylation patterns 
between these two chromosomal regions. Genetic influences were further corroborated 
by twin data showing moderate-to-high heritability estimates for DNA methylation sites 
in this module. Together, these findings suggest that underlying genetic variation might 
largely account for observed associations between DNA methylation in this region and sleep 
duration. This is in line with existing literature indicating that variation in DNA methylation 
is best explained by genetic influences and gene-environment interactions, as opposed to 
environmental main effects38, 39. Finally, DNA methylation variability in the identified module 
showed high blood-brain concordance, highlighting that the signals currently found in blood 
might be useful proxies for DNA methylation status in the brain. Future studies will need to test 
concordance with other brain areas implicated in sleep duration, e.g. the hypothalamus, and 
establish whether the degree of correspondence differs across specific cell-types in the brain.
Of the 9 genes annotated to our module, several stood out for their role in brain-related 
processes and previous links to sleep outcomes based on GWAS data. Specifically, a single-
nucleotide polymorphism (SNP) in MAPT was recently identified as a top GWAS hit for self-
reported sleep duration40 and SNPs in MAPK81P1P2 and KANSL1-AS1 were identified as top 
hits in a GWAS on accelerometer-based sleep duration41. Additionally, a study based on UK 
Biobank and 23andMe data indicated that variants in ARHGAP27, LRRC37A, CRHR1, MAPT, 
and KANSL1 associated with various self-reported sleep traits, including sleep duration42. 
These findings further support genetic influences on DNA methylation and sleep duration 
in this region.
The most strongly associated probe in module1 was annotated to the MAPT antisense RNA 1, 
a non-protein coding RNA gene identified as epigenetic regulator of MAPT expression43, while 
six sites where annotated to the MAPT gene itself. MAPT encodes the Tau protein, which is 
important for neuronal stabilization. Its aberrant aggregation has been frequently linked to 
Alzheimer’s disease and other neurodegenerative diseases44 as well as neurodevelopmental 
disorders45. A recent study suggested the involvement of Tau proteins and sleep in the 
pathogenesis of neurodegenerative diseases, though this process is not yet fully understood46. 
Another gene annotated to module1 was CRHR1 (corticotropin-releasing hormone receptor 
1), a pivotal player in hypothalamic-pituitary-adrenal axis functioning47 as well as sleep48. Our 
study adds to this growing body of evidence by showing for the first time that, in childhood, 
epigenetic variation in MAPT and surrounding regions are associated with sleep duration.
The epigenetic patterns associated with sleep in this study did not overlap with those 
associated with mental health. This may be due to several reasons. First, although the link 
between sleep and mental health is well-established1, it is possible that such associations 
may not be epigenetically-mediated. Second, associations between sleep and mental health 
tend to be stronger for self-report than objective measures1. As such, there might be different 
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underlying biological correlates driving the associations between mental health and reported 
sleep and actigraphic derived sleep. For example, cortisol levels, associated with anxiety and 
depression, have been linked to self-reported sleep quality but not to actigraphy-derived 
sleep quantity49. Third, our population-based cohort may have lacked psychiatric severity to 
detect shared associations. Future studies are needed to clarify the mechanisms underlying 
associations between sleep and mental health.
Limitations and future directions
This study has several limitations. First, from our cross-sectional data, we are unable to 
determine the direction of effect for the association between DNA methylation and sleep 
regulation, and we cannot exclude that the observed association may result from a common 
influence (e.g. environmental or genetic modulation). In the future, the use of longitudinal 
data on DNA methylation and sleep, the application of advanced causal inference methods 
(e.g. two-step Mendelian randomization), as well as integration with genetic data will mark 
important steps for furthering our understanding of DNA methylation-sleep associations. 
Second, the sample was based on participants of European ancestry. Studies including 
other ethnicities are necessary to investigate the generalizability of our findings. Third, our 
independent sample was smaller, limiting statistical power. Fourth, our measure of midpoint 
sleep, derived from actigraphy, is constrained by school schedules. Studying free nights may 
better describe underlying circadian processes. Fifth, while we assume that focusing on 
modules as opposed to single sites may help us to identify broader, functionally meaningful 
DNA methylation networks associated with sleep, (a) this does not preclude that there may 
be important sleep-associated single CpG sites, which might have been missed by using this 
approach; and (b) integration with gene expression data will be necessary to establish the 
extent to which the identified module may play a regulatory role, which we could not do in 
our study. In addition to the clock genes tested in the current study, it would be interesting to 
examine associations with CpG sites annotated to genes that have been previously implicated in 
other sleep parameters, such as sleep duration or chronotype (e.g. by GWAS studies). Sixth, the 
blood-brain concordance tool we used is based on an elderly population. As such, it is unclear 
to what extent the identified pattern of concordance extends to the pediatric population, 
for which there are currently no available tools. Finally, it is unclear whether identified DNA 
methylation patterns are functionally relevant. The use of experimental models could inform 
the biological consequences of these associations. Additionally, it is important to see in future 
studies whether DNA methylation levels at these sites change across development. If there is 
no change in DNA methylation levels over time, this could indicate that a regulatory process 
is acting from birth, whereas an epigenetic mark that changes throughout life might indicate 




In summary, the preliminary results of the current study show promising sleep-associated 
DNA methylation patterns in the pediatric population. Specifically, we identified an association 
between sleep duration and DNA methylation in the 17q21.31 region, spanning multiple genes 
previously linked to sleep by GWAS studies, including MAPT. These epigenetic patterns did not 
overlap with those associated with self-reported sleep problems, midpoint sleep or mental 
health. Future studies are needed to replicate our findings and establish causality. Overall, 
our findings offer novel insights into epigenetic patterns associated with typical variation in 
sleep duration in children.
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Supplemental Table 1. Selection of clock and clock-related genes based on van den Berg et al., 2017 
(ngenesv= 39; nCpGs = 939)
Gene CpG (n) Gene CpG (n) Gene CpG (n)
AKT1 41 FOXO3 44 PRDX6 15
ARNTL 23 GSK3B 19 PRKAA1 9
ARNTL2 13 MAPK1 18 PRKAB1 11
BHLHE40 19 NPAS2 34 PRKACA 23
BHLHE41 16 NR1D1 24 PRKCA 79
CLOCK 14 NR1D2 17 RORA 106
CRTC1 40 PER1 18 RORB 11
CRY1 14 PER2 24 RORC 13
CRY2 24 PER3 25 SIRT1 17
CSNK1E 24 PRDX1 17 SIRT2 18
DBP 20 PRDX2 12 STRA13 22
FGF21 10 PRDX3 16 TIMELESS 15
FOXO1 33 PRDX5 22 WEE1 19
Supplemental Table 2. WGCNA-derived modules and number of CpG sites
Module n CpG Module n CpG Module n CpG Module n CpG
Module1 32 Module17 669 Module33 963 Module49 33
Module2 5845 Module18 794 Module34 132 Module50 40
Module3 17473 Module19 1783 Module35 757 Module51 42
Module4 1952 Module20 122 Module36 30 Module52 65804
Module5 31 Module21 73 Module37 42 Module53 68
Module6 3845 Module22 21133 Module38 88 Module54 1242
Module7 47 Module23 33 Module39 36 Module55 448
Module8 33 Module24 32 Module40 448 Module56 191
Module9 31 Module25 31 Module41 786 Module57 41
Module10 35 Module26 2596 Module42 50775 Module58 33
Module11 61 Module27 125 Module43 35 Module59 32
Module12 31 Module28 5750 Module44 267 Module60 41
Module13 47 Module29 788 Module45 549 Module61 9177
Module14 30 Module30 86 Module46 37 Module62 33
Module15 218 Module31 32 Module47 63 Module63 41
Module16 1040 Module32 61 Module48 261374 Module64 56
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Supplemental Table 3. Functional characterization of module1 (part I)













Gene Std B p-value Mean SD
cg15295732 Body  43942128 17 MAPT-
L7:L31AS1
0.3018893 9.9E-05 0.70 0.05
cg00846647 Body Island 44060252 17 MAPT 0.2465164 0.001391 0.85 0.05
cg18228076 5’UTR  43983362 17 MAPT 0.2514921 0.001591 0.45 0.15
cg23955979   45126661 17 [ARL17] -0.259001 0.001847 0.57 0.05
cg07870213 Body Island 140052090 5 DND1 -0.234355 0.002187 0.67 0.05
cg24801067   62843696 17 - -0.236203 0.003393 0.9 0.03
cg17117718  Island 43663208 17 [LRRc37A] -0.219581 0.003635 0.13 0.1
cg18391203  N_Shelf 44317291 17 - -0.211059 0.004529 0.57 0.06
cg24801230 5’UTR S_Shelf 43978533 17 MAPT 0.2130216 0.005724 0.68 0.23
cg16228356   43848958 17 [CRHR1] 0.1982664 0.012255 0.46 0.06
cg22968622  Island 43663579 17 [LRRc37A] -0.178802 0.017754 0.22 0.21
cg13704117 Body  44207360 17 KANSL1 0.1851593 0.020294 0.78 0.07
cg19832721 TSS1500  44249866 17 KANSL1 -0.187245 0.02096 0.67 0.1
cg04703951   43578652 17 - -0.176918 0.022176 0.6 0.06
cg20120463  N_Shore 44301886 17 [KANSL1] 0.1776023 0.025006 0.2 0.03
cg04282206 TSS1500 S_Shore 62833786 17 PLEKHM1P -0.163108 0.029668 0.11 0.03
cg27060340 5’UTR N_Shelf 43502999 17 ARHGAP27 0.1872267 0.032394 0.39 0.09
cg01135538 Body N_Shore 43678735 17 LOC644172/
MAPK8IP1P2
0.1659441 0.033713 0.89 0.02
cg03915738   43651976 17 [LRRc37A] -0.166783 0.034135 0.86 0.02
cg01570182  Island 44337453 17 - -0.151754 0.050768 0.36 0.04
cg15921436  Island 44337874 17 [ARHGAP27] -0.13892 0.064751 0.58 0.04
cg26471390 TSS1500 S_Shore 43511301 17 ARHGAP27 -0.156186 0.070719 0.64 0.04
cg17911788  Island 44343683 17 - 0.1410486 0.079972 0.12 0.05
cg05159804  Island 44343776 17 - 0.1404805 0.106976 0.22 0.06
cg02228913 Body N_Shelf 44058016 17 MAPT 0.1238992 0.118991 0.85 0.08
cg06680147  S_Shore 44344931 17 - -0.104775 0.162643 0.08 0.02
cg09234465  S_Shore 43664173 17 [LRRc37A] -0.091065 0.24945 0.91 0.02
cg08113562 5’UTR Island 43508428 17 ARHGAP27 -0.071283 0.346673 0.09 0.03
cg04927033 Body Island 43679265 17 LOC644172/
MAPK8IP1P2
-0.062307 0.439858 0.88 0.02
cg07368061 Body  44090862 17 MAPT 0.0542763 0.519156 0.87 0.02
cg06291494  N_Shore 44321403 17 - 0.0399064 0.629656 0.88 0.02
cg05301556 TSS1500 N_Shore 43971177 17 MAPT/MAPT-
AS1
0.0075591 0.922981 0.85 0.04
CpGs with a dash (-) are not annotated to genes (intergenic)
CpGs with a gene name are actually annotated/located in that gene
CpGs with a gene in brackets [] are located in proximity to these genes
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Supplemental Table 3. Functional characterization of module1 (part II)
  Blood-CNS concordance 1 (Hannon et al.. 2015)
CpG  PFC  STG  EC  CER
  r p-value  r p-value  r p-value  r p-value
cg15295732  0.422 1.82E-04  0.535 1.53E-06  0.491 7.87E-06  0.291 1.38E-02
cg00846647  0.598 1.82E-08  0.584 9.07E-08  0.475 1.68E-05  0.285 1.58E-02
cg18228076  0.82 3.99E-19  0.829 4.31E-19  0.855 1.53E-22  0.572 1.87E-07
cg23955979  -0.09 4.17E-01  -0.12 3.18E-01  -0.00282 9.81E-01  0.542 1.02E-06
cg07870213  0.848 1.42E-21  0.753 3.47E-14  0.824 1.06E-19  0.652 7.08E-10
cg24801067  0.682 2.31E-11  0.741 1.45E-13  0.695 4.67E-12  0.707 5.44E-12
cg17117718  0.97 4.87E-46  0.961 4.44E-40  0.973 2.86E-48  0.921 6.23E-30
cg18391203  0.6595 6.45E-12  0.577 1.37E-07  0.684 1.37E-11  0.673 1.31E-10
cg24801230  0.986 2.51E-57  0.983 1.61E-52  0.987 2.82E-59  0.835 1.54E-19
cg16228356  0.243 3.73E-02  0.277 1.91E-02  0.262 2.30E-02  0.073 5.45E-01
cg22968622  0.995 1.03E-72  0.99 5.17E-61  0.996 7.64E-80  0.979 2.36E-49
cg13704117  0.81 2.40E-18  0.839 7.25E-20  0.82 1.89E-19  0.855 2.47E-21
cg19832721  0.08 4.87E-01  0.0396 7.43E-01  0.0387 7.41E-01  0.26 2.85E-02
cg04703951  0.717 6.67E-13  0.841 4.65E-20  0.812 9.15E-19  0.842 3.63E-20
cg20120463  0.358 1.73E-03  0.322 6.16E-03  0.211 6.93E-02  0.232 5.13E-02
cg04282206  0.10 0.417  0.30 1.10E-02  0.25 2.87E-02  0.12 3.26E-01
cg27060340  0.71 1.3E-07  0.74 2.58E-13  0.73 1.18E-13  0.75 5.79E-14
cg01135538  0.53 1.54E-06  0.59 5.05E-08  0.52 2.03E-06  0.65 8.70E-10
cg03915738  -0.08 0.502  -0.07 0.55  -0.05 6.72E-01  0.30 1.08E-02
cg01570182  0.77 1.17E-15  0.80 4.08E-17  0.78 3.56E-16  0.62 7.22E-09
cg15921436  0.47 2.83E-05  0.50 9.33E-06  0.67 4.48E-11  0.57 2.61E-07
cg26471390  -0.23 0.0229  -0.41 0.000352  -0.52 1.94E-06  -0.66 5.95E-10
cg17911788  0.51 3.45E-06  0.50 9.72E-06  0.64 9.25E-10  0.17 1.67E-01
cg05159804  0.38 0.00836  0.22 7.24E-02  0.18 1.21E-01  -0.35 3.20E-03
cg02228913  0.99 1.32E-61  0.99 8.07E-60  0.99 1.10E-58  0.99 1.27E-54
cg06680147  0.56 1.75E-07  0.46 6.28E-05  0.52 2.28E-06  0.44 1.51E-04
cg09234465  0.41 0.000242  0.28 1.99E-02  0.44 7.09E-05  -0.19 1.09E-01
cg08113562  -0.25 0.0355  -0.30 0.0122  -0.17 0.155  -0.19 0.109
cg04927033  0.21 0.0755  0.22 6.41E-02  0.02 8.44E-01  0.16 1.85E-01
cg07368061  0.12 0.323  0.30 1.09E-02  0.30 8.17E-03  0.16 1.80E-01
cg06291494  0.01 0.89  0.19 1.16E-01  0.00 9.90E-01  0.12 3.26E-01
cg05301556  0.09 0.433  0.21 7.79E-02  0.01 9.46E-01  0.04 7.38E-01
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Supplemental Table 3. Functional characterization of module1 (part III)
 Twin heritability estimates (Hannon et al.. 2018)  Genetic influences 











(Chen et al.. 2013) Mean Mean Mean  
cg15295732 0.66637303 5E-13 0.33362697   TRUE
cg00846647     TRUE  
cg18228076      TRUE
cg23955979       
cg07870213     TRUE  
cg24801067     TRUE  
cg17117718 0.969856123 5.42E-14 0.030143877  TRUE  
cg18391203      TRUE
cg24801230      TRUE
cg16228356 0.837183536 1.34E-13 0.162816464  TRUE  
cg22968622 0.996728437 5.32E-14 0.003271563  TRUE  
cg13704117      TRUE
cg19832721 0.880572078 2.06E-14 0.119427922    
cg04703951     TRUE  
cg20120463     TRUE  
cg04282206     TRUE  
cg27060340 0.712452588 0.061709448 0.225837964   TRUE
cg01135538       
cg03915738       
cg01570182     TRUE  
cg15921436     TRUE  
cg26471390       
cg17911788     TRUE  
cg05159804 0.787265816 2.07E-13 0.212734184    
cg02228913      TRUE
cg06680147       
cg09234465       
cg08113562 0.712193943 3.45E-12 0.287806057    
cg04927033       
cg07368061 0.344706126 0.068495184 0.58679869    
cg06291494       
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Bullying among children is ubiquitous and associated with pervasive mental health 
problems. However, very little is known about the biological pathways that change after 
exposure to bullying.
Epigenome-wide changes in DNA methylation in peripheral blood were studied from 
pre- to post measurement of bullying exposure, in a longitudinal study of the population-
based cohorts Generation R Study and Avon Longitudinal Study of Parents and Children 
(combined N = 1,352). Linear mixed-model results were meta-analyzed to estimate how 
DNA methylation changed as a function of exposure to bullying. Sensitivity analyses 
including co-occurring child characteristics and risks was performed, as well as a Gene 
Ontology analysis. A candidate gene follow-up was employed for CpG (cytosine-phosphate-
guanine) sites annotated to 5-HTT and NR3C1.
One CpG site, cg17312179, showed small changes in DNA methylation associated to 
bullying exposure (b = 2.67x10-03, SE = 4.97x10-04, p = 7.17x10-08). This site is annotated 
to RAB14, an oncogene related to Golgi apparatus functioning, and its methylation 
levels decreased for exposed whereas they increased for non-exposed. This result was 
consistent across sensitivity analyses. Enriched Gene Ontology pathways for differentially 
methylated sites included cardiac function and neurodevelopmental processes. Top CpG 
sites tended to have overall low levels of DNA methylation, decreasing in exposed, while 
increasing in non-exposed individuals. There were no gene-wide corrected findings for 
5-HTT and NR3C1.
This is the first study to identify changes in DNA methylation associated with bullying 
exposure at the epigenome-wide significance level. Consistent with other population-





The social environment is a major contributor to mental health. Bullying is a ubiquitous social 
stressor, with worldwide estimates ranging from one in ten to almost half of all children 
that are exposed1. Following Olweus’ definition, a person is being bullied ‘when he or she 
is exposed, repeatedly and over time, to negative actions on the part of one or more other 
persons’. Such negative actions should be intentional and performed by someone perceived 
be more powerful than the subject. Actions can include physical behaviors, such as hitting and 
kicking, verbal behaviors, such as calling names, as well as indirect or relational behaviors, 
such as social exclusion2. Bullying exposure (i.e. bullying victimization) has been associated 
with numerous mental health issues including behavioral problems, depressive symptoms 
3-6 and suicidal ideation7. However, whereas a myriad of harmful and persistent psychiatric 
consequences of being bullied have been identified, the biological pathways that change 
after exposure to bullying remain largely uncharted. Identifying these pathways is a pivotal 
step in understanding how peer-inflicted stress affects the human body.
Research on other environmental stressors, such as parental abuse8, prenatal maternal 
stress9, 10 or childhood trauma in general11-15 has incorporated epigenetic data to investigate 
the hypothesis that stressors affect the molecular configuration on and around the DNA, 
thereby influencing its functionality, with potential downstream effects on stress reactivity 
and mental health16-19. One often studied epigenetic mechanism is DNA methylation, in which 
a methyl-group binds to a cytosine nucleotide of the DNA (cytosine-phosphate-guanine site or 
CpG site). Whereas early epigenetic studies focused on DNA methylation of a single candidate 
gene, there has been an increase in hypothesis-free epigenome-wide methylation studies 
(EWASs) investigating DNA methylation levels of hundreds of thousands of CpG sites (CpGs) 
across the genome. One study11, for example, found multiple epigenome-wide significant 
differentially methylated CpGs related to different types of childhood maltreatment.
In contrast to other forms of adversity, research on bullying exposure and epigenetics is 
markedly scarce. To the best of our knowledge, only three such studies have been performed. 
In 28 monozygotic twin pairs discordant for bullying exposure20, increased levels of methylation 
were observed in the serotonin transporter gene (5-HTT) promoter region for the exposed 
twin siblings from 5 to 10 years, but not for the non-exposed twin siblings. Another study 
in 1,149 13 to 14 year old children found bullying exposure to be associated with increased 
methylation levels of exon 1F of the glucocorticoid receptor gene (NR3C1)21. Further, an 
EWAS was performed on bullying exposure in 1,658 twins13, thereby expanding the search for 
differentially methylated sites beyond the ‘usual suspects’, i.e. candidate genes that have been 
firmly implicated in neurotransmitter and hormonal functions, to enable the identification 
of potentially novel biological pathways. Bullying exposure during childhood as reported by 
mother and child at age 7-12 years, and bullying exposure during adolescence, retrospectively 




reported by the child at 18 years, were however not related to differential methylation. Given 
that DNA methylation is expected to change over time22 due to both extrinsic as well as 
intrinsic factors, a model in which DNA methylation both before and after bullying exposure 
is taken into account should be more sensitive to the effects of exposure.
In the current study, we made use of two population-based cohorts featuring repeated 
measures of DNA methylation to characterize longitudinal epigenome-wide associations 
with bullying exposure. Longitudinal mixed models were performed separately in the two 
cohorts to identify associations between exposure to bullying and changes in DNA methylation 
from pre- to post bullying report. Results were then meta-analyzed to maximize statistical 
power and to evaluate coherence among the estimates derived from the two populations. 
Epigenome-wide associations with bullying were studied in a hypothesis-free analysis. In a 
secondary candidate gene follow-up analysis we examined DNA methylation at 5-HTT and 
NR3C1 for gene-wide associations with bullying.
Results
Sample characteristics
Sample characteristics are described in Table 1. In Generation R, bullying exposure was reported 
by the mother at the mean (SD) age of 8.1 (0.1) years, and DNA methylation was measured at 
6.0 (0.3) years and 9.8 (0.3) years of age. In the Avon Longitudinal Study of Parents and Children 
(ALSPAC), bullying exposure was reported by the child at the mean (SD) age of 8.6 (0.2) years, 
and DNA methylation was measured at 7.5 (0.1) and 17.1 (1.0) years of age (Supplemental 
Figure 1). In the main analysis 45.5% of children in the Generation R sample and 39.4% of 
children in the ALSPAC sample were categorized as exposed to bullying victimization. In the 
sensitivity analysis with a more stringent definition of bullying, these numbers are 9.9% and 
12.1%, respectively. The current selected samples for each cohort were compared with (i) a set 
of participants with complete data on covariates, and (ii) a set of participants with complete 
data on both covariates and bullying exposure (full details in Supplemental Table 1). This 
showed that children in the current sets had a higher gestational age and higher SES, had 
mothers who were older, had a higher non-verbal intelligence quotient (IQ) score and were 
older at bullying exposure report. In Generation R, but not ALSPAC, children in the selected 
sample also had a lower Body Mass Index (BMI), less behavioral problems prior to exposure, 
and had less reported stressful experiences other than bullying exposure. No differences 
were found for child sex, or bullying exposure.
Chapter VII
170
Comparison of longitudinal epigenome-wide association studies
The separate longitudinal EWASs for the two cohorts (Q-Q plots in Supplemental Figure 3), 
identified no epigenome-wide Bonferroni-significant associations, with a lowest obtained 
p-value of p = 5.93x10-06 (CpG site cg034529555, annotated to NAV2) for Generation R and of 
p = 1.08x10-06 (CpG site cg24506221, annotated to GSTM1) in ALSPAC. Estimates for bullying 
exposure among the top 1000 CpG sites in each cohort more often had a negative direction 
(79.8% in Generation R, 66.3% in ALSAPC) than would be expected by chance (Χ2(1) = 355.22, 
p < 2.20x10-16 for Generation R, Χ2(1) = 106.28, p < 2.20x10-16 for ALSPAC). Bullying exposure 
estimates among the top 1000 in Generation R were not significantly correlated with those 
in ALSPAC (r(998) = -0.05, p = 1.09x10-01). The correlation between the top 1000 in ALSPAC 
was slight but significantly negative (r(998) = -0.07, p = 1.09x10-02) with those in Generation R.







Age in years bullying exposure report (mean (SD)) 8.1 (0.1) 8.6 (0.2)
Sex (No. (%) boys) 251 (49.6) 407 (48.3)
Gestational age in weeks (mean (SD)) 40.2 (1.4) 39.6 (1.5)
Maternal education (No. (%))
 Low 21 (4.2) 72 (8.5)
 Medium 101 (20.0) 336 (39.7)
 High 384 (75.9) 438 (51.8)
Maternal age at delivery (mean (SD)) 32.8 (3.9) 29.7 (4.4)
Bullying exposure (No. (%) yes) 229 (45.3) 333 (39.4)
Bullying exposure–sensitivity analysis (No. (%) yes) 50 (9.9) 102 (12.1)
Behavioral problem score (mean (SD))
(GenR n = 451, ALSPAC n = 794)
17.3 (12.2) 6.9 (3.9)
Intelligence quotient (mean (SD))
(GenR n = 465, ALSPAC n = 811)
107.3 (14.0) 102.6 (16.7)
Other stressful experiences (mean (SD))
(GenR n = 482, ALSPAC n = 597)
3.7 (2.1) 1.5 (1.4)
Alcohol use (mean (SD))










Age in years DNA methylation (mean (SD)) 6.0 (0.3) 9.8 (0.3) 7.5 (0.1) 17.1 (1.0)
BMI in kg/m2 (mean (SD)) 15.9 (1.3 17.1 (2.0) 16.2 (2.0) 22.6 (3.6)
AHRR CpG quintiles (No. (%))
 0.769, 0.873 93 (23.0) 66 (16.9) 123 (15.0) 205 (25.0)
 0.873, 0.891 79 (19.6) 80 (20.5) 146 (17.8) 182 (22.2)
 0.891, 0.906 72 (17.8) 87 (22.3) 171 (20.9) 157 (19.2)
 0.906, 0.920 73 (18.1) 86 (22.0) 186 (22.7) 142 (17.3)
 0.920, 0.963 87 (21.5) 72 (18.4) 194 (23.7) 133 (16.2)
SD: standard deviation; No.: number; T1: time point 1; T2: time point 2; BMI: Body Mass Index





In the meta-analysis, one CpG site was significantly associated with bullying exposure: 
cg17312179 (b = -2.67x10-03, SE = 4.97x10-04, p = 7.17x10-08; Supplemental Figure 4), a site in 
the leader sequence (5’UTR) of the RAB14 gene, located on chromosome 9. In Generation R 
(b = -2.47x10-03, SE = 6.17x10-04, p = 6.25x10-05), DNA methylation of this CpG site increased on 
average 0.13% from the mean age of 6.0 to 9.8 years in non-exposed, but decreased -0.12% 
in exposed. In ALSPAC (b = -3.05x10-03, SE = 8.36x10-04, p = 2.64x10-04) methylation of this 
CpG site increased 0.09% from the mean age of 7.5 to 17.1 years in non-exposed, whereas it 
decreased -0.21% in exposed (Figure 1). DNA methylation differences at cg17312179 between 
the non-exposed and the exposed group were not present before exposure measurement, 
but were so after (Supplemental Analysis). The ten CpGs with the lowest p-values are shown 
in Table 2 (see Supplemental Table 2 for associated functions).
The top 1000 CpGs from the meta-analysis had a higher representation of CpGs with a 
negative estimate for bullying exposure (83.5%) than all other CpGs (58.2%, Χ2(1) = 261.07, 
p < 2.20x10-16). Moreover, the top 1000 CpGs had a higher representation of CpGs with a 
positive age estimate (representing change in non-exposed, 79.2%) than the other CpGs 
(65.1%, Χ2(1) = 87.29, p < 2.20x10-16), and a higher representation of CpGs with low levels 
of DNA methylation (mean β value < 0.2 in both Generation R and ALSPAC, threshold as 
elsewhere36) at both time points (55.7% versus 37.0%, Χ2(1) = 149.63, p < 2.20x10-16), and 
Figure 1. Change in DNA methylation pre- and post- bullying exposure measurement for exposed and non-
exposed in Generation R and ALSPAC. Data are residualized for covariates present in linear mixed model
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more often located in promoters (28.8% versus 20.1%, Χ2(1) = 46.66, p = 8.45x10-12) and CpG 
islands (41.8% versus 30.8%, Χ2(1) = 56.63, p = 5.25x10-14). Together, this indicates that top 
sites tended to be located in promoters and CpG islands, and to have overall low levels of 
DNA methylation, decreasing in exposed, while increasing in non-exposed. See Table 3 for 
these characteristics at multiple p-thresholds.
Follow-up analyses
Sensitivity analyses
A series of sensitivity analyses were performed on cg17312179 in each cohort and then 
meta-analyzed. First, an analysis was performed with a more stringent definition of bulling 
Table 3. Characteristics of CpG sites selected for various levels of significance in meta-analysis















all 473864 58.3 65.1 37.0 20.1 30.8
P < 0.1 53168  71.2**  69.2**  44.1**  23.1**  34.6**
P < 0.01 5997  78.6**  75.3**  50.5**  26.3**  37.9**
P < 0.001 644  85.1**  79.7**  56.4**  28.1**  40.8**
P < 0.0001 66  86.4**  83.3**  62.1**  30.3**  47.0**
P < 0.00001 9  100.0**  100.0*  88.9** 44.4  77.8*
Note: CpG sites were classified as having low methylation if β value < 0.2 in Generation R and ALSPAC.
* p < 0.05 compared to all other CpG sites, ** p < 0.001 compared to all other CpG sites
Table 2. Ten CpG sites with lowest p-values in meta-analysis of epigenome-wide associations with bullying exposure









cg17312179 RAB14 9 5’UTR Island -2.67e-03 (4.97e-04) 7.17e-08 -/+
cg09291817 MAZ 16 TSS1500 Island -2.01e-03 (4.03e-04) 6.21e-07 -/+
cg11278602 HCG4 6 Body Island -2.98e-03 (6.41e-04) 3.35e-06 -/+
cg00911813 TNRC18 7 5’UTR Island -1.32e-03 (2.91e-04) 5.37e-06 -/+
cg08971637 DGUOK 2 TSS1500 N shore -9.63e-03 (2.14e-03) 6.66e-06 -/+





Island -2.40e-03 (5.40e-04) 8.92e-06 -/+
cg19790568 PRX 19 Body Island -1.49e-03 (3.36e-04) 9.08e-06 -/+
cg10929442 ST8SIA4 5 Body N shore -1.01e-03 (2.29e-04) 9.60e-06 -/+
ch.4.134822993R 4 -1.20e-03 (2.72e-04) 1.11e-05 -/+
SE: standard error; exposed/non-exposed; exposed to bullying victimization/not exposed to bullying victimization




exposure. Second, we reran separate analyses or additionally adjusting for (i) BMI; (ii) pre-
existing behavior problems; (iii) non-verbal intelligence quotient (IQ); (iv) stressful experiences 
other than bullying exposure; and (v) alcohol use. The bullying exposure coefficients from 
sensitivity analyses were not different from the bullying exposure coefficient from the main 
analysis (lowest p = 7.42x10-02). ‘Other stressful experiences’ was the only added variable that 
independently associated with cg17312179 (b = 2.20x10-04, SE = 9.96x10-05, p = 2.73x10-02).
Genetic associations
A triad of look-ups did not show evidence of genetic associations with cg17312179 methylation. 
First, the probe was not present in a list of polymorphic probes23. Second, no cis or trans 
methylation quantitative trait loci (mQTLs) were found to associate with this probe24, and 
third, low additive genetic influences (1.79x10-10%) and high shared (34.9%) and non-shared 
(65.1%) environmental influences have been reported for this probe based on twin heritability 
analyses25.
Look-up of previous findings in the literature
Results from eleven EWASs on childhood adversity11, 13, 15, 16, 26-32 were searched for cg17312179 
or other CpGs annotated to RAB14. No RAB14-associated probes were reported. Since 
cg17312179 was not reported in these studies, we could not establish if the direction of 
association was congruent with the one currently reported.
Candidate gene-wide analyses
Results from the meta-analysis were separately studied for probes annotated to 5-HTT and 
NR3C1 (Supplemental Figure 5). None of the probes reached gene-wide Bonferroni-significance 
(thresholds p = 3.13x10-03 for 5-HTT and p = 1.22x10-03 for NR3C1).
Functional associations
Gene Ontology (GO) analysis on CpGs with p < 0.001 (n = 644 CpGs, n = 396 genes) yielded 126 
pathways, 25 of which were confirmed by a GO analysis on CpGs with p < 0.01 (n = 5997 CpGs, 
n = 3722 genes) and 43 of which were confirmed by a GO analysis on CpGs with p < 0.0001 (n 
= 66 CpGs, n = 53 genes). Ryanodine-sensitive calcium-release channel activity as the most 
enriched (p = 9.99x10-08) biological process (Supplemental Tables 4-6, Supplemental Figure 6). 
Three isoforms of the ryanodine receptors exist 33, RYR1, RYR2, and RYR3, each present in a 
different tissue. Here, RYR2 was part of the GO pathway, a gene specifically active in the heart 
tissue. Other enriched terms for biological processes involve various neurodevelopmental 
processes, such as astrocyte differentiation and action potential regulation, as well as processes 




The current study is the first to characterize epigenome-wide intra-individual changes in 
DNA methylation related to bullying exposure. Our meta-analysis identified a CpG site with 
increasing levels of DNA methylation in non-exposed but decreasing levels in the exposed 
group. Other research 23-25 on this probe suggests that variance in DNA methylation at this 
CpG is primarily explained by environmental influences, with weak evidence of genetic 
effects. Sensitivity analyses showed that this association was not explained by co-occurring 
child characteristics, co-occurring risks, or consequences of bullying, including pre-existing 
behavioral problems, IQ, BMI, alcohol use or exposure to stressful experiences other than 
bullying. The site is located in the 5’ untranslated region of RAB14, a member of the Ras 
oncogene family of GTPases. Ras GTPases are important in cellular signaling and RAB14 is 
involved in vesicle transport and Golgi apparatus functioning34, and is expressed in multiple 
tissues (Supplemental Figure 7). No RAB14-associated probes have been reported in previous 
EWAS on childhood adversity.
RAB14 expression has however been associated to stress in different tissues. In rat hippocampus 
it was shown to be downregulated after prenatal stress35 and upregulated after mild chronic 
stress in stress-resilient rats36, possibly marking an adaptive response. In humans, its expression 
was found to be reduced in the prostate of men with prostate cancer after nutrition and 
lifestyle intervention focused on stress reduction37. Also, RAB14 expression in human brain 
tissue has been linked to depression and suicide38, as was Syntaphilin, a protein that regulates 
synaptic vesicle processing39 and encoded by SYNPH, a gene associated to one of the top 10 
CpG sites from the meta-analysis. How the observed changes in RAB14 methylation might 
relate to expression levels in this gene and what the downstream effects of these changes 
might be, however, remains to be elucidated in future functional studies.
GO analysis showed enrichment of the biological process of ryanodine-sensitive calcium release 
channel activity; these channels are a pathway important in cardiac functioning and the fight-
or-flight response40. This finding is congruent with several other enriched pathways associated 
with cardiac functioning, and fits with GO findings from other research on epigenetics and 
physical abuse 11. Further, GO analysis showed many neurodevelopmental processes, such as 
neuron differentiation, a biological pathway in which two of the associated genes, SYNPH and 
ST8SIA4, were among the top meta-analysis hits. ST8SIA4 (CMP-N-acetylneuraminate-poly-
alpha-2,8-sialyltransferase) is present in the Golgi apparatus, involved in neural plasticity41, 
and ST8SIA4 knockout mice have been shown to display a decreased motivation for social 
interaction42. Functioning of both genes has been associated with brain disorders, such as 
schizophrenia43, 44 and Alzheimer’s disease45, 46. Interestingly, in contrast to previous studies20, 
21, no associations with bullying exposure were found at candidate genes 5-HTT and NR3C1. 
Failure to replicate candidate epigenetic studies with epigenome-wide analyses is not 




uncommon13. This discrepancy may be explained by the stricter multiple testing correction 
applied in (candidate gene analyses as part of) epigenome-wide studies, or in the different 
specific regions tested by targeted gene approaches and microarray studies, rendering direct 
comparison unfeasible.
A pattern emerged of enrichment for CpGs with low overall methylation levels, increased 
over time, but decreased for exposed individuals. Furthermore, the top CpGs from the 
meta-analysis were more often located in CpG islands and promoter regions than would be 
expected by chance. Together this might indicate that bullying exposure is associated with 
an overall delayed downregulation of gene expression. However, promoter regions typically 
have low levels of methylation, and the enrichment of CpGs with low overall methylation 
levels in general seems to be more pronounced than the enrichment of promoter CpGs. In 
an EWAS on childhood abuse and promoter DNA methylation in adulthood8, the stressor was 
also more often negatively than positively associated with DNA methylation. In another EWAS 
on childhood maltreatment and DNA methylation around 10 years of age (range 5-14 years)29, 
researchers found an enrichment of CpGs with low methylation levels, often located in promoter 
regions as we did in the current study, but the association with maltreatment was more often 
positive. Unfortunately, direct comparison among studies is not straightforward because of 
timing differences in the measurement of DNA methylation, as well as the inherently unclear 
timing of often retrospectively reported stressors32. In the current study, effect estimates for 
the top ranking CpGs were incongruent and even seemed slightly oppositional between the 
two cohorts. One explanation might be the longer time period between bullying exposure 
and the DNA methylation measurement in ALSPAC. One study on timing differences in ALSPAC 
for example, found that recency of adversity exposure was more important in explaining DNA 
methylation levels than accumulation of adversity, regardless of timing32. On the other hand, 
even among top ranking CpGs associations were weak. Such effect sizes are in line however, 
with other epigenome-wide studies in population-based samples13, 15, 47-49, where exposures are 
generally less extreme and abundant than in risk samples that typically encounter larger effect 
sizes11, 29. In any case, thorough knowledge of normative development of DNA methylation 
levels is currently lacking and needed to interpret dissimilar estimates in the face of different 
measurement periods. Regarding the interpretation of the top hit, we further highlight that 
while stringent significance thresholds were used to reduce the risk of false positives, our 
current results may still reflect a chance finding and will need to be replicated in future studies.
 To facilitate harmonization of the bullying exposure measurements in both cohorts, bullying 
exposure was defined with a lenient threshold. This implies that the difference in DNA 
methylation found for the CpG in RAB14 is associated with exposure to bullying that is 
prevalent for children in the normal population. A more stringent definition of bullying might 
have brought forward different results, but a larger sample would be preferential for such an 
analysis. Additionally, with the current design we were unable to control for bullying exposure 
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that participants might have been subjected to outside of the moment of measurement. 
More measurements of bullying exposure would likely lead to more precise estimates. 
Further, more questions on the different types of bullying in the Generation R Study would 
have permitted us to differentiate between specific bullying exposures. Multiple reporters 
of bullying would have been preferable as well, especially the current use of mother report 
in one cohort and child report in the other is suboptimal. For the RAB14 CpG site, there 
was converging agreement however. Another constraint of the study was that the current 
selected samples were more affluent than the fuller populations of their respective cohorts, 
where ideally the full spectrum of characteristics for the children in our cohorts would be 
represented. Last, we do not know if changes in DNA methylation are the consequence of 
bullying exposure, or that such changes are associated with children who are more at risk 
of being bullied50. An experimental set-up, for example with an anti-bullying intervention51, 
would shed more light on this.
In conclusion, the current study is the first to report an epigenome-wide hit related to bullying 
exposure. This CpG site is located in the RAB14 gene and suggests that exposure bullying 
might be associated with Golgi apparatus functioning. The effect size was small, but in line 
with other population-based studies. Further, we found an enrichment for CpGs related to 
cardiac functioning and neurodevelopment, as well as for CpGs with low levels of methylation 
and sites for which DNA methylation decreased in exposed but increased in non-exposed. 
We believe that experimental and longitudinal research into DNA methylation is the path to 
a broader understanding of social stress and its effect on biological pathways.
Methods
Setting
Data were drawn from two population-based prospective birth cohorts, the Dutch Generation 
R Study (Generation R) and the British Avon Longitudinal Study of Parents and Children 
(ALSPAC). Pregnant women residing in the municipality of Rotterdam, the Netherlands, with 
an expected delivery date between April 2002 and January 2006 were invited to enroll in the 
Generation R Study. A more extensive description of the study can be found elsewhere52. The 
Generation R Study is conducted in accordance with the World Medical Association Declaration 
of Helsinki and has been approved by the Medical Ethics Committee of the Erasmus Medical 
Center, Rotterdam. Written informed consent was obtained for all participants.
Pregnant women residing in the study area of former county Avon, United Kingdom, with 
an expected delivery date between April 1991 and December 1992 were invited to enroll in 
the ALSPAC study. Detailed information on the study design has been published previous ly53, 
54. The ALSPAC website contains details of all available data through a fully searchable data 




dictionary and variable search tool (http://www.bristol.ac.uk/alspac/researchers/our-data/). 
Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee and 
the Local Research Ethics Committees. Consent for biological samples has been collected in 
accordance with the Human Tissue Act (2004). Informed consent for the use of data collected 
via questionnaires and clinics was obtained from participants following the recommendations 
of the ALSPAC Ethics and Law Committee at the time.
In both cohorts DNA methylation was studied before and after reported bullying exposure. 
A timeline can be found in Supplemental Figure 1.
Study Population
In the Generation R Study, 9,778 pregnant mothers gave birth to 9,749 live-born children. 
For a subsample of 608 singletons DNA methylation data was collected at 6 and/or 10 years 
old (343 at both time points). Of these, 506 children had information available on bullying 
exposure and relevant covariates, including 289 children with DNA methylation available for 
both time points (Supplemental Figure 2a). This subsample consisted of participants with 
parents born in the Netherlands, with European ancestry confirmed based on genetic principle 
component analysis for all children with genetic data available (99.6% of the current sample).
In ALSPAC, the inclusion of 14,541 pregnant mothers resulted in 14,062 live births. DNA 
methylation was available at 7 and/or 17 years old for a subsample of 936 European singletons 
(877 at both time points) as part of the Accessible Resource for Integrated Epigenomic 
Studies (ARIES) study55. For 846 of these children data on bullying exposure and relevant 
covariates was available, including 793 children with DNA methylation data at both time 
points (Supplemental Figure 2b), leading to a combined sample size of 1,352 children in the 
meta-analysis. In each cohort, bullying exposure and covariates were compared between the 
selected sample and (i) a set of participants with complete data on covariates, irrespective of 
availability of data on bullying exposure or DNA methylation (n = 8,528 in Generation R and 
n = 12,393 in ALSPAC), and (ii) a set of participants with complete data on both covariates 
and bullying exposure, irrespective of availability of DNA methylation data (n = 4,336 in 
Generation R and n = 6,347 in ALSPAC).
Bullying exposure
In Generation R, mothers filled out a questionnaire (adapted56) containing three questions 
on bullying exposure in the past few months, covering physical (‘In the past few months, 
how often has your child been bullied by way of spitting, hitting, kicking, or pinching?’), 
verbal (‘In the past few months, how often has your child been bullied by insulting, calling 
names or laughed at?’), and relational bullying (‘In the past few months, how often has your 
child been bullied by being excluded from activities, ignored by other children, or gossiped 
about?’). Items were rated on a 5-point scale (ranging from never to several times a week). In 
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ALSPAC, bullying exposure was measured through self-report with an adapted version of the 
Bullying and Friendship Interview Schedule (BFIS)57. Nine questions covered physical (being 
hit or beaten up/belongings taken), verbal (threatened or blackmailed/tricked/called nasty 
names), and relational forms of bullying (others would not play with them/being made to do 
things they did not want to do/others told lies or nasty things about them/had games spoilt) 
in the preceding six months on a 4-point scale (ranging from never to at least once a week). 
Internal reliability of both measures was acceptable (Generation R: α = 0.74, ALSPAC: α = 
0.73). Scores were dichotomized to harmonize the two bullying scales and avoid issues arising 
from extreme skewness of the data. Children were classified as being exposed to bullying if 
they were bullied ‘at least once or twice in the past few months’ on at least one of the items 
in Generation R, and at least ‘1-3 times in the past six months’ in ALSPAC58-61.
Variables sensitivity analyses
A more stringent bullying exposure variable was defined, in which children were classified 
as exposed when at least indicated to be bullied ‘2 or 3 times a month’ in Generation R, and 
they at least indicated to be bullied ‘about once a week’ in ALSPAC.
Body Mass Index (BMI) (kg/m2) was measured at 6 and 10 years in the Generation R and 7 
and 17 years in the ALSPAC. Values were standardized to SD scores, adjusted for age and sex.
Child behavioral problems were measured at age 3 years with the mother-reported Child 
Behavior Checklist for toddlers (CBCL1½-5)62 in Generation R. Ninety-nine items were scored 
one a 3-point scale (range 0-2), regarding symptoms of anxiety, sadness, withdrawn behavior, 
attention problems, and aggressive behaviors (α = 0.92). Items were summed into a weighed 
total problem behavior scale, with 25% missing allowed. In ALSPAC, the mother-reported 
Strengths and Difficulties Questionnaire (SDQ)63 at 4 years was used. The scales for emotional, 
conduct, and hyperactivity problems were used as a total problem behavior score, consisting 
of 15 items, each rated on a 3-point scale (range 0-2) (α = 0.74). The remaining problem scale 
of the SDQ, the ‘peer problems’ scale, was excluded from the total score due to content 
overlap with bullying exposure.
Child non-verbal intelligence quotient (IQ) was measured by testing visuospatial abilities 
(Mosaics) and abstract reasoning (Categories) with the Snijders-Oomen Niet-verbale Intelligentie 
Test-Revisie (SON-R 2½-7)64 at age 6 years in Generation R. In ALSPAC, a shortened version 
of the Wechsler Intelligence Scale for Children (3rd UK edition (WISC-III))65 was measured at 
age 9 years.
Other stressful experiences were measured in Generation R with a major life events inventory66, 
reported by the mother, when the child was 10 years. This inventory covers stressful life 
events spanning the lifetime of the child, such as physical abuse, sexual abuse, conflict in 




the household, illness or death in the family, and parental separation. Three items related to 
bullying exposure were excluded, leaving 21 items (range 0-1). In ALSPAC, we used an Adverse 
Child Experiences (ACE) lifetime composite score15, 67. This score is based on 541 questions 
mapping on to 10 ACEs up to age 16 years. Participants were included if there was at least 
50% of the data available for each ACE. We excluded the ACE for bullying, leaving physical, 
sexual, and emotional abuse, emotional neglect, substance use in the household, violence 
between parents, parental mental health, parent conflict, parent offence, and parental 
separation (each range 0-1).
Last, alcohol use was measured in ALSPAC with Alcohol Use Disorders Identification Test 
(AUDIT) at age 17. This tests consists of 10 items (range 0-4); a total score of 8 or more is 
considered hazardous68.
DNA methylation
Both cohorts used the EZ-96 DNA Methylation kit (Shallow) (Zymo Research Corporation, 
Irvine, USA) for bisulfite conversion on the extracted DNA. DNA methylation profiles were 
generated using the Illumina Infinium HumanMethylation450 BeadChip (Illumina Inc., San 
Diego, USA). Quality control and normalization steps can be found in Supplemental Methods. 
Analyses were restricted to 473,864 autosomal CpGs. DNA methylation levels are characterized 
by beta values (β values), representing the ratio of methylated signal relative to the sum of 
methylated and unmethylated signal measured per CpG. Outlying data points outside the 
3*interquartile range were winsorized to the nearest point for each CpG. White blood cell 
(WBC) composition was estimated using the reference-based Houseman method69. Batch 
effects and additional unknown confounding were estimated using surrogate variable analysis 
(SVA) in meffil70, 71 in R version 3.4.372.
Statistical analyses
Associations between bullying exposure and changes in DNA methylation were analyzed 
with a linear mixed model:
Mij = β0 + u0i + β1Ageij + β2Bulliedij + covariates + ϵij
Here, M denotes DNA methylation level, β0 fixed intercept, u0i random intercept, β1 fixed age 
coefficient, β2 fixed bullying exposure coefficient, and ϵ random error. The Bullied variable was 
set to 0 for the first DNA methylation measurement and to 1 or 0 for the second measurement 
depending on whether the participant had been exposed to bullying, or not, respectively, 
and random intercept u0i allowed for inter-individual variation in DNA methylation at the 
first measurement. Participants are denoted by i and time points by j. Covariates included 
sex, gestational age, socio-economic status as indicated by highest attained educational 
level of the mother (low versus medium or high), surrogate variables (n = 20), WBCs (CD4+ 
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T-lymphocytes, CD8+ T-lymphocytes, natural killer cells, B-lymphocytes, monocytes, and 
granulocytes). Current direct and second-hand smoking was adjusted for with the methylation 
level of AHRR cg05575921, which has proven to be a valid marker of tobacco exposure73-76. 
Methylation level for this CpG at both time points was entered into the equation, with levels 
divided into quintiles (as described elsewhere77) and lower levels indicating more smoking. 
Linear mixed models were applied using the lme4 package78.
To compare congruency between results from the two cohorts, estimates of the top 1000 
CpGs in each cohort were correlated with estimates of those CpGs in the other cohort (as 
elsewhere15). Meta-analysis of estimates and standard errors of the two cohorts was performed 
using fixed models within the metafor79 R package. To account for multiple testing (n = 473,864 
CpGs), the significance threshold was set at a Bonferroni-corrected p-value of 1.06x10-07.
Follow-up analyses
Sensitivity analyses
A series of sensitivity analyses were performed on CpGs with p < 1.06x10-07 in the meta-analysis. 
First, because the classification of bullying exposure is rather broad in the main analysis, we 
performed a sensitivity analysis with a more stringent dichotomization. Second, we reran 
analyses additionally adjusting for the following potential confounders or mediators that have 
been previously shown to associate with bullying exposure and DNA methylation. In each 
sensitivity analysis, one of the following variables was added to the main analysis: (i) Body 
Mass Index (BMI) (kg/m2) SD scores, adjusted for age and sex, at 6 and 10 years in Generation 
R and 7 and 17 years in ALSPAC (full sample size available)60, 80; (ii) pre-existing behavioral 
problems (Generation R n = 451, ALSPAC n = 794)5, 50; (iii) child non-verbal IQ (Generation R n 
= 465, ALSPAC n = 811)81; (iv) stressful experiences other than bullying exposure (Generation 
R n = 482, ALSPAC n = 597)82, 83; and (v) alcohol use in ALSPAC (n = 624), where children are 
older84, 85. For each sensitivity analysis, the coefficient for bullying exposure was compared 
with that for the main analysis with a z-test86, 87.
Genetic associations
DNA methylation for CpGs with p < 1.06x10-07 in the meta-analysis were tested for genetic 
associations in three ways. First, a look-up was performed in a list of CpGs located on a single 
nucleotide polymorphism (SNP), e.g. polymorphic CpGs23. Second, we tested for known 
associations with genetic variants, e.g. methylation quantitative trait loci, in cis (cis mQTLs) 
and in trans (trans mQTLs; http://www.mqtldb.org/; GCTA set)24. Third, we tested for additive 
genetic influences versus shared and unique environmental influences on the DNA methylation, 
as based on twin heritability analyses25.




Look-up of previous findings in the literature
Previous studies on childhood adversity and DNA methylation, measured with the Illumina 
Infinium HumanMethylation450 BeadChip, were searched for current CpGs with p < 1.06x10-
07 and their associated genes in the meta-analysis. Eleven studies were selected11, 13, 15, 16, 26-32. 
All studies examined childhood abuse or trauma, on study additionally examined bullying13.
Candidate gene-wide analyses
A candidate gene follow-up analysis was conducted on the results stemming from the meta-
analysis, for sites annotated to 5-HTT and NR3C1. The significance threshold was set at a 
Bonferroni gene-level corrected p-value of 3.13x10-03 (n = 16 CpGs) and 1.22x10-03 (n = 41 
CpGs), respectively.
Functional associations
Enrichment of Gene Ontology (GO) pathways was tested for genes associated with CpGs 
with p < 0.001 in the meta-analysis (cutoff described elsewhere 11), while adjusting for gene 
size and pruning for redundant terms (a full method description can be found elsewhere 
11). Terms with p < 0.05 and more than one associated genes are reported, and highlighted 
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Quality control and normalization of DNA methylation
In Generation R, quality control was performed using the CPACOR workflow1 on all 2,467 
available DNA methylation samples, including cord blood samples (1,475 cord bloods, 500 
peripheral bloods at 6 years, and 492 peripheral bloods at 10 years). Arrays with observed 
technical problems such as failed bisulfite conversion, hybridization or extension, as well as 
arrays with a mismatch between sex of the proband and sex determined by the chr X and 
Y probe intensities were removed from subsequent analyses. Additionally, only arrays with 
a call rate>95% per sample were processed further, resulting in 2,355 samples, 44 of which 
were sibling pairs. Hence 2,333 were carried forward into normalization.
In ALSPAC, quality control was performed on 6,057 samples (including 1,127 from cord blood, 
1086 from peripheral blood at 7 years, and 1,073 from peripheral blood at 17 years from 
ALSPAC children and 2,771 peripheral bloods from their parents),using the meffil package2. After 
removing samples with mismatched genotypes, mismatched gender, incorrect relatedness, 
low concordance with samples collected at other time points, extreme dye bias, and poor 
probe detection, 5,337 samples remained, including 2,845 samples for 1,003 children.
To minimize cohort effects as much as possible, we normalized both cohorts together as a 
single dataset. In detail, functional normalization (10 control probe principal components, slide 
included as a random effect) was performed in R version 3.4.33 with the meffil package on a 
combined Generation R and ALSPAC set including cord and whole blood samples comprising 
a total of 5,178 samples for a total of 485,512 CpG sites.






The association between bullying exposure and DNA methylation at cg17312179 was analyzed 
separately for each time-point (pre- (T1) and post-measurement (T2) of bullying exposure), 
to understand if reported change stemmed from a larger difference between exposed and 
non-exposed children after bullying report, rather than beforehand. Associations between 
bullying exposure at 6 years in Generation R and at 7 years in ALSPAC (combined n = 1,224) were 
meta-analyzed, as were those at 10 years in Generation R and 17 years in ALSPAC (combined 
n = 1,210). Results showed that the association with DNA methylation change at cg17312179 
was driven by a difference in exposed versus non-exposed individuals at T2 (b = -2.43x10-03, 
SE = 5.20x10-04, p = 3.04x10-06), not at T1 (b = 7.24x10-04, SE = 4.86x10-04, p = 1.37x10-01). This 









































































   
   
   
   
   
   
   







   
   
   
   
   
   
   
   












































































































































































































































































































































































































































































































































































































































































































   
   
   
   
   
   
   







   
   
   
   
   
   
   
   




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Supplemental Table 2. Functions of genes associated with the ten CpG sites with the lowest p-values in the meta-
analysis of epigenome-wide associations with bullying exposure
CpG site Gene Associated functions
cg17312179 RAB14 Golgi apparatus functioning, vesicle processing6
cg09291817 MAZ Inflammation induced, regulates amyloid A protein7
cg11278602 HCG4 Unknown; located in major histocompatibility region, which is important for 
immune functioning8
cg00911813 TNRC18 Unknown; other trinucleotide repeat (TNR) genes associated to transcripti-
on regulation and neurological disorders9
cg08971637 DGUOK Mitochondrial functioning10
cg12767834 SNPH Synaptic vesicle processing11
cg26394220 MIR375;
CCDC108
Micro RNA, pancreas functioning12
cg19790568 PRX Peripheral myelin upkeep13
cg10929442 ST8SIA4 Golgi apparatus functioning, neural cell plasticity14
ch.4.134822993R



























































































































































































































































































































































































































































































































































































































































































































Supplemental Table 4-6 are available online in the published article–https://www.tandfonline.com/doi/full/10.1
080/15592294.2020.1719303





Supplemental Figure 1. Timeline of measurements in Generation R and ALSPAC
Supplemental Figure 2. Overlap samples sizes per time point (a) in Generation R (n data points = 795, n 
participants = 506) and (b) in ALSPAC (n data points = 1,639, n participants = 846)
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Supplemental Figure 3. QQ-plot of epigenome-wide study in (a) Generation R (λ = 1.063) and (b) QQ- ALSPAC (λ = 
1.064)
Supplemental Figure 4. Manhattan plot of -log10 p-values from meta-analysis




Supplemental Figure 6. Enriched biological processes (p < 0.05) in Gene Ontology analysis of CpG sites with p 
< 0.001 (n = 644 CpG sites, n = 396 genes) ordered by significance. Circle size represents percentage of genes 
represented in pathway versus all genes in that pathway.
Supplemental Figure 5. Regional Manhattan plot of -log10 p-values from meta-analysis for candidate genes 
for the (a) serotonin transporter 5-HTT, and (b) glucocorticoid receptor, NR3C1. Green points indicate a more 




Supplemental Figure 7. RAB14 mRNA expression in human tissues as portrayed by https://www.genecards.org/
cgi-bin/carddisp.pl?gene=RAB1415
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DNA methylation is known to play a pivotal role in childhood health and development, 
but a comprehensive characterization of genome-wide DNA methylation trajectories 
across this age period is currently lacking. We have therefore performed a series of 
epigenome-wide association studies in 5,019 blood samples collected at multiple time-
points from birth to late adolescence from 2,348 participants of two large independent 
cohorts. DNA methylation profiles of autosomal CpG sites (CpGs) were generated using 
the Illumina Infinium HumanMethylation450 BeadChip. Change over time was widespread, 
observed at over one-half (53%) of CpGs. In most cases DNA methylation was decreasing 
(36% of CpGs). Inter-individual variation in linear trajectories was similarly widespread 
(27% of CpGs). Evidence for nonlinear change and inter-individual variation in nonlinear 
trajectories was somewhat less common (11% and 8% of CpGs, respectively). Very little 
inter-individual variation in change was explained by sex differences (0.4% of CpGs) even 
though sex-specific DNA methylation was observed at 5% of CpGs. DNA methylation 
trajectories were distributed non-randomly across the genome. For example, CpGs with 
decreasing DNA methylation were enriched in gene bodies and enhancers and were 
annotated to genes enriched in immune-developmental functions. By contrast, CpGs 
with increasing DNA methylation were enriched in promoter regions and annotated to 
genes enriched in neurodevelopmental functions. These findings depict a methylome 
undergoing widespread and often nonlinear change throughout childhood. They support a 
developmental role for DNA methylation that extends beyond birth into late adolescence 
and has implications for understanding life-long health and disease. DNA methylation 




DNA methylation, an epigenetic process whereby DNA is modified by the addition of methyl 
groups, has gained increasing attention over the past few decades, due to its pivotal role in 
development. In utero, DNA methylation is involved in a range of essential processes including 
cell differentiation1-3, X-chromosome inactivation4 and fetal growth5. Its role extends well 
beyond birth, e.g. by maintaining cell type identity and genome stability6-8, responding to 
environmental exposures9-11, and its involvement in immune12 and neural development13. 
Since it is influenced by both genetic and environmental factors14, 15, DNA methylation has 
also emerged as a key mechanism of interest for understanding the gene-environmental 
interplay in normal ageing and disease development.
Numerous studies have identified strong associations between DNA methylation and age. 
While most have relied on cross-sectional data16-18, but a few have utilized longitudinal 
measurements of DNA methylation within individuals19-23. Longitudinal measurements allow 
one to distinguish intra-individual change from inter-individual differences in change, thereby 
greatly improving the power to detect change over time and to identify differences between 
individuals24. Identifying and characterizing CpGs for which DNA methylation changes differently 
over time between individuals (i.e. inter-individual variation in change) is a necessary step in 
identifying genetic and environmental influences on the methylome as well as their potential 
impact on health outcomes25. Moreover, longitudinal designs facilitate the study of nonlinear 
trajectories26, 27, which might help to identify sensitive periods for DNA methylation change in 
development. To date, the largest epigenome-wide longitudinal study on DNA methylation 
included 385 elderly individuals who were followed up to five times over a maximum period 
of 18 years, identifying DNA methylation change at 1,316 CpG (Cytosine-phosphate-Guanine) 
sites19 and inter-individual variation at change at 570 CpGs20. Yet, little is known about DNA 
methylation trajectories across early development, as existing studies in childhood DNA 
methylation typically have been limited by small sample sizes21, 23, short time-periods22, 28 or 
focused on specific CpGs in relation to maternal smoking29, birthweight30, or maternal BMI31.
In the current study, we aim to provide a benchmark of typical epigenome-wide age-related 
DNA methylation trajectories within individuals, spanning the first two decades of life. This 
study combines repeated measurements of DNA methylation at nearly half a million CpG sites 
across the genome from two large population-based cohorts, the Generation R Study and 
Avon Longitudinal Study of Parents and Children (ALSPAC), to form one integrated dataset 
with four time-points of measurement. In a series of three epigenome-wide mixed model 
analyses we study linear (Model 1), nonlinear (Model 2) and sex-related (Model 3) trajectories 
of change across development. Further, we aim to identify CpGs for which trajectories vary 
between individuals (Model 1 and 2). Results are interpreted in the context of CpG location 




and biological pathways. The key findings are discussed here, full results per CpG can be freely 
accessed and visualized at http://epidelta.mrcieu.ac.uk/.
Results
Cross-cohort comparability
Sample characteristics of 1,399 Generation R participants (total DNA methylation samples = 
2,333) and of 949 ALSPAC participants (total DNA methylation samples = 2,686; Figure 1) are 
provided in Supplemental Table 1. After the DNA methylation datasets of the two cohorts 
underwent joint functional normalization (see Supplemental Figure 1 for distributions of 
mean DNA methylation levels), within-cohort stability of DNA methylation at birth and 
6 or 7 years (in Generation R and ALSPAC, respectively) was compared. Stability of DNA 
methylation at individual CpG sites (437,864 autosomal sites) was estimated in three ways: 
relative concordance using Spearman correlations between time points, absolute concordance 
using intraclass correlations between time points (children with data for both time points: n 
Generation R = 476, n ALSPAC = 826), and change over time using change estimates from a 
linear mixed model (Model 1, see Methods) applied within each cohort (children with data 
for at least one of the two time-points: n Generation R = 1,394, n ALSPAC = 944). Estimates 
of all stability measures for both cohorts are depicted in Figure 2. Next, agreement of these 
stability estimates between the two cohorts was estimated with the Spearman (ρ) or Pearson 
(r) correlation (depending on normality of the data) across all CpGs, between the datasets. 
The Spearman correlation of the relative concordance was ρ = 0.62, the Pearson correlation of 
the absolute concordance was ρ = 0.60, and the Pearson correlation of the change estimates 
was r = 0.86, indicating strong agreement between datasets. Based on these results the two 
Figure 1. Longitudinal sample sizes. Sample sizes for (a) Generation R (N total children = 1,399, N total DNA 
methylation samples = 2,333); and (b) ALSPAC (N total children = 949, N total DNA methylation samples = 2,686). 




datasets were joined to form one set with four different time-points of DNA methylation 
(birth, age 6/7 years, 10 years, 17 years).
Linear DNA methylation change from birth to early adulthood
Estimates of overall change in DNA methylation from birth to early adolescence (Model 1; see 
Methods) indicated linear change at 51.6% of CpGs at a Bonferroni-corrected threshold (P 
< 1x10-07) (Figure 3a and 3b). Specifically, DNA methylation decreased over time at 35.5% of 
all CpGs and increased at 16.0% (Figure 4). The mode intercept indicated that the decreasing 
CpGs were 88% methylated at birth (Figure 5). DNA methylation levels for increasing CpGs 
typically started at 5%.
The mode estimate DNA methylation change was b = -9.24x10-04 (with corresponding mode SE 
= 6.85x10-05), indicating an overall 0.09% DNA methylation decrease per year at a typical CpG 
site. This translates into a 1.66% decrease in DNA methylation over the course of 18 years. 
An example of a CpG site with a typical change in DNA methylation is depicted in Figure 3a. 
The largest observed absolute change in DNA methylation was b = -3.47x10-02 (SE = 3.65x10-
04, p < 9.88x10-324), indicating an overall DNA methylation decrease of 62.5% over 18 years 
(Figure 3b). Only twenty-two CpGs showed an absolute change > 50% over the course of 18 
years (Supplemental Table 2). From this it follows that typically in (cord-/peripheral) blood 
tissue, DNA methylation levels for CpGs do not change from a fully unmethylated to fully 
methylated state, or vice versa, over the course of 18 years.
Further, we observed substantial inter-individual variation in linear DNA methylation changes 
over time at 27.4% of all CpGs (i.e. random slope variance was greater than zero at Bonferroni-
corrected threshold p < 1x10-07; Figure 3c). On average, this variation accounted for 2.7% (SD = 
1.5%) of all estimated inter-individual variation (for intercept, age, batch, and residual) at these 
CpGs. At 17.3% of all CpGs, we observed both change and inter-individual variation in change.
Figure 2. Scatterplots of within-cohort stability of DNA methylation. Showing (a) Spearman correlations, (b) 
intraclass correlation coefficients and (c) change estimates from birth to 6/7 years per CpG for Generation R and 
ALSPAC.




Figure 3. DNA methylation levels of selected CpG sites across childhood. Parts (a-c) show CpG sites with linear 
change over time (Model 1). A typical site is shown in (a), the site with the largest observed change in (b) and 
with inter-individual variation in DNA methylation change (c). Parts (d-f) show CpG sites with non-linear change 
(Model 2). A Positive-Neutral trajectory is shown in (d), a Negative-Neutral trajectory in (e) and a Positive-More 
Positive-Less Positive in (f). Parts (g-i) show CpG sites with inter-individual variation in change (Model 2). A site 
with slope variation from birth is shown in (g), slope change variation at 6 in (h) and slope change variation at 9 
in (i). Parts (j-l) show CpG sites with sex-specific DNA methylation. A site with stable sex differences is shown in 
(Model 3) (j), sex-specific slope in (Model 3) (k) and sex-specific slope change at 6 in (Model 2) (l).
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Nonlinear DNA methylation change
Model 2 (see Methods) was identical to Model 1 but permitted slope changes at ages 6 and 
9 years to test for nonlinear DNA methylation trajectories. At 11.0% of CpGs a nonlinear 
trajectory was detected. Specifically, at 4.8% of all CpGs, DNA methylation increased from 
birth and remained stable from 6 onward (Positive-Neutral; Figure 3d). Second, at 3.1% of all 
CpGs, DNA methylation decreased from birth and then remained stable at 6 years (Negative-
Neutral; Figure 3e). The remaining 3.0% of all CpGs followed other nonlinear trajectories 
(e.g. Figure 3f), with each trajectory observed in < 1.0% of all CpGs. Overall, linear and/or 
nonlinear changes in Model 1 or 2 were observed in 52.6% of CpGs (Figure 3), indicating that 
most nonlinear patterns were also detected as linear patterns in Model 1.
Inter-individual differences in change (i.e. random variance in slopes) from birth onward was 
detected at 3.4% of all sites (Figure 3g), inter-individual differences in slope change at 6 years 
in 0.2% (Figure 3h), and inter-individual differences in slope change at 9 years at 8.2% of CpGs 
(Figure 3i). Inter-individual differences in slope (change) at each time-point were detected more 
often at CpGs with an increasing rather than decreasing overall DNA methylation change in 
Figure 4. Overview of results from the three models. Model 1 (M1) was applied for overall change in DNA 
methylation and inter-individual variation in linear change; Model 2 (M2) for nonlinear change in DNA 
methylation and inter-individual variation in nonlinear change; and Model 3 (M3) for stable sex differences 
in DNA methylation and sex differences in change of DNA methylation (Sex by Time interaction). Percentages 
represent percentage of autosomal CpGs below Bonferroni-corrected threshold (p < 1x10-07).




Model 1 (p = 2.37x10-144). Last, both Positive-Neutral and Negative-Neutral changes coincided 
more often with inter-individual variation from birth (p < 9.88x10-324). Any inter-individual 
differences in change, detected by Model 1 or 2, was observed at 27.9% of CpGs. In total, 
Models 1 and 2 detected age-related change whether linear, non-linear or inter-individual 
differences in change at 62.8% of all CpG sites (Figure 3).
Sex differences in longitudinal DNA methylation and DNA methylation 
change
According to Model 3 (see Methods), sex differences in DNA methylation were present at 
4.9% of (autosomal) CpGs (Figure 3). Specifically, stable longitudinal sex differences (main 
sex effects) were observed at 4.8% of all (autosomal) CpGs (Figure 3j), and sex differences in 
DNA methylation change (sex by age interaction effects) were found at 0.4% of all (autosomal) 
CpGs (Figure 3k). At sites with stable sex differences, DNA methylation levels were higher in 
girls at 3.6% (Figure 3j) and lower at 1.2% of CpG sites. DNA methylation at sites with higher 
Figure 5. Density plots of intercepts of CpGs. Intercepts for CpGs with (a) directions of change in Model 1 (n = 
473,864); (b) nonlinear trajectories in Model 2 (n = 52,043); (c) stable sex differences in Model 3 (n = 22,821); (d) 
sex differences in DNA methylation change in Model 3 (n = 1,768).
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DNA methylation in girls tended to increase over time, whereas DNA methylation at sites 
with higher DNA methylation in boys tended to decrease (p = 4.20x10-205). Most commonly 
(at 0.2% of all CpGs), DNA methylation was higher in girls at birth but DNA methylation in 
boys increased at a higher rate.
Both CpGs with stable sex differences and those with sex differences in DNA methylation 
change were less likely to show inter-individual variation than other sites (20.8% versus 
27.5% and 18.1% versus 27.3%; p = 5.36x10-111 and p = 7.57x10-18). Finally, CpGs with stable 
sex differences or sex differences in DNA methylation change detected in Model 3 were 
much more likely to follow an overall Positive-Neutral trajectory of DNA methylation change 
detected in Model 2 than other CpG sites were (24.2% of CpGs with stable sex differences 
followed a Positive-Neutral trajectory versus 3.8% of other CpGs and 53.9% of CpGs with sex 
differences in DNA methylation change followed a Positive-Neutral trajectory versus 4.6% of 
other CpGs; p < 9.88x10-324, p < 9.88x10-324; Figure 3l). Albeit less prominently so, CpGs with 
stable sex differences or sex differences in DNA methylation change also more often followed 
a Negative-Neutral trajectory than other CpGs did (stable sex differences: 5.0% versus 3.0%, 
p = 5.43x10-62; sex differences in DNA methylation change: 7.7% versus 3.1%, p < 7.11x10-28).
Follow-up analyses
Follow-up analyses were performed to understand how different types of age-related DNA 
methylation trajectories are distributed across the genome (Supplemental Tables 3-5). All 
reported enrichments have significance below a Bonferroni-corrected threshold of p < 4.46x10-
04, corrected for the number of chi-square tests (n = 112). We further report enrichment of 
Gene Ontology (GO) pathways (nominal p < 0.05) for genes annotated to CpG sites in each 
trajectory (Supplemental Tables 5-7). Last, we study enrichment of age-related DNA methylation 
trajectories in reported hits of different EWASs (Figure 6). All reported EWAS enrichments 
are below a Bonferroni-corrected threshold of p < 1.38x10-04, corrected for the number of 
Fishers’ exact tests (n = 363; Supplemental Table 8).
Patterns of DNA methylation change and CpG location
CpG sites with DNA methylation change associated patterns were labeled by gene associated 
regions, CpG island associated regions, as well as enhancer elements. Although many exceptions 
exist, low levels of DNA methylation in the promoter area but high levels of DNA methylation in 
the gene body are generally associated with increased gene transcription32, 33. CpGs annotated 
to TSS200 regions more often showed an overall DNA methylation increase (Model 1) than 
other CpGs (19.0% versus 15.6%), whereas CpGs annotated to the gene body more often 
showed an overall DNA methylation decrease than other sites (38.8% versus 33.7%). TSS200 
CpGs showed less inter-individual variation in overall DNA methylation change than other 
sites (22.2% versus 28.1%), whereas gene body CpGs showed somewhat more inter-individual 
variation in overall DNA methylation change than other sites (28.9% versus 26.5%).




Promoter areas often coincide with CpG islands34. Here, 63.3% of TSS200 CpGs were also 
annotated to CpG islands. As in TSS200 areas, CpGs annotated to CpG islands had lower 
DNA methylation levels (mode M1 intercept 2.4% (SD = 30.2%)), and more often showed an 
overall DNA methylation increase than other sites (25.2% versus 12.0%). DNA methylation 
sex differences were especially present in the shores of CpG islands compared to all other 
island associated regions (stable sex differences: 7.5% versus 4.0%, sex differences in DNA 
methylation change: 0.6% versus 0.3%).
Enhancers act on promoters to regulate gene transcription35. CpGs annotated to enhancer 
elements (2.0% of CpGs) tended to have low DNA methylation levels (mode M1 intercept 
5.07%; SD = 31.4%) and then increased with age more than other CpGs (23.9% versus 15.9%). 
Inter-individual variation in change from birth was more common at enhancer sites than at 
other sites (5.6% versus 3.3%).




Enrichment of Gene Ontology categories was tested for genes linked to CpGs with different 
DNA methylation trajectories. In short, genes annotated to CpGs with overall decreasing 
DNA methylation levels were enriched in immune-developmental functions, whereas those 
annotated to CpGs with increasing levels were enriched in neurodevelopmental functions. This 
pattern seemed even more pronounced at genes annotated to nonlinear Negative-Neutral 
and Positive-Neutral CpGs, with the former more often associated to immune-development 
and the latter to neurodevelopment. Genes linked to CpGs with stable sex differences and 
sex differences in DNA methylation change were enriched in pathways associated with 
sexual development, such as genital development, as well as pathways associated with 
neurodevelopment. Genes linked to CpGs with sex difference in DNA methylation change 
were also enriched in functions related to tooth and hair development.
Enrichment in EWASs
We further investigated functional relevance of CpG sites with age-related DNA methylation 
trajectories by testing enrichment with published EWAS associations (Figure 6)28, 36-61. 
Unsupervised clustering of the enrichments shows that CpG sites with inter-individual 
variation in change over time have distinct enrichments and cluster differently from those 
with age-associated change that is consistent among individuals. The CpG sites of each age-
associated DNA methylation trajectory were enriched with published age associations in 
adulthood. Multiple smoking EWAS clustered together with enrichment patterns exhibiting 
strongest enrichments among CpG sites with Negative-Neutral trajectories and mostly weak 
enrichments among CpG sites with inter-individual variation in change. Further, despite 
adjusting for cell count heterogeneity in our models, we observed enrichments of CpG sites 
that differ by white blood cell type among sites following nearly all age-associated trajectories. 
Finally, we observed enrichments of CpG sites associated with gestational age and prenatal 
smoking with sex-specific DNA methylation.
Discussion
In this study we described changes in DNA methylation levels through the first two decades 
of human life. We examined DNA methylation levels per CpG by their linear association 
with age, their nonlinear trajectories and inter-individual variation in change, as well as sex 
differences and CpG characteristics.
We found that about half of sites change: consistent linear and/or nonlinear DNA methylation 
change was found at 53% of sites. We further found that over a quarter of sites, 28%, were 
characterized by substantial inter-individual differences in the direction of this change. DNA 




methylation sex differences were present, but not abundant: 5% of autosomal sites displayed 
different DNA methylation levels or differences in change over time for girls and boys.
Specifically, we determined that DNA methylation at 52% of the measured methylome have 
some form of linear change from birth to late adolescence, with DNA methylation decreasing 
at 36% and increasing at 16% of CpGs. CpGs with decreasing DNA methylation tended to 
have high levels of DNA methylation and were more often located in gene bodies. CpGs with 
increasing levels of DNA methylation tended to have low levels of DNA methylation and 
were more likely to be located in promoter regions and at enhancers. The predominance 
of decreasing CpGs is in agreement with literature on epigenome-wide DNA methylation 
and age in cross-sectional research on children and adults18, 62, as well as with longitudinal 
research in adults19.
Nonlinear DNA methylation trajectories were detected at 11% of CpGs, mostly involving changes 
in DNA methylation from birth to age 6 years, after which DNA methylation was more stable. 
We note that this could be due to cord blood being used to generate DNA methylation profiles 
at birth, whereas peripheral blood was used at later ages. A previous study23 including eight 
children showed that the cord blood DNA methylation profile at birth clustered separately 
from later peripheral profiles, after which DNA methylation changed gradually from 1, to 2.5, 
to 5 years. Such differences between DNA methylation in cord and peripheral blood might 
be due to uncaptured differences in white blood cell composition, as well as to different 
gene-regulatory functioning in the intra-uterine versus extra-uterine environment. On the 
other hand, Gene Ontology analyses showed that functional associations for positive and 
negative linear DNA methylation patterns, which are unlikely to be affected by tissue type, 
were consistent with functional associations for nonlinear positive and negative patterns, 
respectively (e.g. positive and negative up to 6 years, and then no change up to 18 years).
Specifically, sites with decreasing levels of DNA methylation, both with or without slope changes 
around the age of 6 years, were functionally enriched for immune-developmental pathways, 
and sites with increasing levels of DNA methylation, both with or without slope changes, were 
enriched for neurodevelopmental pathways. Since these observations were based on blood 
DNA methylation, it remains to be studied what roles genes linked to neurodevelopmental 
pathways play in in blood, or to what extent DNA methylation trajectories in blood mirror 
those in neural tissue.
Inter-individual differences in linear DNA methylation trajectories were found at 27% of 
CpGs, indicating change at different rates or directions for different individuals. Such sites 
tended to have overall increasing rather than decreasing levels of DNA methylation from 
birth to 18 years. This observation is consistent with the only other large study to examine 
inter-individual differences in DNA methylation change20, although we note that this study 
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included elderly subjects and detected a smaller number of relevant CpGs. We are the first 
to investigate inter-individual differences in nonlinear DNA methylation trajectories. These 
were most often found in the slope change at 9 years (8% of CpG sites), indicating that most 
inter-individual differences in DNA methylation emerge after the first decade of life. More 
research is needed to understand if the direction of change in this period is determined by 
stimuli during that period, or rather by preceding, perhaps cumulative, exposures. However, 
it is clear that, given the high proportion of CpG sites with inter-individual variation in DNA 
methylation change over time that we have observed, it is important to restrict the range of 
ages of children included a single EWAS. Specific limits should be discussed given the rapidly 
growing number of studies generating DNA methylation profiles across childhood63.
Stable sex differences were found at 5% of autosomal CpGs, and sex differences in DNA 
methylation change were found at 0.4% of all CpGs. In general, if there were stable sex 
differences, girls had higher levels of DNA methylation (4% of all CpGs), in case of sex differences 
in DNA methylation change, boys had an accelerated upward change (0.2% of all CpGs). The 
direction of stable sex differences detected are congruent with a cross-sectional study on 
newborns, in which girls had higher DNA methylation levels than boys for the large majority 
of the 3031 significant autosomal CpGs54. Sex-discordant associations with age seemed to be 
more prevalent from birth to age 6 years than afterwards, suggesting that any phenotypic 
sex differences associated to DNA methylation would be established in early childhood. 
Their enrichment in the shores of CpG islands, areas at which DNA methylation has been 
associated with tissue differentiation and tissue-specific gene expression64, is consistent with 
the critical role that these processes play in sexual differentiation. Studies into sex differences 
in epigenetic regulation might want to focus on these locations.
We also found the other DNA methylation trajectories to be arranged throughout the genome 
in a nonrandom fashion. Earlier studies32, 65 have shown that, for active genes, lower DNA 
methylation towards the promoter area (TSS200) and higher DNA methylation in the gene 
body relate to increased gene transcription. Here we add the observation that promoter 
DNA methylation tends to increase and gene body DNA methylation tends to decrease with 
age. From this finding, one might infer that a downregulation of gene expression takes place 
from birth to late adolescence. Enrichment analyses of published EWAS associations further 
showed that different traits and exposures exhibited distinct enrichment patterns among 
DNA methylation trajectories. For example, there were clear differences between smoking 
and BMI-related traits. Enrichment of sites with DNA methylation sex differences in EWASs 
on prenatal maternal smoking is consistent with studies finding that prenatal smoking affects 
traits such as birth weight66 , brain development67, 68, and attention69 differently in boys and 
girls. Clustering for prenatal maternal smoking EWASs also showed enrichment for CpGs 
with consistent change among individuals, not for CpGs with inter-individual variation in 
change. This may suggest a link with the well-known effects of prenatal smoking on childhood 




development since consistent DNA methylation change is more likely related to development 
or aging programming than inter-individual variation. This may explain why changes associated 
to prenatal smoking persist throughout life70. Notably, this pattern of change without inter-
individual variation is visible in cg05575921, the AHRR CpG site strongly and persistently 
associated with prenatal smoking71, 72 (Supplemental Figure 2; http://epidelta.mrcieu.ac.uk/).
‘Epigenetic age acceleration’ is a term coined to indicate the deviation of chronological 
age from age as estimated by an ‘epigenetic clock’ and is associated with disease risk and 
mortality73. Existing clocks are all linear models based on DNA methylation. Consequently, 
one might expect that all CpGs included in the clock model change linearly with age. 
Furthermore, to detect age acceleration, one would expect that these CpG sites would also 
vary between individuals. Surprisingly, many CpG sites included in the most popular clocks do 
not match these expectations74, 75 (Supplemental Tables 9, 10). For example, we observe that 
over one-quarter and nearly one-half of the CpG sites included in the Horvath and Hannum 
clocks, respectively, follow non-linear DNA methylation trajectories in childhood. Given the 
widespread use of clocks to investigate biological aging, further investigation is warranted to 
better understand how, and perhaps if, associations using these clocks should be interpreted 
in child DNA methylation profiles.
We note three main limitations of our findings. First, the use of different tissue types (cord 
blood and peripheral blood) could account for some of the differences between birth and 
later time points, e.g. sites that increased or decreased between birth and 6, but did not show 
change after that. Generation of DNA methylation profiles of a single tissue or cell type collected 
across childhood would be needed to disentangle this issue further. Unfortunately, such a 
dataset is not currently available as most cohorts have generated DNA methylation profiles 
from peripheral blood and cord blood63. Analysis of these complex tissues has nevertheless 
yielded many valuable insights. Second, since DNA methylation at 9 years was measured only 
in Generation R and at 17 years only in ALSPAC, DNA methylation differences from 9 to 17 
may be to some extent driven by batch effects or cohort differences. This may explain some 
of the inter-individual differences in slope changes at 9 towards 17 years. However, the high 
level of agreement in both stability and change among the corresponding time points of the 
two cohorts is reassuring. Moreover, it is not entirely surprising that inter-individual variation 
in directionality of change was higher for the largest age interval. This interval, furthermore, 
encompasses the period of adolescent development, a time in which many inter-individual 
phenotypic differences arise. Finally, it should be noted that the current study only included 
children of European ancestry. Considerable DNA methylation differences have been found 
between populations76-78, but research on age-associated DNA methylation differences is 
scarce. One study79 reported evidence for overlap in age-associated CpGs in two African 
populations with studies on European-ancestry populations, but more research is needed to 
map the generalizability of longitudinal DNA methylation changes among different populations.
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In conclusion, in the first comprehensive CpG-by-CpG characterization of DNA methylation from 
birth to late adolescence, we found that DNA methylation at more than half of the studied CpG 
sites changes consistently between individuals, and that considerable inter-individual variation 
in change exists. Further, characteristics such as child sex, CpG location, and environmental 
and disease traits have distinct associations with patterns of DNA methylation change. Further 
analysis of these patterns is made readily available at http://epidelta.mrcieu.ac.uk/, which 
we hope can be used in future studies to test developmental hypotheses that promote our 
understanding of the developmental nature of DNA methylation, its role in gene functioning, 
and the associated biological pathways leading to health and disease.
Methods
Setting
Data were obtained from two population-based prospective birth cohorts, the Dutch Generation 
R Study (Generation R) and the British Avon Longitudinal Study of Parents and Children (ALSPAC). 
Pregnant women residing in the study area of Rotterdam, the Netherlands, with an expected 
delivery date between April 2002 and January 2006 were invited to enroll in Generation R. A 
more extensive description of the study can be found elsewhere80. The Generation R Study is 
conducted in accordance with the World Medical Association Declaration of Helsinki and has 
been approved by the Medical Ethics Committee of the Erasmus Medical Center, Rotterdam. 
Informed consent was obtained for all participants.
Pregnant women residing in the study area of former county Avon, United Kingdom, with 
an expected delivery date between April 1991 and December 1992 were invited to enroll 
in the ALSPAC study. Detailed information on the study design can be found elsewhere3, 81. 
The ALSPAC website contains details of all available data through a fully searchable data 
dictionary and variable search tool (http://www.bristol.ac.uk/alspac/researchers/our-data/). 
Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee and 
the Local Research Ethics Committees. Consent for biological samples has been collected in 
accordance with the Human Tissue Act (2004). Informed consent for the use of data collected 
via questionnaires and clinics was obtained from participants following the recommendations 
of the ALSPAC Ethics and Law Committee at the time.
Study Population
In the Generation R Study, 9,778 pregnant mothers had 9,749 live-born children. For a 
subsample of 1,414 children DNA methylation data was collected at birth and/or 6 years 
and/or 10 years of age. This subsample consisted of participants with parents born in the 
Netherlands (European ancestry82 confirmed for all children with genetic data available 
(95.4%)). Fifteen sibling pairs were present in the dataset. From each pair one sibling with the 




lowest number of DNA methylation measurements, or otherwise randomly, was excluded, 
resulting in a sample with 1,399 children (with 2,333 DNA methylation samples; see below).
In the ALSPAC study, 15,247 pregnant mothers gave birth to 14,973 live-born children. DNA 
methylation at birth and/or 7 years and/or 17 years was available for a subsample of 1,003 
children as part of the Accessible Resource for Integrated Epigenomic Studies (ARIES) study83. 
From this sample, 48 children with non-European ancestry as based on genetic principle 
component analysis and 6 children with missing data on gestational age were excluded, 
resulting in a sample of 949 children with DNA methylation data (with 2,686 DNA methylation 
samples; see below).
DNA methylation
Cord blood was drawn after birth for both cohorts, and peripheral blood was drawn at a 
mean age of 6.0 (SD = 0.47) and 9.8 (SD = 0.3) years for Generation R, and 7.5 (SD = 0.2) 
and 17.1 (SD = 1.0) years for ALSPAC. Both cohorts made use of the EZ-96 DNA methylation 
kit (shallow) (Zymo Research Corporation, Irvine, USA) to perform bisulfite conversion on 
the extracted leukocytic DNA. Samples were further processed with the Illumina Infinium 
HumanMethylation450 BeadChip (Illumina Inc., San Diego, USA) to analyze DNA methylation.
In Generation R, quality control was performed on all 2,467 available DNA methylation samples 
with the CPACOR workflow84. Arrays with observed technical problems such as failed bisulfite 
conversion, hybridization or extension, as well as arrays with a mismatch between sex of the 
proband and sex determined by the chromosome X and Y probe intensities were removed 
from subsequent analyses. Additionally, only arrays with a call rate >95% per sample were 
processed further, resulting in 2,355 samples, 22 of which belonged to half of an excluded 
sibling pair, hence 2,333 samples were carried forward into normalization.
In ALSPAC, quality control was performed on 6,057 samples (3,286 belonging to children, 
2,771 to their mothers), using the meffil package85 in R version 3.4.386. After removing samples 
with mismatched genotypes, mismatched sex, incorrect relatedness, low concordance with 
samples collected at other time points, extreme dye bias, and poor probe detection, 5,337 
samples remained, 2,845 of which belonging to children, used in the current study.
To minimize cohort effects as much as possible, we normalized both cohorts together as a 
single dataset. Functional normalization (10 control probe principal components, slide included 
as a random effect) was performed with the meffil package in R85. Normalization took place 
on the combined Generation R and ALSPAC set comprising a total of 5,178 samples for a total 
of 485,512 CpGs. One-hundred and fifty-nine ALSPAC samples belonging to non-European 
children or children with missing data on gestational age were excluded, leading to a final 
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ALSPAC set of 2,686 samples (for 949 children). Together with 2,333 samples for Generation 
R (of 1,399 children) they formed a combined set of 5,019 samples (of 2,348 children.)
Analyses were restricted to 473,864 autosomal CpGs. DNA methylation levels were 
operationalized as beta values (β values), representing the ratio of methylated signal relative 
to the sum of methylated and unmethylated signal measured per CpG.
Covariates
Sample plate number (N = 29 in Generation R and N = 31 in ALSPAC), was used to correct for 
batch effects, which was added as a random variable in the model (see below). White blood 
cell (WBC) composition was estimated with the reference-based Bakulski method87 for cord 
blood and Houseman method88 for peripheral blood (Supplemental Table 11). Nucleated 
red blood cells were not further analyzed due to its specificity to cord blood, leaving CD4+ 
T-lymphocytes, CD8+ T-lymphocytes, natural killer cells, B-lymphocytes, monocytes, and 
granulocytes. Other covariates included gestational age in weeks, sex of the child, and cohort.
Statistical analyses
Step 1: Assessing cross-cohort comparability in DNA methylation stability
To ascertain comparability amongst the two cohorts we compared within-cohort DNA 
methylation stability between the time points that were present in both cohorts – i.e. birth 
and 6/7 years (Generation R/ALSPAC, respectively).
Longitudinal stability per CpG within each cohort was assessed by studying estimates of 
concordance and change. For concordance, DNA methylation data was first residualized 
within each cohort for all variables present in the longitudinal models except the ‘cohort’ 
variable, in order to remove between-cohort differences due to other covariates. Concordance 
was then measured both with Spearman correlation (data at most CpGs is not normally 
distributed) as a measure of relative concordance, and with intra-class correlations as a 
measure of absolute concordance (children with data for both time points: n Generation R = 
476, n ALSPAC = 826). Longitudinal change from birth to 6/7 years was assessed by studying 
the estimates of the change in DNA methylation per year by applying Model 1 (see below) 
within each cohort (children with data for at least one of the two time-points: n Generation 
R = 1,394, n ALSPAC = 944).
In a second step, cross-cohort comparability was assessed with Spearman (ρ) correlation of 
concordance estimates of the CpGs of each cohort (which were not normally distributed) and 
Pearson correlations (r) amongst the change estimates of the CpGs of each cohort (which 
were normally distributed).




Step 2: Longitudinal modelling of DNA methylation using combined Generation R and ALSPAC 
data
The combined Generation R and ALSPAC dataset had four time points of collection (birth, 
age 6/ 7 years, 10 years, and 17 years). We fit three linear mixed models to CpG site DNA 
methylation across the genome to identify (i) linear change over time (Model 1); (ii) nonlinear 
change over time (Model 2); and (iii) sex differences in change over time (Model 3). Both fixed 
and random effects were examined to allow for inter-individual variation in DNA methylation 
patterns over time. The models are described in detail below.
Model 1: Linear change. This model was applied to identify CpGs that show an overall change 
in DNA methylation from birth to 18 years (i.e. fixed age effect), as well as CpGs with inter-
individual differences in change during that time (i.e. random age effect). The Model 1 is 
defined as:









Here, participants are denoted by i, time points by j, and sample plates by k. M denotes DNA 
methylation level, β0 fixed intercept, u0i random intercept, β1 fixed age coefficient, u1i random 
age coefficient, u0k random intercept for sample plate. Hence, β1 represents the average 
change in DNA methylation per one year. Variability in this change amongst individuals was 
captured with u1i. To avoid problems with model identification, the random slope of age 
was uncorrelated to the random intercept (i.e. a diagonal random effects matrix was used).
Model 2: Nonlinear change. To identify nonlinear changes in DNA methylation, we extended 
Model 1 to allow slope changes at ages 6 and 930, 31:
M2:  Mijk = β0 + u0i + β1Ageij + β2(Ageij−6)
+ + β3(Ageij−9)
+ +u1i Ageij + u2i (Ageij−6)
+
 + u3i  
 (Ageij−9)















Where a+ = a if a>0 and 0 otherwise, so that β2 represents the average change in DNA methylation 
per year from 6 years of age onward, after accounting for the change per year from birth 
onward, as denoted by β1. Likewise, β3represents the average change in DNA methylation 
per year from 9 years of age onward, after accounting for the change per year from 6 years 
of age onward. Hence, with those variables we are able to detect slope changes at 6 and 9 
years old. These slope changes were used to identify different types of nonlinear patterns. 
With u2i and u3i the inter-individual variation in slope changes at 6 and 9 years were captured, 
respectively. General linear hypothesis testing89 was applied to our fitted models to determine 
if there were changes in DNA methylation per year from 6-9 years and from 9-18 years.
Model 3: Sex differences in change: To identify CpGs for which DNA methylation changes 
differently over time for boys and girls, we applied the following model:









Here, Sexi denotes the sex of child i. Both main and interaction effects for sex were studied.
The three mixed models were fitted using maximum likelihood estimation in R with the lme4 
package90. Continuous covariates (WBCs, gestational age) were z-score standardized. Random 
slopes were kept uncorrelated with random intercepts and the NLopt optimizer was used, 
enabling us to improve computational speed compared to the default settings. P-values for the 
fixed effects were computed with a z-test. P -values for random slopes of the Age effects were 
obtained by refitting the model without the random slope and comparing the fit estimates 
of the two models with a likelihood ratio test. Within each model, P-value thresholds were 
Bonferroni-corrected for the number of tested CpGs (i.e. to p < 1x10-07).
Step 3: Functional characterization of probes with comparable patterns of change
To interpret the functionality of the age-related DNA methylation patterns from the three 
models, CpG sites adhering to 8 different age-related patterns (M1 linear change and inter-
individual variation in linear change, M2 nonlinear trajectories, and inter-individual variation 
in change from birth, in slope change at 6 years, and in slope change at 9 years, and M3 stable 
sex differences and sex differences in DNA methylation change) were tested for enrichment in:
(i)  gene-relative genomic regions (TSS1500, TSS200, 5’UTR, 1st exon, gene body, 3’UTR, 
and intergenic regions64),




(ii)  CpG island-relative genomic regions (N shelf, N shore, CpG island, S shore, S shelf, and 
open sea regions64) as indicated by the Illumina HumanMethylation450 v1.2 Manifest 
(Illumina Inc., San Diego, USA), and
(iii)  enhancer elements as those expressed in whole blood, peripheral blood mononuclear 
cells, natural killer cells, CD4+ T cells, CD8+ T cells, monocytes, neutrophils, eosinophils 
or B cells91,
Altogether, these encompassed 14 enrichment analyses for 8 variables. Enrichment was tested 
using χ2-tests of unequal proportions. The enrichment P-value threshold was Bonferroni-
corrected for multiple tests (i.e. p < 4.46x10-04 for 8x14 = 122 tests). Second, we tested 
enrichment of Gene Ontology (GO) categories for genes linked to CpG sites surviving 
adjustment for multiple tests (p < 1x10-07) for each of the main variables of interest. This 
analysis was adjusted for gene size and pruned for near-identical terms (see elsewhere for 
a full description92). For completeness, terms with nominal p < 0.05 were reported. Last, 
we tested enrichment of age-related DNA methylation trajectories (11 different age-related 
patterns: M1 decreasing, increasing, and inter-individual variation in linear change, M2 Positive-
Neutral, Negative-Neutral, other nonlinear, inter-individual variation in change from birth, in 
slope change at 6 years, and in slope change at 9 years, and M3 stable sex differences and 
sex differences in DNA methylation change) in EWASs on age, prenatal smoking, smoking, 
cardiovascular-associated traits, C-reactive protein, allergies, educational attainment, and 
cellular heterogeneity. EWAS summary statistics were retrieved from the EWAS Catalog (http://
www.ewascatalog.org/) and studies were included when performed with the 450K array in 
peripheral or cord blood, resulting in 33 EWASs. Enrichment was tested with Fisher’s exact 
tests, the enrichment P-value threshold was Bonferroni-corrected for multiple tests (i.e. p < 
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Supplemental Figure 1. Distribution of CpG mean methylation levels in (a) Generation R at birth; (b) ALSPAC at 
birth; (c) Generation R 6 years; (d) ALSPAC at 7 years
Supplemental Figure 2. Longitudinal DNA methylation of AHRR cg05575921 as predicted by Model 2











Sex (% boys) 50.8 48.7
Gestational age (weeks) 40.1 (1.5) 39.6 (1.5)
Age (years)
 @6 or 7 years, n = 488 / 970 6.0 (0.4) 7.5 (0.1)
 @10 years, n = 463 9.8 (0.3)
 @17 years, n = 70 17.1 (1.0)
Birth weight (grams) 3546 (510) 3489 (490)
BMI 
 @6 or 7 years, n = 488 / 970 15.9 (1.3) 16.2 (2.0)
 @10 years, n = 463 17.1 (2.0)
 @17 years, n = 970 22.5 (3.8)
Mother characteristics
Maternal age at birth (years) 32.2 (4.2) 30.0 (4.4)
BMI early pregnancy 24.2 (4.0) 22.8 (3.7)
Education level (%)
 low 11.2 8.6
 medium 23.5 41.1
 high 65.3 50.3
Prenatal smoking (% sustained) 13.3 10.2
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Supplemental Tables 3A-H. CpG characteristics per gene region compared to CpGs at all other regions
Supplemental Table 3A. M1 linear DNA methylation change






TSS1500 48.63/31.78/19.59 48.41/36.30/15.29 1164.52 2 1.34x10-253
TSS200 52.79/28.19/19.02 47.82/36.59/15.60 1694.99 2  <9.88x10-324
5’UTR 50.50/30.06/19.44 48.13/36.36/15.51 1200.84 2 1.7 x10-261
1st exon 51.63/25.35/23.02 48.17/36.4/15.43 2527.50 2  <9.88x10-324
Gene body 48.31/38.75/12.94 48.53/33.67/17.80 2420.25 2 <9.88x10-324
3’UTR 48.03/42.77/9.20 48.47/35.21/16.32 880.58 2 6.08x10-192
Intergenic 45.71/38.73/15.56 49.35/34.46/16.19 718.15 2 1.14x10-156
Supplemental Table 3B. M1 inter-individual variation in DNA methylation change
CpGs in area other CpGs
% no/yes % no/yes χ2 df p-value
TSS1500 77.10/22.90 71.71/28.29 984.90 1 3.43x10-216
TSS200 77.76/22.24 71.89/28.11 908.37 1 1.49x10-119
5’UTR 76.11/23.89 72.10/27.9 442.63 1 2.90x10-98
1st exon 76.33/23.67 72.31/27.69 281.83 1 3.00x10-63
Gene body 71.14/28.86 73.49/26.51 305.25 1 2.36x10-68
3’UTR 72.79/27.21 72.63/27.37 0.24 1 6.24x10-01
Intergenic 69.42/30.58 73.70/26.3 814.75 1 3.35x10-179 
Supplemental Table 3C. M2 nonlinear DNA methylation change
CpGs in area other CpGs









TSS1500 88.55/4.70/3.77/2.98 89.11/4.84/3.00/3.05 132.58 3 1.50x10-28
TSS200 92.85/3.14/1.38/2.63 88.46/5.06/3.39/3.09 1227.78 3 6.90x10-266
5’UTR 89.73/4.13/3.06/3.08 88.91/4.92/3.15/3.03 75.95 3 2.27x10-16
1st exon 92.11/3.21/1.56/3.12 88.75/4.95/3.27/3.03 589.94 3 1.53x10-127
Gene body 88.40/4.84/3.66/3.10 89.37/4.80/2.84/2.99 252.42 3 1.96x10-54
3’UTR 88.91/4.64/3.40/3.05 89.02/4.82/3.12/3.03 5.89 3 1.17x10-01
Intergenic 88.12/5.82/2.92/3.14 89.31/4.48/3.21/3.00 371.72 3 2.96x10-80




Supplemental Table 3D. M2 inter-individual variation in DNA methylation change from birth
CpGs in area other CpGs
% no/yes % no/yes χ2 df p-value
TSS1500 96.99/3.01 96.58/3.42 35.70 3 2.30x10-09
TSS200 95.98/4.02 96.75/3.25 95.82 3 1.26x10-22
5’UTR 96.20/3.80 96.72/3.28 45.97 3 1.20x10-11
1st exon 95.09/4.91 96.79/3.21 308.77 3 4.05x10-69
Gene body 97.04/2.96 96.43/3.57 128.26 3 9.82x10-30
3’UTR 97.89/2.11 96.60/3.40 94.92 3 1.98x10-22
Intergenic 96.54/3.46 96.69/3.31 6.45 3 1.11x10-02
Supplemental Table 3E. M2 inter-individual variation in DNA methylation change from 6 years
CpGs in area other CpGs
% no/yes % no/yes χ2 df p-value
TSS1500 99.83/0.17 99.83/0.17 0.21 2 6.49x10-01
TSS200 99.64/0.36 99.86/0.14 149.48 2 2.25x10-34
5’UTR 99.72/0.28 99.85/0.15 56.08 2 6.96x10-14
1st exon 99.47/0.53 99.86/0.14 310.00 2 2.18x10-69
Gene body 99.90/0.10 99.80/0.20 63.49 2 1.61x10-15
3’UTR 99.94/0.06 99.83/0.17 13.93 2 1.90x10-04
Intergenic 99.9/0.10 99.81/0.19 43.23 2 4.88x10-11
Supplemental Table 3F. M2 inter-individual variation in DNA methylation change from 9 years
CpGs in area other CpGs
% no/yes % no/yes χ2 df p-value
TSS1500 93.34/6.66 91.52/8.48 296.39 2 2.01x10-66
TSS200 91.47/8.53 91.89/8.11 12.44 2 4.21x10-04
5’UTR 92.08/7.92 91.80/8.20 5.76 2 1.64x10-02
1st exon 90.79/9.21 91.92/8.08 59.47 2 1.24x10-14
Gene body 91.18/8.82 92.21/7.79 156.20 2 7.64x10-36
3’UTR 92.86/7.14 91.79/8.21 28.01 2 1.20x10-07
Intergenic 92.33/7.67 91.67/8.33 51.46 2 7.30x10-13
Supplemental Table 3G. M3 stable sex differences in DNA methylation
CpGs in area other CpGs
% no/yes % no/yes χ2 df p-value
TSS1500 94.49/5.51 95.33/4.67 544.43 2 5.99x10-119
TSS200 96.66/3.34 94.97/5.03 400.83 2 9.14x10-88
5’UTR 96.41/3.59 95.00/5.00 237.15 2 3.19x10-52
1st exon 96.23/3.77 95.09/4.91 100.04 2 1.89x10-22
Gene body 96.12/3.88 94.65/5.35 755.26 2 9.93x10-165
3’UTR 96.45/3.55 95.13/4.87 103.99 2 2.63x10-23
Intergenic 93.18/6.82 95.85/4.15 1377.23 2 8.68x10-300
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Supplemental Table 3H. M3 sex differences in DNA methylation change
CpGs in area other CpGs
% no/yes % no/yes χ2 df p-value
TSS1500 99.64/0.36 99.62/0.38 7.67 2 2.16x10-02
TSS200 99.73/0.27 99.61/0.39 25.52 2 2.88x10-06
5’UTR 99.68/0.32 99.62/0.38 6.16 2 4.60x10-02
1st exon 99.76/0.24 99.62/0.38 28.74 2 5.74x10-07
Gene body 99.65/0.35 99.62/0.38 7.59 2 2.25x10-02
3’UTR 99.70/0.30 99.62/0.38 2.96 2 2.28x10-01
Intergenic 99.51/0.49 99.66/0.34 54.36 2 1.57x10-12




Supplemental Tables 4A-H. Chi-square of CpG characteristics for each CpG island region compared to CpG characteristics 
in all other regions
Supplemental Table 4A. M1 linear DNA methylation change






N shelf 50.09/42.08/7.83 48.41/36.3/15.29 1395.43 2 9.68x10-304
N shore 49.11/31.25/19.64 47.82/36.59/15.60 940.13 2 7.13x10-205
Island 51.82/23.00/25.18 48.13/36.36/15.51 20798.58 2 <9.88x10-324
S shore 49.26/31.66/19.08 48.17/36.40/15.43 540.32 2 4.68x10-118
S shelf 50.09/42.08/7.83 48.53/33.67/17.80 1344.60 2 1.05x10-292
Open sea 44.67/46.91/8.42 48.47/35.21/16.32 20603.72 2 <9.88x10-324
Supplemental Table 4B. M1 inter-individual variation in DNA methylation change
CpGs in area other CpGs
% no/yes % no/yes χ2 df p-value
N shelf 75.05/24.95 71.71/28.29 74.74 1 5.38x10-18
N shore 73.98/26.02 71.89/28.11 63.72 1 1.44x10-15
Island 71.40/28.60 72.10/27.90 160.31 1 9.69x10-37
S shore 74.26/25.74 72.31/27.69 70.67 1 4.23x10-17
S shelf 75.05/24.95 73.49/26.51 87.17 1 9.97x10-21
Open sea 72.06/27.94 72.63/27.37 44.92 1 2.05x10-11
Supplemental Table 4C. M2 nonlinear DNA methylation change
CpGs in area other CpGs









N shelf 88.51/5.04/3.89/2.56 89.04/4.80/3.10/3.06 68.65 3 8.31x10-15
N shore 86.10/6.79/4.50/2.62 89.45/4.52/2.93/3.10 1090.63 3 3.94x10-236
Island 93.10/3.25/0.79/2.87 87.20/5.51/4.18/3.11 5182.32 3 <9.88x10-324
S shore 85.75/6.86/4.73/2.66 89.38/4.58/2.96/3.08 984.09 3 5.08x10-213
S shelf 88.51/5.04/3.89/2.56 89.04/4.80/3.10/3.06 49.85 3 8.58x10-11
Open sea 87.56/4.85/4.02/3.57 89.85/4.79/2.63/2.73 992.66 3 7.03x10-215
Supplemental Table 4D. M2 inter-individual variation in DNA methylation change from birth
CpGs in area other CpGs
% no/yes % no/yes χ2 df p-value
N shelf 98.09/1.91 96.58/3.42 163.36 3 2.09x10-37
N shore 96.90/3.10 96.75/3.25 13.13 3 2.91x10-04
Island 94.67/5.33 96.72/3.28 2544.09 3 <9.88x10-324
S shore 96.79/3.21 96.79/3.21 3.25 3 7.15x10-02
S shelf 98.09/1.91 96.43/3.57 197.61 3 6.94x10-45
Open sea 97.78/2.22 96.60/3.40 1070.38 3 9.06x10-235
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Supplemental Table 4E. M2 inter-individual variation in DNA methylation change from 6 years
CpGs in area other CpGs
% no/yes % no/yes χ2 df p-value
N shelf 99.97/0.03 99.83/0.17 26.83 2 2.22x10-07
N shore 99.94/0.06 99.86/0.14 44.75 2 2.24x10-11
Island 99.55/0.45 99.85/0.15 1027.50 2 1.89x10-225
S shore 99.93/0.07 99.86/0.14 27.85 2 1.31x10-07
S shelf 99.97/0.03 99.80/0.20 24.15 2 8.93x10-07
Open sea 99.97/0.03 99.83/0.17 328.18 2 2.40x10-73
Supplemental Table 4F. M2 inter-individual variation in DNA methylation change from 9 years
CpGs in area other CpGs
% no/yes % no/yes χ2 df p-value
N shelf 94.58/5.42 91.52/8.48 255.42 2 1.71x10-57
N shore 92.96/7.04 91.89/8.11 118.35 2 1.45x10-27
Island 88.40/11.60 91.80/8.20 3305.19 2 <9.88x10-324
S shore 92.97/7.03 91.92/8.08 91.09 2 1.37x10-21
S shelf 94.58/5.42 92.21/7.79 244.06 2 5.13x10-55
Open sea 93.27/6.73 91.79/8.21 753.18 2 8.18x10-166
Supplemental Table 4G. M3 stable sex differences in DNA methylation
CpGs in area other CpGs
% no/yes % no/yes χ2 df p-value
N shelf 96.54/3.46 95.33/4.67 104.49 2 2.04x10-23
N shore 92.65/7.35 94.97/5.03 1214.08 2 2.32x10-264
Island 95.46/4.54 95.00/5.00 99.69 2 2.25x10-22
S shore 92.24/7.76 95.09/4.91 1379.57 2 2.69x10-300
S shelf 96.54/3.46 94.65/5.35 94.48 2 3.05x10-21
Open sea 96.31/3.69 95.13/4.87 1553.00 2 <9.88x10-324
Supplemental Table 4H. M3 sex differences in DNA methylation change
CpGs in area other CpGs
% no/yes % no/yes χ2 df p-value
N shelf 99.62/0.38 99.62/0.38 0.37 2 8.29x10-01
N shore 99.45/0.55 99.61/0.39 66.45 2 3.72x10-15
Island 99.74/0.26 99.62/0.38 89.21 2 4.26x10-20
S shore 99.36/0.64 99.62/0.38 115.80 2 7.17x10-26
S shelf 99.62/0.38 99.62/0.38 4.16 2 1.25x10-01
Open sea 99.68/0.32 99.62/0.38 21.98 2 1.68x10-05




Supplemental Tables 5. CpGs inside and outside enhancer regions
% enhancer CpGs % other CpGs χ2 df p-value
M1 linear DNAm change
null/negative/positive
47.54/28.58/23.88 48.47/35.66/15.87 508.87 2 3.16x10-111
M1 inter-individual variation in 
DNAm change
no/yes 
72.55/27.45 72.64/27.36 0.03 1 8.70x10-01




78.65/9.85/8.21/3.29 89.23/4.71/3.03/3.03 1434.20 3 1.11x10-310
M2 inter-individual variation in 
DNAm change from birth
no/yes
94.41/5.59 96.7/3.30 150.83 1 1.13x10-34
M2 inter-individual variation in 
DNAm change from 6 years
no/yes
99.83/0.17 99.83/0.17 0.00 1 1.00
M2 inter-individual variation in 
DNAm change from 9 years
no/yes 
92.28/7.72 91.82/8.18 2.55 1 1.10x10-01
M3 stable DNAm sex diffe-
rences
no/yes
94.93/5.07 95.19/4.81 1.30 1 2.55x10-01
M3 sex differences in DNAm 
change
no/yes




Supplemental Table 9. CpGs part of Horvath age estimator
% Horvath CpGs % other CpGs χ2 df p-value
M1 linear DNAm change
null/negative/positive
37.11/29.75/33.14 48.46/35.52/16.02 77.22 2 1.71x10-17
M1 inter-individual variation in 
DNAm change
no/yes 
74.22/25.78 72.63/27.37 0.37 1 5.42x10-01




73.65/5.38/8.22/12.75 89.03/4.81/3.13/3.03 148.54 3 5.43x10-32
M2 inter-individual variation in 
DNAm change from birth
no/yes
95.75/4.25 96.65/3.35 0.63 1 4.28x10-01
M2 inter-individual variation in 
DNAm change from 6 years
no/yes
100/0 99.83/0.17 0.01 1 9.04x10-01
M2 inter-individual variation in 
DNAm change from 9 years
no/yes 
93.2/6.8 91.83/8.17 0.71 1 4.00x10-01
M3 stable DNAm sex differences
no/yes
86.97/13.03 95.19/4.81 50.23 1 1.37x10-12
M3 sex differences in DNAm 
change
no/yes
98.58/1.42 99.63/0.37 7.73 1 5.44x10-03
DNAm: DNA methylation




Supplemental Table 10. CpGs part of Hannum age estimator
% Hannum CpGs % other CpGs χ2 df p-value
M1 linear DNAm change
null/negative/positive
8.45/46.48/45.07 48.45/35.52/16.03 63.2 2 1.89x10-14
M1 inter-individual variation in 
DNAm change
no/yes 
46.48/53.52 72.64/27.36 23.14 1 1.51x10-06




54.93/7.04/7.04/30.99 89.02/4.81/3.14/3.03 196.34 3 2.61x10-42
M2 inter-individual variation in 
DNAm change from birth
no/yes
83.10/16.90 96.65/3.35 36.22 1 1.76x10-09
M2 inter-individual variation in 
DNAm change from 6 years
no/yes
100/0 99.83/0.17 0 1 1.00
M2 inter-individual variation in 
DNAm change from 9 years
no/yes 
71.83/28.17 91.84/8.16 35.27 1 2.87x10-09
M3 stable DNAm sex differences
no/yes
90.14/9.86 95.18/4.82 2.92 1 8.76x10-01
M3 sex differences in DNAm 
change
no/yes




Supplemental Table 11. Estimated white blood cell proportions
Generation R ALSPAC
mean (SD) mean (SD)
0 years – Bakulski method
 CD8T 0.13 (0.05) 0.09 (0.05)
 CD4T 0.16 (0.05) 0.18 (0.06)
 NK 0.03 (0.03) 0.01 (0.02)
 Bcell 0.10 (0.03) 0.17 (0.04)
 Mono 0.09 (0.02) 0.01 (0.02)
 Gran 0.41 (0.11) 0.35 (0.10)
 nRBC 0.12 (0.07) 0.20 (0.09)
6 / 7 years – Houseman method
 CD8T 0.12 (0.04) 0.04 (0.03)
 CD4T 0.17 (0.05) 0.21 (0.05)
 NK 0.02 (0.02) 0.19 (0.04)
 Bcell 0.13 (0.03) 0.14 (0.03)
 Mono 0.06 (0.02) 0.06 (0.03)
 Gran 0.53 (0.08) 0.44 (0.08)
10 years – Houseman method
 CD8T 0.12 (0.04)
 CD4T 0.18 (0.05)
 NK 0.03 (0.03)
 Bcell 0.11 (0.03)
 Mono 0.06 (0.02)
 Gran 0.52 (0.08)
17 years – Houseman method
 CD8T 0.03 (0.03)
 CD4T 0.18 (0.05)
 NK 0.20 (0.05)
 Bcell 0.11 (0.03)
 Mono 0.07 (0.03)
 Gran 0.48 (0.09)
DNAm: DNA methylation















The putative role of DNA methylation in the effects of stress on the developing child are much 
alluded to in the literature on genetic and environment risk factors, and psychological outcomes. 
In the current thesis, we set out to study associations between stress and DNA methylation 
in child development to explain how stress can get ‘under the skin’. We reviewed existing 
literature on DNA methylation and parenting stress and examined associations between DNA 
methylation and family stress as well as interpersonal stress in social situations with peers 
throughout childhood in population-based samples in the Netherlands (Generation R and 
the United Kingdom (ALSPAC. Furthermore, we used these datasets to create an epigenome-
wide characterization of change in DNA methylation from birth to late adolescence.
Stress and DNA methylation
Throughout this thesis, we tried to link DNA methylation levels to the occurrence of stress. In 
our review of the literature on DNA methylation and stress resulting from parenting behavior 
in Chapter II, we saw that there are many studies associated DNA methylation with both 
parenting stress and child psychological outcomes, but also noted important methodological 
drawbacks in the set-up of these studies. Mainly, issues included those of (i reliability and 
validity of the DNA methylation measurement, (ii reproducibility of findings, and (iii causality. 
We will discuss how we addressed each of these methodological issues in our own studies 
in the following paragraphs.
In our own studies on DNA methylation on stress, using a population-based approach, we 
identified several small associations between stress and DNA methylation. In Chapter III, we 
found that methylation of FKBP5, a gene involved in the binding of cortisol to glucocorticoid 
receptors1, together with FKBP5 genotype and resistant attachment of the child to the mother, 
was associated with cortisol reactivity. Since the attachment behavior in the child is seen as 
response to the parenting behavior of the attachment figure, we conclude that for FKBP5, 
genotype, DNA methylation, and environment together are associated with stress regulation. 
In Chapter IV, we found that maternal sensitivity at 3 and 4 years was associated with DNA 
methylation in the child at 6 years at several genomic regions. The top region included 
DOCK4, a a gene involved in neuronal growth and migration and previously linked to the 
stress response in mice. Hence, in this study, we were able to relate an index of early 
maternal caretaking to child DNA methylation. In Chapter V, we studied sleep in 
association with genome-wide DNA methylation and found associations at chromosome 
17, spanning MAPT, a gene for Tau protein and linked to Alzheimer’s disease, as well as 
CRHR1, a gene coding for corticotropin-releasing hormone receptor 1 and pivotal for HPA-
axis functioning. Thus, sleep was associated with methylation of, again, genes involved in 
memory and stress. Last, in Chapter VII, we studied the association of exposure to bullying 
victimization in children of Generation R and ALSPAC and change in DNA methylation in a 
longitudinal epigenome-wide  association study.  We found that  DNA methylation at a site  
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on RAB14 changed differently for children who had been bullied than for those who had 
not been bullied. This gene is important in Golgi apparatus functioning and has previously 
been associated with stress exposure in rats. The effect was small but consistent between 
cohorts and indicates that there might be an association between social stress exposure 
and change in DNA methylation. Together, we conclude that there are indeed associations 
between stress and DNA methylation that were small but measurable in the children from 
these population-based samples. Methodological considerations will be discussed.
Candidate-gene methylation versus epigenome-wide studies–and the 
issue of small effect sizes
Since the study of DNA methylation in humans is relatively new, methodological considerations 
remain a topic of ongoing debate. First of all, when studying DNA methylation one can use 
a candidate-gene or epigenome-wide approach. A candidate-gene methylation study can 
be a great place to start; generally there is already an understanding of the gene’s variants 
in relation to its functioning and a study into DNA methylation can add to the prediction of 
variation in gene function or related outcomes. FKBP5 is an example of such a gene; its key 
role in HPA functioning is well-known1. The study presented in in Chapter III thereby worked 
as a proof-of-principle, showing how gene, environment, and DNA methylation might interact 
to affect HPA functioning. On the other hand, adopting an hypothesis free epigenome-wide 
opens up the possibility of finding new correlates and processes. This is the approach taken 
in Chapter IV, V, VII, and VIII and as a result, we see that the hits that come up are not the 
ones that would be selected for a candidate gene study. Moreover, in candidate-gene look-
ups within an epigenome-wide approach in Chapter IV and VII, we noted that p-values for 
the sites on these genes do not reach gene-wide significance (as opposed to genome-wide 
significance. Similarly, other studies on childhood stress do not report hits associated with 
popular candidate-genes2-11 and neither did one such study that also did a specific candidate-
genes look-up 12.
A reason for this contrast might be that effect sizes in this field of research are generally small. 
In Chapter VIII we saw that changes in DNA methylation were often as small as a cumulative 
change of less than 2% from birth to late adolescence; similarly, in Chapters III, IV, V, and 
VII we saw that associations between DNA methylation and stress were small. This is in line 
with results from other population-based studies on DNA methylation and stress2, 12 as well 
as with results from population-based studies on DNA methylation and exposure to, e.g., 
air pollution13 or prenatal exposure to alcohol14, or arsenic15. When having to control for a 
false positive rate otherwise inflated by half a million tests, the adjusted significance level is 
greatly reduced and true, small, associations may fly under the radar. One way of increasing 
the power to detect an association is through the study of large samples. Generation R has 
one of the largest datasets of childhood DNA methylation in the world, yet larger is always 




Generation R, as well as ALSPAC in a combined dataset. In Chapter VII however, we only found 
one association between DNA methylation and bullying victimization. This indicates that even 
larger sample sizes might be necessary to study such associations, something that could be 
achieved in consortia16. In the epigenome-wide studies performed in Chapter VII and VIII, 
we used a Bonferroni-correction to adjust for multiple testing, thereby treating each test as 
an independent added risk of obtaining a false positive. DNA methylation at different sites is 
however correlated. Research techniques that take into account this correlational structure 
of the data and reduce the multidimensionality based on that structure may therefore be 
worthwhile from a methodological perspective, but also from a theoretical, systems biology 
perspective, and perhaps converging with the idea of epistasis, that a phenotype is build up 
from the interaction of multiple genes17. We indeed applied such reductionist methods in 
Chapter IV where correlated sites were clustered at the regional level, and in Chapter V where 
a network approach was applied to form different modules of sites. In Chapter III, moreover, 
we used a factor analysis to reduce the burden of multiple testing at the gene-level of FKBP5. 
These approaches were successful in that we showed significant associations between DNA 
methylation and maternal sensitivity, sleep, and cortisol reactivity, respectively. The 
power in these studies increased via the reduced number of tests performed and in Chapter 
IV, we additionally saw that effect sizes increased by examining related methylation sites in 
concert as opposed to individually. This favors the interpretation that single sites are unlikely 
to act alone and is in agreement with the systems biology perspective.
Multiple testing could also be reduced by simply not testing all measured methylation 
sites. Results from our study into DNA methylation in development in Chapter VIII 
indicated that there are many sites that do not change and do not show inter-individual 
variation in change. Such sites are unlikely to be affected by environmental stressors in 
childhood and excluding such sites pre-emptively from an epigenome-wide association study 
can reduce the burden of multiple testing, which can easily be done using the website we 
developed (http://epidelta. mrcieu.ac.uk/).
Another way to examine the candidate gene methylation versus the epigenome-wide 
dilemma is through the lens of the developments in the field of Genetics and Psychiatry. The 
field started with candidate studies and evolved towards larger and larger genome-wide 
associations studies (GWASs), and retrospectively one can see that the earlier candidate 
genes do not come up as ‘frontrunners’ in GWAS studies on psychiatric diseases18, 19. It is 
now thought that many such candidate studies were underpowered and showed false 
positive results20. However, a recent epigenome-wide association study of physical 
aggression   did    observe  a   genome-wide   corrected  association  within   a   gene   often 
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used in candidate-gene studies; in dopamine-receptor coding gene DRD421. This offers 
hope that ultimately, the gene-candidate and epigenome-wide approach might produce 
converging or complementary results. To this end, it is important keep power enhancing 
methods in mind, not by increasing sample size and reducing the number of tests, but also 
by improving the quality of the measurements and thus reducing measurement error. Such 
approaches are discussed in the paragraphs below.
Temporal change, reliability, and validity of DNA methylation 
measurement
The first methodological issue noted in our literature review in Chapter II was that essential 
characteristics of the DNA methylation measurement were unknown, the most important 
ones being lack of clarity to which extent DNA methylation changes over time, or to which 
extent intra-individual DNA methylation patterns between different tissues are the same.
It is important to understand whether DNA methylation changes, and furthermore, to what 
extent the rate of DNA methylation change differs between people, in order to identify sites 
that might be susceptible to environmental influences, or might be responsible for a changing 
phenotype. In Chapter VIII, we were able to track almost half a million genomic sites and 
characterize their DNA methylation levels from birth to late adolescence. Here we saw a large 
proportion of sites that changed, and a considerable proportion of sites with a different rate 
of DNA methylation change for different individuals, or for the two sexes. These findings 
could aid in narrowing down the search for sites that are affected by stressful environments 
and in interpreting findings from such studies by placing them in a developmental context. 
For example, inter-individual variation in change was more often measured between 9 and 
18 years of age than between birth and 9 years, indicating that the former period may be 
of more interest for researchers interested in developmentally formative periods for DNA 
methylation. With our freely accessible website that visualizes the trajectory of change and 
contains downloadable results at the level of the individual site, we provide a valuable tool 
for the research community. Last, it was encouraging for other studies using similar array-
type DNA methylation data that the epigenome-wide estimates of DNA methylation stability 
and change between Generation R and ALSPAC in the study of Chapter VIII were remarkably 
similar. This adds to the reliability of these data in our and other cohorts and supports the 
practice of pooling effect estimates from different epidemiological cohorts in epigenome-
wide meta-analyses in consortia. 
Another challenge to the validity of the DNA methylation measurement is the extent to 
which DNA methylation levels in one tissue are informative of those in another tissue. In 
our sample, as is not uncommon for population-based samples, we had access to cord blood 
and peripheral blood. Not much research existed however on the extent to which cord blood 




cross-sectionally. In Chapter VIII we found many sites at which DNA methylation changed 
consistently across individuals from birth (cord blood to late adolescence (peripheral blood, 
indicating that relative levels of DNA methylation in one tissue were indicative of relative 
levels in another. This is encouraging for developmental population-based epigenomic studies 
interested in longitudinal study designs.
On a related note, in the study of DNA methylation in stress and psychosocial functioning, brain 
tissue would be a tissue of high interest. In humans, DNA methylation studies in stress have 
been performed in post-mortem brain tissues22, but such studies do not have the advantages 
of a prospective research design; information on psychopathology is generally obtained 
retrospectively, often via family members. Further, the post-mortem state of the brain itself 
may affect the epigenetic configuration of the DNA23. A study of epigenome-wide concordance 
of DNA methylation in peripheral blood and brain tissue showed that only around 6% of DNA 
methylation in blood at least moderately predicts DNA methylation in the brain, with the 
exact percentages depending on the location in the brain24. In addition, DNA methylation 
levels at sites with such cross-tissue covariance were more determined by genetic variation, 
indicating that sites with high brain-blood concordance may be influenced relatively less by 
the environment. Online tools (http://epigenetics.essex.ac.uk/bloodbrain/; https://redgar598. 
shinyapps.io/BECon/ stemming from such studies24, 25 are useful in determining the extent 
to which DNA methylation for sites of interest in blood mirrors that in the brain. In Chapter 
IV and V we performed such a look-up of hits of regions associated with maternal 
sensitivity and sleep, respectively, and in both cases meaningful blood-brain associations  
were found for top regions, indicating that in these cases, blood proved an informative tissue 
on DNA methylation in the brain. Genetic associations with DNA methylation were apparent 
for the region associated with sleep in Chapter V, but not for the top region associated 
with maternal sensitivity in Chapter IV. It should be noted, however, that even when DNA 
methylation in peripheral or cord blood is not associated with DNA methylation in the brain, 
blood DNA methylation in patterns can still be informative for research on psychosocial 
functioning, since there are many peripheral bodily functions associated with the functions 
of the mind. For example, when cortisol is produced by the adrenal cortices, the hormone 
travels through the blood and leukocytes themselves express glucocorticoid receptors, which 
have been associated with stress-induced inflammatory reactions26, 27. Relatedly, glucocorticoid 
sensitivity in leukocytes has been associated with FKBP5 expression28, indicating that blood 
can be a tissue of interest in the study of DNA methylation and stress.
Reproducibility
A second issue we discussed in Chapter II, is that previous research on DNA methylation 
and parenting stress was often based on small samples, thereby increasing the chances of 
reporting falsely positive results. We noted a need for large samples and built-in replication 
or meta-analytic effort. Results from meta-analyses, further, are more generalizable since 
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they are produced by converging results from different populations, with variables measured 
at different time-points and often with different methods. Indeed, we made use of the large 
datasets of Generation R in all our studies and combined our data with those of the ALSPAC 
cohort in Chapter VII on bullying and VIII on change in DNA methylation. Despite our best 
efforts to maximize sample sizes, as mentioned, effect sizes were small and confirmation of 
findings by replication would be optimal. Consortia of cohorts with DNA methylation data 
offer great opportunities for replication or meta-analysis, however the number of cohorts 
that have longitudinal DNA methylation is currently small, as are the number of cohorts that 
have used observational measures such as those on attachment (Chapter III) or maternal 
sensitivity (Chapter III, IV). Observational measures are costly but valuable, for example when 
children are too young to report how they feel, and, as discussed in Chapter VI with regard 
to facial expressions, may not be influenced by reporter biases that affect questionnaire 
data. In the current thesis therefore, we took a meta-analytic and longitudinal approach 
where possible, while also aiming to maintain a high quality of data by using observational 
measures where possible.
Causality
The last issue raised in our literature review in Chapter II concerned directionality of causality, 
an matter not limited to DNA methylation research, but relevant to research in general, 
especially epidemiological research. Within epidemiology, longitudinal modelling is a method 
to study temporality and approach causality. In Chapter VII, we studied if being bullied was 
associated with change in DNA methylation from pre- to post bullying. This does not preclude 
the possibility that some children were already bullied before the first measurement of DNA 
methylation, or that children who are at risk of being bullied also, for a reason unrelated to 
the bullying itself, show certain changes in DNA methylation. Yet, longitudinal modelling within 
epidemiological DNA methylation research is a large step forward from the commonly used 
cross-sectional research designs. Another methodological tool is mediation analysis, which 
can help understand if one variable affects another variable via a third variable. Mediation 
analysis requires the putative predictor, mediator, and outcome to be measured in chronological 
order, which unfortunately made it impossible for us to perform a mediational analysis. In 
future research, such an analysis could be applied to study if stress affects DNA methylation, 
which in turn affects mental health. Another issue of causality, for example discussed in 
Chapters IV and V, is that associations between DNA methylation and a phenotype, may be 
caused by genetic variants associated with DNA methylation, and that phenotype. Online 
tools29-31 are helpful in finding such associations between DNA methylation and genetics, 
but direct measurement of both genetic and epigenetic influences within the same dataset 
are necessary to disentangle the in(ter)dependence of effects. We took this approach in 
Chapter III by measuring both FKBP5 genotype and FKBP5 methylation, but in genome-wide 
analyses the combination of both aspects is more complex and further increases the burden of 




randomization, genetic variants are used as instrumental variables32, 33. With genome-wide 
analyses becoming more ubiquitous, and polygenic risk scores thereby more readily available, 
these methods are gaining popularity, although limitations should be taken into account34. The 
ultimate approach to tackle issues of causality are intervention studies, preferably within the 
setting of randomized controlled trials. Such studies are pivotal in understanding the causal 
associations between stress and DNA methylation.
Future research
In order to fully understand how stress and DNA methylation are related during development, 
we will need to further address issues of power, tissue, and causality. Within our own field of 
epidemiology, more collaboration between different cohorts will help increase sample size 
and add to the reproducibility of our results. Carefully conducted data reduction approaches, 
that are mindful of increased type I error, can be applied to minimize the burden of multiple 
testing. As the number of sites measured at profiling platforms increases, most recently 
from the Illumina 450K to 850K array (Illumina Infinium HumanMethylation450 BeadChip 
to Infinium MethylationEPIC Beadchip; Illumina Inc., San Diego, USA), such approaches may 
become indispensable. Moreover, estimates of change and inter-individual variation might 
change with this new platform. The new platform includes more sites located at enhancer 
elements35, sites that in Chapter VIII more often had increasing DNA methylation over time 
with more inter-individual variation in change, thus this pattern may more often occur on 
the new platform. Longitudinal patterns will need to be readdressed, however, to establish 
whether this is the case.
In addition, more research is needed to learn to map out blood-brain associations of DNA 
methylation. Current online tools are valuable but based on small samples with data stemming 
from older individuals. Tissues from children would be necessary to understand how patterns 
of covariation change throughout development. The measurement of buccal cells may be a 
useful and accessible addition to that of blood36, since buccal and brain cells both originate 
from the mesodermal germ layer that develops during gastrulation, whereas blood cells 
originate from the ectodermal germ layer, thus variation in DNA methylation may be more 
coherent between buccal and brain cells, than between blood and brain cells.
Longitudinal measurements and mediation models will help to separate cause and effect in the 
study of DNA methylation and stress. Natural experiments, such as the current COVID-19 crisis, 
may offer epidemiological studies an even more effective approach to study directionality of 
effects. Assuming that the crisis increases stress, a study on perinatal stress and postnatal DNA 
methylation can be envisioned not unlike the one applied in the Dutch Hunger Winter studies37. 
For example, DNA methylation of children conceived at the beginning of the crisis could be 
compared to that of children conceived just after the crisis. However, to truly model stress 
as an independent factor, intervention studies with random group assignment are pivotal38.
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Lastly, in the current thesis, we have treated DNA methylation as an isolated player in the 
epigenetic machinery. Whereas data on DNA methylation is relatively easily obtainable and 
therefore often studied, DNA methylation interacts with other forms of epigenetics39-41. On 
a related note, the research fields of Genomics, Epigenomics, and Transcriptomics are by 
and large separate entities. Integration of different types of – omics data may come with 
statistical and computational challenges but is ultimately a necessary step in understanding 
the full picture of how genetics and the environment together are associated with stress in 
development.
Conclusions
In this thesis, we studied associations between stress and DNA methylation in the developing 
child. In the process of doing so, we developed a micro-coding system for facial expressions 
within an experiment on interpersonal stress and we detailed an epigenetic landscape of 
change by mapping out half a million longitudinal patterns of DNA methylation. Throughout 
our studies, we found associations between stress and DNA methylation, and indications that 
effect sizes are small. These results call for a continuation of research in the field of stress 
and DNA methylation, but we advise to do so thoughtfully. Large sample sizes are necessary, 
preferably within consortial efforts. Longitudinal studies will help the researcher understanding 
the pathways of effects, as will mediation analyses. We recommend an integration of –omics 
data on the one hand, and reductionist approaches on the other. Ultimately, this might 
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In research on the interaction between genes and the environment in psychosocial 
development of children, attention has turned towards epigenetics. ‘Epigenetics’ are 
the molecular structures on and around the DNA that regulate the expression of the 
DNA. Because it is believed that these epigenetic structures adapt to the environment 
in which one grows up, epigenetics has been lauded as the putative mechanism through 
which ‘nature affects nurture’. Such a mechanism could explain how early stressful 
experiences can have major emotional psychological consequences later in life. An often-
studied form of epigenetics is DNA methylation – a methyl group bound to the DNA 
sequence itself–since it is relatively easy to measure. However, research on DNA 
methylation is oftentimes limited by small sample sizes as well as cross-sectional study 
designs, which make it difficult to interpret research results within a developmental 
framework. In the current thesis, we therefore studied DNA methylation throughout 
development, in a large prospective population-based study of the Generation R Study in 
Rotterdam, in some cases supplemented by data from the prospective population-based 
Avon Longitudinal Study of Parent and Children (ALSPAC) in the United Kingdom. We 
studied associations between DNA methylation and stress in child development.
In Chapter II, we performed a literature study on DNA methylation and stress within the 
family environment to obtain an understanding of existing studies. We described that 
associations were found between parenting stress and DNA methylation, as well as 
between DNA methylation and child psychosocial outcomes in multiple studies. The 
designs of these studies were however often limited by small sample sizes and cross-
sectional designs. We further noted that little was known about stability and change in 
DNA methylation in development. In designing our own studies, we therefore set out to 
address these issues.
We studied early parent-child relations and DNA methylation in Generation R in Chapter III 
and IV, firstly focusing on a single gene, and secondly on a genome-wide level. In Chapter 
III, we selected FKBP5 as a candidate gene. This gene codes for a co-chaperone of the 
glucocorticoid receptor, which makes it important for stress regulation. We studied 
attachment behavior of the child towards the mother as well as reactivity of the stress 
hormone cortisol in the child, during the Strange Situation Procedure. We found that 
DNA methylation of FKBP5, together with FKBP5 genotype and attachment, was 
associated to cortisol reactivity in the child. In Chapter IV, we studied associations 
between observed maternal sensitivity towards the child and genome-wide DNA 
methylation. DNA methylation was studied at the site-level, as well as at the level of co-
localized correlating sites, i.e. the region level. No associations were found at site-level, 
but  DNA methylation  was associated to maternal sensitivity at  13  different regions,  4 of 
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which remained after adjustment for DNA methylation at birth. One of the top-regions 
was located at the DOCK4 gene, a gene involved in neuronal growth and migration and 
previously related to stress reactivity in mice.
We report on the association between sleep and DNA methylation in Chapter V. Sleep 
is related to diurnal cortisol fluctuations. We applied a network analysis to cluster genome-
wide DNA methylation and found a cluster encompassing MAPT and CRH1. MAPT is a gene 
coding for Tau protein, a protein often linked to Alzheimer’s disease; CRHR1 codes for 
corticotropin-releasing hormone, which is a key player in stress regulation.
Social stress was examined in studies presented in both Chapter VI and Chapter VII. In 
Chapter VI, we tested a new method for the micro-coding of facial expressions of 
emotions within a computerized social exclusion paradigm. We found that facial 
expressions of sadness and anger were associated to self-report on feelings during the 
game. We conclude that we have created a new measure of emotions during stress with 
good utility. In Chapter VII, we examined bullying exposure and epigenome-wide changes 
of DNA methylation in Generation R and ALSPAC. In this longitudinal study, we found an 
association between being bullied and changes in DNA methylation at a site located on 
RAB14. This gene is involved in Golgi apparatus functioning and has previously been 
associated to stress exposure in rats.
We joined forces again with ALSPAC in our last study in Chapter VIII, to address an 
important issue of validity within research on DNA methylation, which is to find out to what 
extent DNA methylation changes over time. We combined the longitudinal sets of DNA 
methylation of the two cohorts into one dataset with measurements from birth until late 
adolescence. We studied epigenome-wide change in DNA methylation, within and 
between individuals. We found that a little over half of all the methylation sites change, 
and that the rate of change was different for a little over a quarter of all sites. The website 
we developed to present our results can function as a stepping stone for other 
researchers, by placing findings on DNA methylation within a longitudinal perspective.
From this thesis, we conclude that associations between stress and DNA methylation in 
the developing child can be found. Such associations are small, which leads us to 






In onderzoek naar de interactie tussen genen en omgeving in de psychosociale ontwikkeling 
van het kind zijn de ogen vaak gericht op epigenetica. Met ‘epigenetica’ worden de moleculaire 
structuren op en rondom het DNA bedoeld, die de expressie van het DNA beïnvloeden. Omdat 
wordt gedacht dat deze epigenetische structuren zich aanpassen aan de omgeving waarin 
men opgroeit, wordt epigenetica gezien als een mogelijk mechanisme waardoor ‘nurture’ 
‘nature’ kan beïnvloeden. Zo’n mechanisme zou kunnen verklaren hoe vroege stressvolle 
ervaringen grote emotionele gevolgen kunnen hebben later in het leven. In onderzoek naar 
epigenetica wordt vooral gekeken naar DNA-methylering, een vorm van epigenetica waarbij 
een methylgroep is gebonden aan de DNA sequentie en die relatief makkelijk te meten is in 
het lab. Echter, onderzoek naar DNA-methylering werd in het verleden vaak gekenmerkt door 
kleine streekproeven en wordt vaak cross-sectioneel uitgevoerd, waardoor het moeilijk is om 
de resultaten in een ontwikkelingsperspectief te plaatsen. In de huidige studiereeks keken 
we daarom naar epigenetica tijdens de ontwikkeling van het kind, in de grote prospectieve 
populatiestudie van Generation R Study in Rotterdam, waar mogelijk aangevuld door data 
uit de prospectieve populatiestudie van de Avon Longitudinal Study of Parent and Children 
(ALSPAC) in het Verenigd Koninkrijk. We onderzochten associaties tussen DNA-methylering 
en stress in de ontwikkeling van het kind.
In Hoofdstuk II hebben we een literatuurstudie gedaan om een beeld te krijgen van bestaande 
literatuur aangaande DNA-methylering en stress in de familiesfeer. We beschreven dat 
verschillende studies associaties hebben laten zien tussen een stressvolle opvoeding en 
DNA-methylering en tussen DNA-methylering en psychosociale uitkomsten in het kind. Deze 
studies zijn echter vaak beperkt door kleine streekproeven en vaak alleen cross-sectioneel 
in opzet. We benoemden daarnaast dat er nog te weinig bekend was over de stabiliteit en 
verandering van DNA-methylering tijdens de ontwikkeling van het kind. In de opzet van onze 
eigen onderzoeken hebben we daarom geprobeerd deze kwesties te adresseren.
In Hoofdstuk III en IV hebben we onderzoek gedaan naar de vroege ouder-kindrelatie en DNA-
methylering in Generation R, in eerste instantie gericht op één enkel gen en in tweede instantie 
op het niveau van het hele genoom. In de studie beschreven in Hoofdstuk III richtten we ons 
op het FKBP5 gen, welke codeert voor een co-chaperone van de glucocorticoid receptor en 
daarmee belangrijk is voor de stressregulatie. We observeerden de gehechtheidsrelatie van 
het kind met de moeder en de reactiviteit van het stresshormoon cortisol in het kind tijdens 
de Strange Situation Procedure. We vonden dat DNA-methylering van FKBP5, samen met 
FKBP5 genotype en gehechtheidsrelatie, geassocieerd is met cortisolreactiviteit in het kind. In 
Hoofdstuk IV onderzochten we associaties tussen geobserveerde sensitiviteit van de moeder 
in de interactie met haar kind en genoomwijde DNA-methylering. Associaties werden zowel 
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per locatie (site bekeken als per regio, dat is een gebied met geassocieerde sites. We vonden 
geen associaties op site-niveau, maar wel 13 regio’s waar DNA-methylering geassocieerd 
is met sensitiviteit van de moeder, waarvan er vier overbleven na adjustering voor DNA-
methylering vlak na de geboorte. Eén van deze regio’s lag op het DOCK4 gen, een gen dat 
betrokken is bij neuronale groei en migratie en welke eerder geassocieerd is met 
stressreactiviteit in muizen.
In Hoofdstuk V onderzochten we de associatie tussen DNA-methylering en slaap. Slaap is 
gerelateerd aan cortisolfluctuaties over de dag heen. We pasten een netwerkanalyse 
toe om genoomwijde DNA-methylering te clusteren en vonden een cluster met onder 
andere MAPT en CRHR1. MAPT is een gen dat codeert voor het Tau eiwit en dat vaak 
geassocieerd wordt met Alzheimer; CRHR1 codeert voor corticotropine-releasing hormoon, 
een belangrijk hormoon voor de stressregulatie.
In de studies beschreven in Hoofdstuk VI en VII hebben we gekeken naar sociale stress. In 
Hoofdstuk VI testten we een nieuwe methode om emotionele expressies in het 
gezicht tijdens een gecomputeriseerd sociaal-exclusie paradigma minutieus te coderen. 
We vonden dat gezichtsuitdrukkingen van boosheid en verdriet samenhangen met de 
gevoelens die het kind zelf rapporteerde te hebben gehad tijdens de sociale exclusie. Hieruit 
concluderen we dat deze nieuwe codeermethode goed bruikbaar is om emoties tijdens 
sociale stress te meten. In Hoofdstuk VII hebben we op epigenoomwijd niveau gekeken of 
gepest worden samenhangt met verandering in DNA-methylering in Generation R en 
ALSPAC. In deze longitudinale studie konden we ‘gepest worden’ relateren aan verandering 
in DNA-methylering voor één site op RAB14. Dit gen is belangrijk voor het functioneren 
van het Golgi apparaat en is eerder in verband gebracht met blootstelling aan stress in 
knaagdieronderzoek.
In onze laatste studie, beschreven in Hoofdstuk VIII, hebben wederom de krachten 
van Generation R en ALSPAC gebundeld om een belangrijke valideitskwestie binnen het 
onderzoek naar DNA-methylering aan te kaarten, namelijk in hoeverre genoomwijde DNA-
methylering verandert over de tijd. We hebben de longitudinale DNA-methylering 
datasets van beide cohorten samengevoegd tot één set met metingen van de geboorte tot 
de late adolescentie. We onderzochten de epigenoom-wijde verandering in DNA-
methylering, waarbij we zowel verschillen binnen als tussen personen in beeld brachten. 
We vonden dat iets meer dan de helft van de methylatie sites veranderen over de tijd en 
dat voor iets meer dan een kwart van de sites de richting van verandering verschillend is 
voor verschillende personen. De website die we hebben ontwikkeld om deze resultaten te 
presenteren kan als springplank fungeren voor andere onderzoekers door bevindingen 




Uit deze  studiereeks  concluderen  we dat er associaties zijn tussen stress  en  DNA-
methylering in de ontwikkeling van het kind. Deze associaties zijn klein. Daarom 
raden we aan om onderzoek naar DNA-methylering uit te voeren in grote groepen en 
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Dit boekje had nooit tot stand kunnen komen zonder de helpende handen, waardevolle 
bijdragen en steunbetuigingen van velen. Allereerst wil ik de kinderen en ouders van Generation 
R bedanken. Jullie trouwe toewijding en openheid in eindeloze interviews en vragenlijsten 
maakt Generation R tot wat het is. Dan alle focusmedewerkers; de bezige bijen op het 
onderzoekscentrum die de boel binnen strakke tijdsschema’s draaiende houden, onder de 
geduldige supervisie van Ronald. En speciaal de dames van het gedragsblok–Anneke, Rukiye, 
Sabah, Ineke en later ook Yvette – veel dank voor jullie inzet, vooral ook met betrekking tot de 
afname van Cyberball. Michael, op het lab, dank je voor je werk aan de DNA methylatiedata 
en je uitleg. Datamanagement natuurlijk, Claudia, Marjolein, Annemiek en Eline, dank voor 
jullie hulp. Op de verschillende secretariaten in Rotterdam: Patricia, Erica, Laureen, Mireille, 
dank, dank, dank. In Leiden: Gea en Esther, dank voor de kletspraatjes en de flexibiliteit die 
af en toe nodig was door het schipperen tussen twee universiteiten. Ook de vele stagiaires 
die hebben geholpen in het ontwikkelen van een codeermethode van Cyberball en het 
coderen van de vele video’s wil ik graag bedanken: Luna, Jiske, Johan, Lisette, Burcu, Manouk, 
Eleni. Johan en Etiënne, jullie hebben een prachtig programma ontwikkeld waarmee we een 
immense hoeveelheid data snel konden coderen. Eleni, you pushed through the last videos 
and played a big part in finalizing the dataset.
Rien en Marian, terwijl jullie je in een onvoorzien moeilijke en slepende situatie bevonden 
heb ik me altijd gesteund gevoeld door jullie. Veel dank voor jullie toewijding. Henning, ook 
na jouw emigratie kon ik altijd rekenen op kritisch commentaar. Je daagt me uit en bent een 
leermeester waar menig onderzoeker jaloers op zou zijn. Dank voor je begeleiding.
Vanuit de afdeling Kinder- en Jeugdpsychiatrie en Psychologie wil ik graag ok Frank en Manon 
bedanken voor hun steun. Frank, ook bedankt voor je co-auteurschap.
De commissieleden, Pauline, wat fijn dat je secretaris wil zijn van mijn leescommissie, het is 
een eer. Professor Relton, Caroline, I learned so much at the IEU in Bristol and am honored 
that you agreed to be part of the reading committee. Professor Slagboom, hartelijk dank 
voor de tijd en moeite die u neemt om deel uit te maken van de leescommissie. Janine, de 
DNA-methylering data in Generation R staat of valt bij jouw inzet, ik ben daarom dankbaar 
dat je onderdeel wilt zijn van de oppositiecommissie. Daarnaast ben ik ontzettend blij dat ik 
mijn werk aan deze dataset mag voortzetten onder jouw supervisie. Professor Williams, the 
Cyberball paradigm has been an integral part of my PhD; I am honored that you agreed to be 
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a part of my opposition committee. Professor Franken, hartelijk dank dat u wilt plaatsnemen 
in de oppositiecommissie.
Naar werk gaan was altijd leuk, dankzij de gezellige collega’s van de Gedragsgroep. Koen, mijn 
Roffa-buddy, Pamela wil graag weer witte-chocolade-oreos eten met Sjoerd! Elize, ik vind 
het nog steeds een raar idee dat je niet meer op de afdeling werkt. Gelukkig hebben wij nog 
wat slaapprojecten lopen! Ivonne, met jou door Rotterdam racen in een klein Generation R 
autootje was de beste vervulling van de algemene taken. Drinken uit waterflesjes terwijl jij 
rijdt heb ik snel afgeleerd. Yllza, you are such a lovely person and obviously, I’ve been missing 
your chocolates a lot lately! Michiel, wat fijn om de promotieperikelen met jou te kunnen 
delen! Binnenkort zijn we allebei klaar! Clair, ons adoptiekind binnen de Gedragsgroep, 
jouw vrolijkheid en enthousiasme waren altijd een welkome afleiding. Gosia, die trip naar 
Barcelona komt eraan! Alex, I feel lucky to have been able to work with you. Your statistical 
insight (I know you think otherwise) has definitely elevated my work. Fadila, never have I met 
such a wonderfully chaotic person. I am happy our paths collided. Desi, I remember being 
placed next to you in our office when I just started, and eyeballing you to get an idea if we 
could be friends. That turned out pretty well. You made my time in Rotterdam so much more 
worthwhile, I cannot imagine how it would have been without you. Lorenza, starting as a 
master student and now fulfilling your own PhD-candidacy, thank you for your contribution, 
it really ties this thesis together. Ryan, is there a more reasonable person than you? I feel so 
lucky I get to learn all about neuroimaging from you. Jolien, beide zijn we in de afgelopen 
periode heen-en-weer gebounced tussen het EMC en Universiteit Leiden. Dank je voor je 
begeleiding. Charlotte, your work is inspiring and I was so happy that you came to Rotterdam, 
am thankful for your supervision, and delighted we get to continue to work together. A 
‘thank you’ to many others of the Behavioral group that make for such a wonderful working 
environment – I pray I didn’t miss anyone: Hanan, Andrea, Fernando, Monica (looking at 
brains has never been so fun), Tessa, Lisa, Elisabeth (it’s all about the pineal gland), Runyu, 
Deborah, Sander, Sara (the meta-analysis-queen), Louk, Annemarie, Mannan (and the Scottish 
egg with Watson and Crick), Cees, Novika, Lisanne, Lizzy, Tessa, Nienke (convergeren kun je 
leren), Isabel, Serena, Patricia, as well as all those that I’ve worked with before but have gone 
on to work in different places.
Twee daarvan toch even direct: Dafna en Andrea, nu alweer zo lang geleden, maar ontzettend 
fijn dat ik bij jullie terecht kon aan het begin van mijn PhD voor alle Leiden-Generation 
R gerelateerde vragen! Rens, ook jij bedankt voor je hulp bij het programmeren van het 
Cyberball paradigma. En niet te vergeten de vele andere collega’s in Leiden die mijn werkdagen 
opleukten. Katharina, met jou heb ik vele problemen beklommen, of het nou ging om Leidse 
perikelen, of om Italiaans rotsformaties. Renate, de kletspraatjes met jou waren altijd zeer 
welkom! Fenne, kamergenoot wiens bureau altijd geordender was dan dat van mij, dank 
voor je gezelschap. Chloë, je droge humor gebracht met zacht fluwelen Vlaamse tongval 
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is ongeëvenaard. Esther, met jou valt er altijd wat te lachen, op de afdeling, op congres in 
Austin, én tijdens het crossen over Texaanse achterwegen.
Then many thanks to the amazing team at ALSPAC: Esther, Lotte, Matt, Caroline, thank you 
for giving me the opportunity to learn so much. Matt, thank you for introducing me to the 
wonderful world of longitudinal modelling. Thank you for your supervision, and for all your 
help in setting up the EpiDelta website. Professor Gaunt, Tom, thank you as well for morphing 
something that was just a piece of code, into an actual website people can actually visit. Esther, 
your analytical eye has improved many of my analyses, and besides, you’re just a wonderful 
person. I feel lucky to be able to continue to work with you. Lotte, een klein stukje Nederland 
in Bristol, dank je voor al je hulp in de ‘Epi-‘ projecten en wat leuk dat ik nu af en toe een 
klein stukje Bristol tegen het lijf loop op consortium meetings in Nederland! Nancy, Charlie, 
Matt, Steph, Paul, Nour, and of course Jeroen, thank you for making me feel so welcome 
at the department. Nancy, Steph, Paul, can we go swimming in the woolly whatever again 
please? Tasha, partner in climb, thank you for showing me the best of Bristol. Giordano, the 
best housemate I could’ve wished for, can you play the guitar yet?
Dan alle co-auteurs die ik nog niet genoemd heb: Maartje, Vincent, Bas, dank voor de 
samenwerking en jullie waardevolle bijdragen aan de stukken in dit boekje. Andrew, thank 
you for your collaboration, thank you for your help in the nonlinear models.
Stefanie, Sabrina, Jentien, jullie vriendschap is me goud waard. Steef, jij wist gedurende deze 
PhD periode altijd haarfijn aan te voelen wanneer het weer eens tijd werd mij naar Amsterdam 
toe te halen. Sab, fantastisch mens dat je er bent, ook een afstand(je) voel ik me gesteund 
door jou. Jeanny, je bent een lieverd en ik ben blij dat ik af en toe even met je kon nerden over 
onderzoek. Roel, ook met jou is het heerlijk nerden. Indra, ons middagje scripten was super. 
Mickey, wat fijn dat jij en Juul weer in het land zijn, met jou is het altijd een feestje. Div, talking 
with you about everything and nothing is the best pastime there is. Especially when it is in 
a tree house in between the coconut-palms in Chitrapur. Benny-boy, you’re mostly far away 
but somehow you manage to keep me close. Counting seven cities in five countries. Where 
to next? Diana, I love how we went through the same PhD process from different places in 
the world. Un apapacho desde Holanda. Nellie, van onbevangen psychologiestudentjes naar 
verstandige volwassenen (of zoiets), dank voor al je steun en gezelligheid! Megan en Marg, 
vriendinnen van het eerste uur, dank voor jullie vriendschap, voor, tijdens en na deze PhD.
Papa en mama, dankzij jullie heb ik altijd geloofd in mijn eigen kunnen. Papa, jouw mogelijkheid 
om iets vanuit vele verschillende perspectieven te benaderen heeft mij altijd geïntrigeerd en 
inspireert me om altijd kritisch blijven. Mama, jouw nuchterheid en inzicht hebben mij juist 
geholpen om dingen vooral niet ingewikkelder te maken dan ze hoeven zijn. Lieve Nienke, 
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als er iemand is die me heeft laten zien dat je met een duidelijk doel en een goede dosis 
doorzettingsvermogen precies kunt bereiken wat je wilt, ben jij het wel.
Some things, like this thesis, take effort and patience. Other ‘things’, like you, Michalis, just 
sort of seem to appear. Thank you for your support through the last part of my PhD, thank 
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EPIGENETICS HAS BEEN LAUDED AS THE PUTATIVE MECHANISM THROUGH 
WHICH ‘NATURE AFFECTS NURTURE’. SUCH A MECHANISM COULD EXPLAIN 
HOW EARLY STRESSFUL EXPERIENCES CAN HAVE MAJOR PSYCHOLOGICAL 
CONSEQUENCES LATER IN LIFE.  AN OFTEN-STUDIED FORM OF EPIGENETICS IS 
DNA METHYLATION. HOWEVER, RESEARCH ON DNA METHYLATION IS TYPICALLY 
LIMITED BY SMALL SAMPLE SIZES AS WELL AS CROSS-SECTIONAL STUDY 
DESIGNS, WHICH MAKE IT DIFFICULT TO INTERPRET RESEARCH RESULTS WITHIN 
A DEVELOPMENTAL FRAMEWORK. IN THE CURRENT THESIS, WE THEREFORE 
STUDIED DNA METHYLATION AND STRESS THROUGHOUT CHILD DEVELOPMENT 
IN A POPULATION-BASED APPROACH.
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